[{"uuid": "0e52548c-2ac3-471f-83be-bb6b3cc2c162", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "12", "age_at_initial_pathologic_diagnosis": "74", "days_to_last_known_alive": "", "days_to_last_followup": "12", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Hormone Therapy", "name": "Dexamethasone", "start": "0", "end": null, "duration": "", "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "bc42345b-db99-4d94-882a-b0f18ecdda3e", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "36", "days_to_last_known_alive": "", "days_to_last_followup": "195", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "9aa5e36e-685a-4e4a-a5f8-ab6b27024544", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "38", "days_to_last_known_alive": "", "days_to_last_followup": "115", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Targeted Molecular therapy", "name": "Avastin", "start": "56", "end": "70", "duration": 14, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "35", "end": "67", "duration": 32, "dosis": null, "dosis_unit": "mg"}, {"type": "Hormone Therapy", "name": "Dexamethasone", "start": "0", "end": null, "duration": "", "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "35", "end": "76", "duration": 41, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "b5b3edf8-7f93-4bfb-bff2-67a804c375e4", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "845", "age_at_initial_pathologic_diagnosis": "38", "days_to_last_known_alive": "", "days_to_last_followup": "845", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "11698b96-d071-4da4-a88a-b551a44a9644", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "35", "age_at_initial_pathologic_diagnosis": "69", "days_to_last_known_alive": "", "days_to_last_followup": "35", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Hormone Therapy", "name": "Dexamethasone", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "9147993d-8f0b-4ea8-9aec-b9b2134f6451", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Glioblastoma Multiforme (GBM)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "30", "days_to_last_known_alive": "", "days_to_last_followup": "165", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 5, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "25", "end": "71", "duration": 46, "dosis": null, "dosis_unit": null}, {"type": null, "name": "Plexxikon PLX3397", "start": "25", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": null, "name": "Temozolomide", "start": "103", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Lomustine", "start": "209", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Procarbazine", "start": "209", "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "25", "end": "71", "duration": 46, "dosis": "60", "dosis_unit": "Gy"}]}, {"uuid": "7d1c6597-a438-449e-b690-a97386e53383", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "630", "age_at_initial_pathologic_diagnosis": "18", "days_to_last_known_alive": "", "days_to_last_followup": "630", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "20", "end": "145", "duration": 125, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "20", "end": "145", "duration": 125, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Carboplatin", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Iressa", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "20", "end": "61", "duration": 41, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "5c3bf419-dc0b-4b80-89aa-58bdaac9cc27", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "320", "age_at_initial_pathologic_diagnosis": "65", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 7, "drug_details": [{"type": "Chemotherapy", "name": "Gliadel Wafers", "start": "0", "end": "0", "duration": 0, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "14", "end": "110", "duration": 96, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "CCNU", "start": "110", "end": "155", "duration": 45, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "CCNU", "start": "155", "end": "210", "duration": 55, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "210", "end": "267", "duration": 57, "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "O6B6", "start": "281", "end": "283", "duration": 2, "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "O6B6", "start": "281", "end": "283", "duration": 2, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "14", "end": "75", "duration": 61, "dosis": null, "dosis_unit": null}]}, {"uuid": "9dce7079-a445-4767-8811-ca5f77e35100", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Glioblastoma Multiforme (GBM)", "days_to_death": "67", "age_at_initial_pathologic_diagnosis": "81", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "d31bdb80-250f-4245-a980-bebdb04f05b3", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "414", "age_at_initial_pathologic_diagnosis": "81", "days_to_last_known_alive": "", "days_to_last_followup": "414", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "353d1cc9-a47f-4bcb-9599-68afc0d6df7c", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "30", "age_at_initial_pathologic_diagnosis": "88", "days_to_last_known_alive": "", "days_to_last_followup": "30", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "8c1610fd-f16a-48d7-b739-99b4cafc3773", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "486", "age_at_initial_pathologic_diagnosis": "66", "days_to_last_known_alive": "", "days_to_last_followup": "364", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 5, "drug_details": [{"type": "Chemotherapy", "name": "Panzem", "start": "339", "end": "364", "duration": 25, "dosis": null, "dosis_unit": "mg"}, {"type": "Immunotherapy", "name": "ATTAC", "start": "126", "end": "317", "duration": 191, "dosis": null, "dosis_unit": "mL"}, {"type": "Chemotherapy", "name": "Temodor", "start": "105", "end": "317", "duration": 212, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temozolamide", "start": "339", "end": "364", "duration": 25, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temodor", "start": "38", "end": "79", "duration": 41, "dosis": null, "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "38", "end": "79", "duration": 41, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "b9024bf7-e171-4425-9896-3379c00bda8a", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "83", "days_to_last_known_alive": "", "days_to_last_followup": "262", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "42", "end": null, "duration": "", "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "42", "end": "73", "duration": 31, "dosis": "600", "dosis_unit": "cGy"}]}, {"uuid": "cb70db37-e4c6-4f6a-980c-2bbf661e685a", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "448", "age_at_initial_pathologic_diagnosis": "78", "days_to_last_known_alive": "", "days_to_last_followup": "448", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "0edd8235-4f70-4e48-b09b-3412ccd7ccb3", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "20", "age_at_initial_pathologic_diagnosis": "77", "days_to_last_known_alive": "", "days_to_last_followup": "13", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "d1b85f60-18dc-4cee-90c8-718c0f9d4573", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "235", "age_at_initial_pathologic_diagnosis": "69", "days_to_last_known_alive": "", "days_to_last_followup": "235", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "CCNU", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "41", "end": "100", "duration": 59, "dosis": null, "dosis_unit": null}]}, {"uuid": "af9ddf59-f721-4860-b6fa-c7dea78feb4a", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "434", "age_at_initial_pathologic_diagnosis": "61", "days_to_last_known_alive": "", "days_to_last_followup": "434", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "34", "end": "84", "duration": 50, "dosis": "120", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "129", "end": "270", "duration": 141, "dosis": "260", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "34", "end": "84", "duration": 50, "dosis": "6100", "dosis_unit": "cGy"}]}, {"uuid": "0ce41e74-20a8-42e8-92a3-2906402335c7", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Glioblastoma Multiforme (GBM)", "days_to_death": "324", "age_at_initial_pathologic_diagnosis": "52", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 4, "drug_details": [{"type": null, "name": "Oxaliplatin", "start": "31", "end": "31", "duration": 0, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "122", "end": "153", "duration": 31, "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "Accutane", "start": "122", "end": "153", "duration": 31, "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "Gleevec", "start": "184", "end": "214", "duration": 30, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "47", "end": "103", "duration": 56, "dosis": "6040", "dosis_unit": "cGy"}]}, {"uuid": "27f146d4-4e30-4aa7-ad8c-388261b48cd9", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "28", "days_to_last_known_alive": "", "days_to_last_followup": "128", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "44", "end": null, "duration": "", "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temozolomode", "start": "35", "end": "76", "duration": 41, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temozolomode", "start": "105", "end": "433", "duration": 328, "dosis": null, "dosis_unit": null}], "qty_radiation": 2, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "35", "end": "74", "duration": 39, "dosis": "6000", "dosis_unit": "cGy"}, {"type": "EXTERNAL BEAM", "start": "35", "end": "74", "duration": 39, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "e09a708b-2dd1-4c3c-933a-c25eccfcc5f5", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "333", "age_at_initial_pathologic_diagnosis": "46", "days_to_last_known_alive": "", "days_to_last_followup": "333", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 12, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "26", "end": "72", "duration": 46, "dosis": "75", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "91", "end": "148", "duration": 57, "dosis": "200", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "239", "end": "307", "duration": 68, "dosis": "10", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "91", "end": "148", "duration": 57, "dosis": "10", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "152", "end": "239", "duration": 87, "dosis": "200", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "26", "end": "72", "duration": 46, "dosis": "10", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Tarceva", "start": "239", "end": "307", "duration": 68, "dosis": "200", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "148", "end": "239", "duration": 91, "dosis": "10", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "307", "end": "333", "duration": 26, "dosis": "10", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "CPT 11", "start": "91", "end": "148", "duration": 57, "dosis": "340", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "CPT 11", "start": "152", "end": "239", "duration": 87, "dosis": "125", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "VP 16", "start": "307", "end": "333", "duration": 26, "dosis": "50", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "26", "end": "72", "duration": 46, "dosis": "5940", "dosis_unit": "cGy"}]}, {"uuid": "6159657e-74f4-4815-88ef-191b91de9d7d", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "22", "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": "", "days_to_last_followup": "9", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "3a632819-6217-4c0b-881c-b58e031d69c1", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "468", "age_at_initial_pathologic_diagnosis": "76", "days_to_last_known_alive": "", "days_to_last_followup": "352", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Immunotherapy", "name": "IL-13 with Pseudomonas exotoxin", "start": "130", "end": "134", "duration": 4, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "45", "end": "93", "duration": 48, "dosis": "5940", "dosis_unit": "cGy"}]}, {"uuid": "80ea6f7b-68ab-40dc-bb02-25c08ec71487", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "646", "age_at_initial_pathologic_diagnosis": "57", "days_to_last_known_alive": "", "days_to_last_followup": "556", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "34", "end": "76", "duration": 42, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "82805728-00e4-4bba-87a1-8e76fc65bdd0", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "442", "age_at_initial_pathologic_diagnosis": "34", "days_to_last_known_alive": "", "days_to_last_followup": "357", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 6, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "46", "end": "87", "duration": 41, "dosis": "75", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "128", "end": "224", "duration": 96, "dosis": "150", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "316", "end": "371", "duration": 55, "dosis": "10", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Angiocept", "start": "287", "end": "315", "duration": 28, "dosis": "2", "dosis_unit": "mg"}, {"type": "Immunotherapy", "name": "Daclizumab", "start": "128", "end": "224", "duration": 96, "dosis": "1", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "VP 16", "start": "316", "end": "371", "duration": 55, "dosis": "50", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "46", "end": "87", "duration": 41, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "3ad2ea1d-3430-4c7a-ae6d-a259d7e0097e", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "53", "days_to_last_known_alive": "", "days_to_last_followup": "470", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "51", "end": "92", "duration": 41, "dosis": "75", "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temodar", "start": "93", "end": "186", "duration": 93, "dosis": "150", "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "51", "end": "92", "duration": 41, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "1de94661-6810-4060-ad90-60b1e0e7361a", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "256", "age_at_initial_pathologic_diagnosis": "58", "days_to_last_known_alive": "", "days_to_last_followup": "195", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "112", "end": "174", "duration": 62, "dosis": null, "dosis_unit": "mg/m2/day"}, {"type": "Chemotherapy", "name": "Temodar", "start": "6", "end": "76", "duration": 70, "dosis": null, "dosis_unit": null}], "qty_radiation": 2, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "12", "end": "76", "duration": 64, "dosis": "6000", "dosis_unit": "cGy"}, {"type": "OTHER", "start": "192", "end": "196", "duration": 4, "dosis": "4545", "dosis_unit": "cGy"}]}, {"uuid": "0c6a82e9-f239-45cc-8909-b1447cda8f6d", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "82", "age_at_initial_pathologic_diagnosis": "78", "days_to_last_known_alive": "", "days_to_last_followup": "82", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "9", "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "9", "end": null, "duration": "", "dosis": null, "dosis_unit": "cGy"}]}, {"uuid": "52dcad1e-7ba9-4331-9e25-b1a64911f416", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "232", "age_at_initial_pathologic_diagnosis": "76", "days_to_last_known_alive": "", "days_to_last_followup": "119", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "21", "end": "65", "duration": 44, "dosis": "5940", "dosis_unit": "cGy"}]}, {"uuid": "a6cf6609-75d4-4b76-8bb6-9e9cb558de0b", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "54", "days_to_last_known_alive": "", "days_to_last_followup": "226", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 6, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "89", "end": "209", "duration": 120, "dosis": null, "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "242", "end": "323", "duration": 81, "dosis": "10", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "301", "end": "331", "duration": 30, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Targeted Molecular therapy", "name": "Bevacizumab", "start": "242", "end": "323", "duration": 81, "dosis": "10", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Irinotecan", "start": "246", "end": "288", "duration": 42, "dosis": "125", "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Doxil", "start": "445", "end": "546", "duration": 101, "dosis": "30", "dosis_unit": "mg/m2"}], "qty_radiation": 2, "radiation_details": [{"type": "OTHER", "start": "51", "end": "51", "duration": 0, "dosis": "1200", "dosis_unit": "cGy"}, {"type": "EXTERNAL BEAM", "start": "16", "end": "57", "duration": 41, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "db88fdf8-4264-492f-91a1-ae17cc4c268f", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "62", "age_at_initial_pathologic_diagnosis": "67", "days_to_last_known_alive": "", "days_to_last_followup": "62", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Hormone Therapy", "name": "Dexamethasone", "start": "0", "end": "15", "duration": 15, "dosis": null, "dosis_unit": "mg/day"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "071c0225-8ddd-4a6f-a9fc-f4469a62a365", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "167", "age_at_initial_pathologic_diagnosis": "53", "days_to_last_known_alive": "", "days_to_last_followup": "167", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "6e7c3ddd-d07a-4802-87c6-1e363a6b2e26", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "372", "age_at_initial_pathologic_diagnosis": "63", "days_to_last_known_alive": "", "days_to_last_followup": "372", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "117", "end": "122", "duration": 5, "dosis": "200", "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temodar", "start": "18", "end": "59", "duration": 41, "dosis": "160", "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "19", "end": "61", "duration": 42, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "71c190ff-f3af-448d-b29a-6ef6f7f69e90", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "291", "age_at_initial_pathologic_diagnosis": "56", "days_to_last_known_alive": "", "days_to_last_followup": "245", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Carmustine", "start": "137", "end": "258", "duration": 121, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Taxol", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "9AC 9 Aminocamplotecian", "start": "106", "end": "137", "duration": 31, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": "cGy"}]}, {"uuid": "37dd87f8-3207-4bf5-8fee-b12301a11a48", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "298", "age_at_initial_pathologic_diagnosis": "46", "days_to_last_known_alive": "", "days_to_last_followup": "231", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": null, "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Targeted Molecular therapy", "name": "Thalidomide", "start": "38", "end": "93", "duration": 55, "dosis": null, "dosis_unit": "mg/day"}, {"type": "Chemotherapy", "name": "Temodar", "start": "38", "end": "93", "duration": 55, "dosis": null, "dosis_unit": "mg/m2/day"}, {"type": "Chemotherapy", "name": "BCNU", "start": "105", "end": "183", "duration": 78, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Fenretinide", "start": "231", "end": "259", "duration": 28, "dosis": null, "dosis_unit": "mg/day"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "38", "end": "85", "duration": 47, "dosis": "5940", "dosis_unit": "cGy"}]}, {"uuid": "8367532f-3f04-4ede-a896-53c9a3f33e38", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "119", "age_at_initial_pathologic_diagnosis": "85", "days_to_last_known_alive": "", "days_to_last_followup": "119", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "6859317f-0d10-46d2-ba5e-c9e8f351e083", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "48", "days_to_last_known_alive": "", "days_to_last_followup": "184", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "115", "end": null, "duration": "", "dosis": "320", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "27", "end": "71", "duration": 44, "dosis": "160", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "temodar", "start": "202", "end": "289", "duration": 87, "dosis": "400", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "OTHER", "start": "27", "end": "71", "duration": 44, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "a05e1c0b-b7fa-4e9e-a95c-f3bbc479680b", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "110", "age_at_initial_pathologic_diagnosis": "74", "days_to_last_known_alive": "", "days_to_last_followup": "110", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "c5ce6c77-c44e-4d4a-bed5-fff2f8c54687", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "598", "age_at_initial_pathologic_diagnosis": "59", "days_to_last_known_alive": "", "days_to_last_followup": "579", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "28", "end": "76", "duration": 48, "dosis": "75", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "136", "end": "458", "duration": 322, "dosis": "200", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Carmustine", "start": "488", "end": "519", "duration": 31, "dosis": "200", "dosis_unit": "mg"}], "qty_radiation": 2, "radiation_details": [{"type": "OTHER", "start": "537", "end": "537", "duration": 0, "dosis": "1800", "dosis_unit": "cGy"}, {"type": "EXTERNAL BEAM", "start": "28", "end": "76", "duration": 48, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "52aa47bf-a789-4682-b2d8-416615d7a857", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "58", "days_to_last_known_alive": "", "days_to_last_followup": "436", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "98", "end": "103", "duration": 5, "dosis": "150", "dosis_unit": "mg/day"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "222", "end": null, "duration": "", "dosis": "10", "dosis_unit": "mg/kg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "38", "end": "80", "duration": 42, "dosis": "150", "dosis_unit": "mg/day"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "38", "end": "80", "duration": 42, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "2e8edb78-23c7-4cfb-a2c3-ec4e8433de02", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "2512", "age_at_initial_pathologic_diagnosis": "25", "days_to_last_known_alive": "", "days_to_last_followup": "2512", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Anti necplatens", "start": "2349", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temozolomide", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "2310", "end": "2347", "duration": 37, "dosis": "3600", "dosis_unit": "cGy"}]}, {"uuid": "c6a27bd1-904e-4caa-9b7f-5e5aeaaa6801", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "82", "age_at_initial_pathologic_diagnosis": "50", "days_to_last_known_alive": "", "days_to_last_followup": "66", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "ec635f99-f0cd-4813-b0b5-240f0e4e9771", "tumor_tissue_site": null, "pathologic_stage": "", "histological_type": null, "days_to_death": null, "age_at_initial_pathologic_diagnosis": null, "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": null, "ethnicity": null, "race": null, "vital_status": null, "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "046cd63a-cdfc-42ec-b2ae-8938b6c16886", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "454", "age_at_initial_pathologic_diagnosis": "74", "days_to_last_known_alive": "", "days_to_last_followup": "330", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 5, "drug_details": [{"type": "Targeted Molecular therapy", "name": null, "start": "275", "end": "330", "duration": 55, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "VP16", "start": "293", "end": "330", "duration": 37, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "BCNU", "start": "161", "end": "193", "duration": 32, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "216", "end": "274", "duration": 58, "dosis": null, "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Marimastat", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": "mg/day"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "32", "end": "79", "duration": 47, "dosis": "6600", "dosis_unit": "cGy"}]}, {"uuid": "f225e19b-5296-4c3f-ba25-18cbd605e83d", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "819", "age_at_initial_pathologic_diagnosis": "61", "days_to_last_known_alive": "", "days_to_last_followup": "784", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 8, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "738", "end": "784", "duration": 46, "dosis": "50", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "126", "end": "452", "duration": 326, "dosis": "100", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "CPT 11", "start": "508", "end": "731", "duration": 223, "dosis": "125", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Vp 16", "start": "738", "end": "784", "duration": 46, "dosis": "50", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "738", "end": "784", "duration": 46, "dosis": "10", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "14", "end": "67", "duration": 53, "dosis": "75", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "508", "end": "731", "duration": 223, "dosis": "10", "dosis_unit": "mg"}, {"type": "Immunotherapy", "name": "PEP3 KLH", "start": "83", "end": "452", "duration": 369, "dosis": "500", "dosis_unit": "ug"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "14", "end": "67", "duration": 53, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "ba8a1558-cf49-46c2-98f4-2f93e6d84448", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "133", "age_at_initial_pathologic_diagnosis": "77", "days_to_last_known_alive": "", "days_to_last_followup": "133", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "b436e084-d459-40a9-a91d-70371e0986c6", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Glioblastoma Multiforme (GBM)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "54", "days_to_last_known_alive": "", "days_to_last_followup": "449", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "36", "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": null, "start": "79", "end": "79", "duration": 0, "dosis": null, "dosis_unit": null}]}, {"uuid": "0e0501bb-40a2-4367-8b2d-5407e659c586", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "330", "age_at_initial_pathologic_diagnosis": "73", "days_to_last_known_alive": "", "days_to_last_followup": "330", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "31", "end": "70", "duration": 39, "dosis": "140", "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temodar", "start": "88", "end": "245", "duration": 157, "dosis": "380", "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "31", "end": "70", "duration": 39, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "eec132ce-4b21-4fc1-9c6c-d913b3c92654", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "53", "days_to_last_known_alive": "", "days_to_last_followup": "432", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 6, "qty_drugs": 7, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "20", "end": null, "duration": "", "dosis": "1750", "dosis_unit": "mg/m2/day"}, {"type": "Chemotherapy", "name": "Temodar", "start": "20", "end": null, "duration": "", "dosis": "1750", "dosis_unit": "mg/m2/day"}, {"type": "Chemotherapy", "name": "CPT 11", "start": "262", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Avastin", "start": "262", "end": null, "duration": "", "dosis": "10", "dosis_unit": "mg/kg"}, {"type": "Chemotherapy", "name": "Avastin", "start": "262", "end": null, "duration": "", "dosis": "10", "dosis_unit": "mg/kg"}, {"type": "Chemotherapy", "name": "CPT 11", "start": "262", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temodar", "start": "20", "end": "62", "duration": 42, "dosis": null, "dosis_unit": null}], "qty_radiation": 5, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "20", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "EXTERNAL BEAM", "start": "20", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "OTHER", "start": "324", "end": "324", "duration": 0, "dosis": "1600", "dosis_unit": "cGy"}, {"type": null, "start": "324", "end": "324", "duration": 0, "dosis": "1600", "dosis_unit": "cGy"}, {"type": "External", "start": "20", "end": "67", "duration": 47, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "fcbdc671-aef3-4766-9ec4-9d35c70327ca", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "406", "age_at_initial_pathologic_diagnosis": "67", "days_to_last_known_alive": "", "days_to_last_followup": "406", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Bevacizumab", "start": "133", "end": "351", "duration": 218, "dosis": "1200", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Temodar", "start": "34", "end": "76", "duration": 42, "dosis": "180", "dosis_unit": "mg"}], "qty_radiation": 2, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "34", "end": "76", "duration": 42, "dosis": "5040", "dosis_unit": "cGy"}, {"type": "OTHER", "start": "78", "end": "80", "duration": 2, "dosis": "1800", "dosis_unit": "cGy"}]}, {"uuid": "acd752f5-e680-44f0-8b07-baf85fe6b933", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "102", "age_at_initial_pathologic_diagnosis": "67", "days_to_last_known_alive": "", "days_to_last_followup": "102", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "ea23f615-d34a-4255-aaa9-c7476311f48b", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "30", "days_to_last_known_alive": "", "days_to_last_followup": "165", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 8, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "160", "end": null, "duration": "", "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "17", "end": "60", "duration": 43, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "113", "end": "205", "duration": 92, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "236", "end": "403", "duration": 167, "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "Bevacizumab", "start": "236", "end": "403", "duration": 167, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Irinotecan", "start": "447", "end": "487", "duration": 40, "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "Bevacizumab", "start": "447", "end": "502", "duration": 55, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Carboplatin", "start": "502", "end": "502", "duration": 0, "dosis": null, "dosis_unit": null}], "qty_radiation": 3, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "17", "end": "60", "duration": 43, "dosis": "6000", "dosis_unit": null}, {"type": "OTHER", "start": "411", "end": "418", "duration": 7, "dosis": "3200", "dosis_unit": "cGy"}, {"type": "EXTERNAL BEAM", "start": "17", "end": "60", "duration": 43, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "05600959-4bf8-4f28-a781-77958b94ee19", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "65", "days_to_last_known_alive": "", "days_to_last_followup": "131", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": null, "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "27", "end": "47", "duration": 20, "dosis": "4000", "dosis_unit": "cGy"}]}, {"uuid": "f1e843a1-f979-4e66-bcc1-5a38a4fc2e9c", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "469", "age_at_initial_pathologic_diagnosis": "55", "days_to_last_known_alive": "", "days_to_last_followup": "454", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "45439a59-99b4-4d21-8a58-0b90f5aa7be8", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "256", "age_at_initial_pathologic_diagnosis": "69", "days_to_last_known_alive": "", "days_to_last_followup": "132", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Hydroxyurea", "start": "20", "end": "68", "duration": 48, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "20", "end": "68", "duration": 48, "dosis": "5940", "dosis_unit": "cGy"}]}, {"uuid": "a06e845e-8405-4672-baa3-74f8f6d69aa7", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "486", "age_at_initial_pathologic_diagnosis": "52", "days_to_last_known_alive": "", "days_to_last_followup": "486", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": null, "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "37", "end": "341", "duration": 304, "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "OS1-774", "start": "370", "end": "402", "duration": 32, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temodar", "start": "6", "end": "39", "duration": 33, "dosis": null, "dosis_unit": "mg/m2/day"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "6", "end": "39", "duration": 33, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "5f93a196-3c08-4851-8353-eb5408a9ee64", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "883", "age_at_initial_pathologic_diagnosis": "49", "days_to_last_known_alive": "", "days_to_last_followup": "883", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 2, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "53", "end": "64", "duration": 11, "dosis": "1200", "dosis_unit": "cGy"}, {"type": "EXTERNAL BEAM", "start": "22", "end": "54", "duration": 32, "dosis": "4600", "dosis_unit": "cGy"}]}, {"uuid": "eb41dc18-d249-41fe-844e-a9ad591ed921", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "50", "days_to_last_known_alive": "", "days_to_last_followup": "181", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}]}, {"uuid": "0bb6d899-dbbc-4598-bb17-dfec4ed5952e", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "3", "age_at_initial_pathologic_diagnosis": "69", "days_to_last_known_alive": "", "days_to_last_followup": "3", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "3f0b8856-bd88-4a78-9555-44e96236f6f6", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "1024", "age_at_initial_pathologic_diagnosis": "30", "days_to_last_known_alive": "", "days_to_last_followup": "989", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "14", "end": "120", "duration": 106, "dosis": null, "dosis_unit": null}, {"type": "Immunotherapy", "name": "IL-13PE", "start": "183", "end": "238", "duration": 55, "dosis": null, "dosis_unit": "mL"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "14", "end": "53", "duration": 39, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "bd7f8288-5e66-4449-95c5-158bbc1e8cf7", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "47", "age_at_initial_pathologic_diagnosis": "52", "days_to_last_known_alive": "", "days_to_last_followup": "47", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "15", "end": null, "duration": "", "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "16", "end": "43", "duration": 27, "dosis": "4000", "dosis_unit": "cGy"}]}, {"uuid": "ff9ca5ad-8457-4bd0-b698-ddead72f1c81", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "123", "age_at_initial_pathologic_diagnosis": "75", "days_to_last_known_alive": "", "days_to_last_followup": "109", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "18", "end": "75", "duration": 57, "dosis": null, "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "18", "end": "75", "duration": 57, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "820c6f61-4231-4f93-b6e7-d88eda8f3e6f", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "690", "age_at_initial_pathologic_diagnosis": "62", "days_to_last_known_alive": "", "days_to_last_followup": "690", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Targeted Molecular therapy", "name": "Thalidomide", "start": "34", "end": "483", "duration": 449, "dosis": null, "dosis_unit": "mg/day"}, {"type": "Chemotherapy", "name": "Temodor", "start": "34", "end": "75", "duration": 41, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "34", "end": "75", "duration": 41, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "9dc74866-947d-4d79-a077-f049dbf934cb", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "67", "days_to_last_known_alive": "", "days_to_last_followup": "319", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 6, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temodar", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": null, "name": "Temodar", "start": "138", "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 3, "radiation_details": [{"type": "EXTERNAL BEAM", "start": null, "end": null, "duration": "", "dosis": "6000", "dosis_unit": "cGy"}, {"type": "EXTERNAL BEAM", "start": null, "end": null, "duration": "", "dosis": "6000", "dosis_unit": "cGy"}, {"type": "External", "start": null, "end": null, "duration": "", "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "110e01b7-6f8f-4d2c-9615-54be525c57bb", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "801", "age_at_initial_pathologic_diagnosis": "55", "days_to_last_known_alive": "", "days_to_last_followup": "801", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Hormone Therapy", "name": "Dexamethasone", "start": "0", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temodar", "start": "21", "end": "325", "duration": 304, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "31", "end": "70", "duration": 39, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "9ba4f981-7c29-4b79-b4e3-e80e26d733e1", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "460", "age_at_initial_pathologic_diagnosis": "49", "days_to_last_known_alive": "", "days_to_last_followup": "460", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Gliadel", "start": "207", "end": null, "duration": "", "dosis": null, "dosis_unit": "{Wafer}"}, {"type": "Hormone Therapy", "name": "Dexamethasone", "start": "0", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temador", "start": "371", "end": "376", "duration": 5, "dosis": null, "dosis_unit": "mg"}, {"type": "Hormone Therapy", "name": "Dexamethasone", "start": "128", "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "58", "end": "102", "duration": 44, "dosis": "5940", "dosis_unit": "cGy"}]}, {"uuid": "5fa7a6a4-532d-4901-be77-ee879f2ca38e", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "369", "age_at_initial_pathologic_diagnosis": "63", "days_to_last_known_alive": "", "days_to_last_followup": "186", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "117", "end": "159", "duration": 42, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temodar", "start": "159", "end": "186", "duration": 27, "dosis": null, "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "46", "end": "78", "duration": 32, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "4fe64e21-865e-4527-ac77-0f1749e67942", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "72", "days_to_last_known_alive": "", "days_to_last_followup": "271", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 5, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "98", "end": "271", "duration": 173, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "17", "end": "60", "duration": 43, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "112", "end": "416", "duration": 304, "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "Bevacizumab", "start": "462", "end": "1146", "duration": 684, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Irintocean", "start": "462", "end": "560", "duration": 98, "dosis": null, "dosis_unit": null}], "qty_radiation": 2, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "17", "end": "60", "duration": 43, "dosis": "6000", "dosis_unit": null}, {"type": "OTHER", "start": "446", "end": "446", "duration": 0, "dosis": "2000", "dosis_unit": "cGy"}]}, {"uuid": "8b2f7237-2dc8-43a6-9344-6042e4496780", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "23", "days_to_last_known_alive": "", "days_to_last_followup": "204", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "99", "end": null, "duration": "", "dosis": "150", "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "36", "end": "77", "duration": 41, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "a48fdc30-d277-4230-a33a-9557fbf7883b", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "150", "age_at_initial_pathologic_diagnosis": "83", "days_to_last_known_alive": "", "days_to_last_followup": "150", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "28", "end": "49", "duration": 21, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "OTHER", "start": "28", "end": "49", "duration": 21, "dosis": "45", "dosis_unit": "cGy"}]}, {"uuid": "6e1ec2a9-3e35-4f89-92a9-e5c35a56487b", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "1161", "age_at_initial_pathologic_diagnosis": "51", "days_to_last_known_alive": "", "days_to_last_followup": "1161", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 17, "drug_details": [{"type": "Chemotherapy", "name": "Gliadel Wafers", "start": "876", "end": "876", "duration": 0, "dosis": null, "dosis_unit": "{Wafer}"}, {"type": "Chemotherapy", "name": "Cytoxan", "start": "1041", "end": "1070", "duration": 29, "dosis": null, "dosis_unit": "mg"}, {"type": "Hormone Therapy", "name": "Tamoxifen", "start": "473", "end": "600", "duration": 127, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "VP-16", "start": "224", "end": "278", "duration": 54, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "VP-16", "start": "1041", "end": "1070", "duration": 29, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "CCNU", "start": "120", "end": "221", "duration": 101, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "CCNU", "start": "340", "end": "417", "duration": 77, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "VP-16", "start": "417", "end": "473", "duration": 56, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Hormone Therapy", "name": "Tamoxiten", "start": "278", "end": "334", "duration": 56, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "600", "end": "604", "duration": 4, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "CPT-11", "start": "889", "end": "1028", "duration": 139, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temodar", "start": "627", "end": "844", "duration": 217, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Targeted Molecular therapy", "name": "06GB", "start": "1133", "end": "1135", "duration": 2, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Targeted Molecular therapy", "name": "06GB", "start": "1133", "end": "1135", "duration": 2, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temodar", "start": "1133", "end": "1137", "duration": 4, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Immunotherapy", "name": "Celbrex", "start": "1113", "end": "1161", "duration": 48, "dosis": null, "dosis_unit": "mg"}, {"type": "Immunotherapy", "name": "Thalidomide", "start": "1073", "end": "1090", "duration": 17, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "47", "end": "88", "duration": 41, "dosis": "5800", "dosis_unit": "cGy"}]}, {"uuid": "7d08fc95-6581-4640-a56a-8b6187634ba1", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Treated primary GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "43", "days_to_last_known_alive": "", "days_to_last_followup": "2818", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "1930", "end": "2628", "duration": 698, "dosis": null, "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "286", "end": "333", "duration": 47, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "fe09f10e-a578-4231-8677-e869a07bdfb0", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "754", "age_at_initial_pathologic_diagnosis": "49", "days_to_last_known_alive": "", "days_to_last_followup": "754", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 7, "drug_details": [{"type": "Chemotherapy", "name": "Procarbazine", "start": "505", "end": "624", "duration": 119, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "BCNU", "start": "258", "end": "376", "duration": 118, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Carboplatin", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Topotecan", "start": "442", "end": "495", "duration": 53, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Targeted Molecular therapy", "name": "mu81c6", "start": "6", "end": "180", "duration": 174, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "BCNU", "start": "376", "end": "442", "duration": 66, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Targeted Molecular therapy", "name": "MAB I 131", "start": "6", "end": "180", "duration": 174, "dosis": null, "dosis_unit": "mCi"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "180", "end": "219", "duration": 39, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "e84b683f-0615-4ae4-87f0-0cfaa09733cc", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "282", "age_at_initial_pathologic_diagnosis": "61", "days_to_last_known_alive": "", "days_to_last_followup": "282", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "12320864-d16f-4259-983f-b1beb5b1776e", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "498", "age_at_initial_pathologic_diagnosis": "52", "days_to_last_known_alive": "", "days_to_last_followup": "496", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 2, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "476", "end": "489", "duration": 13, "dosis": "1200", "dosis_unit": "cGy"}, {"type": "EXTERNAL BEAM", "start": "20", "end": "66", "duration": 46, "dosis": "6020", "dosis_unit": "cGy"}]}, {"uuid": "7a08e37f-55e1-4181-ba50-6e08848e59df", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Treated primary GBM", "days_to_death": "537", "age_at_initial_pathologic_diagnosis": "56", "days_to_last_known_alive": "", "days_to_last_followup": "537", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "100", "end": "130", "duration": 30, "dosis": null, "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "55", "end": "103", "duration": 48, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "252d4814-d854-4651-98bb-269b6a3f2f12", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "254", "age_at_initial_pathologic_diagnosis": "64", "days_to_last_known_alive": "", "days_to_last_followup": "254", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": null, "end": null, "duration": "", "dosis": "250", "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "7de29aa4-17ef-40a6-9db2-bcda159fc94d", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "425", "age_at_initial_pathologic_diagnosis": "69", "days_to_last_known_alive": "", "days_to_last_followup": "322", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "105", "end": "132", "duration": 27, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "28", "end": "69", "duration": 41, "dosis": null, "dosis_unit": "mg/day"}, {"type": "Immunotherapy", "name": "Tarceva", "start": "28", "end": "69", "duration": 41, "dosis": null, "dosis_unit": "mg"}, {"type": "Immunotherapy", "name": "Tarceva", "start": "105", "end": "132", "duration": 27, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "28", "end": "69", "duration": 41, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "27ea0b76-7605-4def-9d89-33f63d5690c8", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "100", "age_at_initial_pathologic_diagnosis": "74", "days_to_last_known_alive": "", "days_to_last_followup": "100", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": null, "end": "75", "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "39", "end": "75", "duration": 36, "dosis": "52.0", "dosis_unit": null}]}, {"uuid": "6cc5a361-60b7-4f40-9da7-b40a3b9e7ab7", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "202", "age_at_initial_pathologic_diagnosis": "47", "days_to_last_known_alive": "", "days_to_last_followup": "202", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "34", "end": "42", "duration": 8, "dosis": "1750", "dosis_unit": "cGy"}]}, {"uuid": "5fa853ae-658e-4fdb-bb78-644d674c911d", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "48", "days_to_last_known_alive": "", "days_to_last_followup": "316", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 5, "drug_details": [{"type": "Chemotherapy", "name": "Fotemustine", "start": "302", "end": null, "duration": "", "dosis": "130", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "133", "end": "259", "duration": 126, "dosis": "300", "dosis_unit": "mg"}, {"type": "Hormone Therapy", "name": "Levetiracetam", "start": "-10", "end": null, "duration": "", "dosis": "1500", "dosis_unit": "mg"}, {"type": "Hormone Therapy", "name": "Dexamethasone", "start": "-10", "end": null, "duration": "", "dosis": "16", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "49", "end": "95", "duration": 46, "dosis": "140", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "49", "end": "95", "duration": 46, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "54c3d4bc-9ee2-4d47-bc68-7a7b254af0b0", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "67", "days_to_last_known_alive": "", "days_to_last_followup": "224", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 8, "qty_drugs": 3, "drug_details": [{"type": "Targeted Molecular therapy", "name": "Bevacizumab or placebo RTOG 0825", "start": "49", "end": "133", "duration": 84, "dosis": "10", "dosis_unit": "mg/kg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "26", "end": "68", "duration": 42, "dosis": null, "dosis_unit": "mg/day"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "110", "end": "114", "duration": 4, "dosis": null, "dosis_unit": "mg/day"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "26", "end": "68", "duration": 42, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "8d2c3361-bd4f-4dba-a2ba-7db4bb292927", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "345", "age_at_initial_pathologic_diagnosis": "62", "days_to_last_known_alive": "", "days_to_last_followup": "345", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Cis-retinoic acid", "start": "269", "end": "288", "duration": 19, "dosis": null, "dosis_unit": "ug/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "32", "end": "76", "duration": 44, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "0f31f92b-bf1c-4817-94d8-bb63aac42711", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "426", "age_at_initial_pathologic_diagnosis": "55", "days_to_last_known_alive": "", "days_to_last_followup": "406", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "20", "end": "62", "duration": 42, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "481b500e-fa2c-4809-9d88-e739e42fd5d7", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Treated primary GBM", "days_to_death": "3041", "age_at_initial_pathologic_diagnosis": "37", "days_to_last_known_alive": "", "days_to_last_followup": "3041", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 5, "drug_details": [{"type": "Chemotherapy", "name": "Procarbazine", "start": "75", "end": "197", "duration": 122, "dosis": null, "dosis_unit": "mg/m2/day"}, {"type": "Chemotherapy", "name": "CCNU", "start": "75", "end": "197", "duration": 122, "dosis": null, "dosis_unit": "mg/m2/day"}, {"type": "Chemotherapy", "name": "Vincristine", "start": "84", "end": "197", "duration": 113, "dosis": null, "dosis_unit": "mg/m2/day"}, {"type": "Chemotherapy", "name": "Carboplatin", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Tarceva", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "47", "end": "88", "duration": 41, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "cfa3a710-490b-4fcc-be8c-387d5586db23", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "52", "days_to_last_known_alive": "", "days_to_last_followup": "699", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 12, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "67", "end": null, "duration": "", "dosis": null, "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "dcVax", "start": "84", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "19", "end": "60", "duration": 41, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "117", "end": "435", "duration": 318, "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "dc Vax (Dendritic Cell Vaccine)", "start": "84", "end": "580", "duration": 496, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "718", "end": "960", "duration": 242, "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "Dendritic Cell Vaccine (dcvax)", "start": "708", "end": "942", "duration": 234, "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "Cedicanib", "start": "998", "end": "1025", "duration": 27, "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "Cilengitide", "start": "998", "end": "1025", "duration": 27, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Lomustine CCNU", "start": "1029", "end": "1029", "duration": 0, "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "Bevacizumab", "start": "1029", "end": "1205", "duration": 176, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Carboplatin", "start": "1085", "end": "1085", "duration": 0, "dosis": null, "dosis_unit": null}], "qty_radiation": 2, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "19", "end": "60", "duration": 41, "dosis": "6000", "dosis_unit": null}, {"type": "OTHER", "start": "1091", "end": "1098", "duration": 7, "dosis": "3200", "dosis_unit": "cGy"}]}, {"uuid": "d24b23dd-d429-4b94-a9b6-fdea0e6766da", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "1731", "age_at_initial_pathologic_diagnosis": "47", "days_to_last_known_alive": "", "days_to_last_followup": "1730", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "c964fc91-c245-4458-bca9-d7b1e9f7e332", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "82", "days_to_last_known_alive": "", "days_to_last_followup": "4", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "a4ff784e-5965-4f4e-9312-8dbed764078b", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "77", "days_to_last_known_alive": "", "days_to_last_followup": "161", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "73", "end": "88", "duration": 15, "dosis": "125", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "131", "end": "290", "duration": 159, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Avastin", "start": "360", "end": "388", "duration": 28, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "39", "end": "89", "duration": 50, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "7af21e42-6a8f-43bb-820b-dd94ebf4d3a6", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "641", "age_at_initial_pathologic_diagnosis": "21", "days_to_last_known_alive": "", "days_to_last_followup": "641", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 7, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "99", "end": "417", "duration": 318, "dosis": "390", "dosis_unit": null}, {"type": "Chemotherapy", "name": "Avastin", "start": "549", "end": "631", "duration": 82, "dosis": "949", "dosis_unit": null}, {"type": "Chemotherapy", "name": "Irinotecan", "start": "549", "end": "631", "duration": 82, "dosis": "125", "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temodar", "start": "521", "end": "542", "duration": 21, "dosis": "150", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "22", "end": "64", "duration": 42, "dosis": "300", "dosis_unit": null}, {"type": "Chemotherapy", "name": "BIBW2992", "start": "521", "end": "542", "duration": 21, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Metexafin Gadolinium", "start": "23", "end": "32", "duration": 9, "dosis": "5", "dosis_unit": "mg/kg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "23", "end": "64", "duration": 41, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "0b6d5880-d2c3-46dc-a4d1-9ee18a1f7972", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "285", "age_at_initial_pathologic_diagnosis": "68", "days_to_last_known_alive": "", "days_to_last_followup": "285", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "101", "end": "148", "duration": 47, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "31", "end": "73", "duration": 42, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "2fba9ea2-0880-496b-ab59-a5d78e740751", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "532", "age_at_initial_pathologic_diagnosis": "52", "days_to_last_known_alive": "", "days_to_last_followup": "532", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Hormone Therapy", "name": "Dexamethasone", "start": "0", "end": null, "duration": "", "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "RADIOISOTOPE", "start": "43", "end": "43", "duration": 0, "dosis": "80", "dosis_unit": "mCi"}]}, {"uuid": "4681b814-6eed-4667-939f-405f4b437be2", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "587", "age_at_initial_pathologic_diagnosis": "66", "days_to_last_known_alive": "", "days_to_last_followup": "587", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 5, "drug_details": [{"type": "Chemotherapy", "name": "Oxaliplatin", "start": "25", "end": "95", "duration": 70, "dosis": null, "dosis_unit": "mg"}, {"type": "Hormone Therapy", "name": "Dexamethasone", "start": "326", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "PS 341", "start": "346", "end": "433", "duration": 87, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "439", "end": "538", "duration": 99, "dosis": null, "dosis_unit": "mg"}, {"type": "Hormone Therapy", "name": "Dexamethasome", "start": "0", "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "118", "end": "165", "duration": 47, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "250ac2e0-b848-45fd-a2c3-daf9d1a1632e", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "321", "age_at_initial_pathologic_diagnosis": "67", "days_to_last_known_alive": "", "days_to_last_followup": "321", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "3e0dc6ef-557a-4dcf-9834-b1d4533838d4", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "66", "days_to_last_known_alive": "", "days_to_last_followup": "595", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "81", "end": "111", "duration": 30, "dosis": "75", "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "111", "end": "477", "duration": 366, "dosis": "150", "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "81", "end": "111", "duration": 30, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "e8d0780f-d63f-4519-84ff-aeb9fe8fe689", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "64", "days_to_last_known_alive": "", "days_to_last_followup": "253", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "68", "end": "127", "duration": 59, "dosis": "150", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "11", "end": "56", "duration": 45, "dosis": "75", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "11", "end": "56", "duration": 45, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "b5141018-d3e2-4f92-a9c1-d9b2cb7dc2af", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "345", "age_at_initial_pathologic_diagnosis": "59", "days_to_last_known_alive": "", "days_to_last_followup": "345", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "44", "end": "153", "duration": 109, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "44", "end": "153", "duration": 109, "dosis": null, "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "59", "end": "94", "duration": 35, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "9a62d08c-3a0b-47f3-836a-8323e5475636", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "62", "age_at_initial_pathologic_diagnosis": "59", "days_to_last_known_alive": "", "days_to_last_followup": "62", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "24", "end": "59", "duration": 35, "dosis": "75", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "24", "end": "59", "duration": 35, "dosis": "4680", "dosis_unit": "cGy"}]}, {"uuid": "5806336a-eeab-4158-8162-8b9f43df96e2", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "279", "age_at_initial_pathologic_diagnosis": "70", "days_to_last_known_alive": "", "days_to_last_followup": "279", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "OTHER", "start": "40", "end": "71", "duration": 31, "dosis": null, "dosis_unit": null}]}, {"uuid": "6744ac4a-829b-4537-a6b4-59553d20fe6c", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "452", "age_at_initial_pathologic_diagnosis": "51", "days_to_last_known_alive": "", "days_to_last_followup": "434", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 7, "drug_details": [{"type": "Chemotherapy", "name": "CPT-11", "start": "101", "end": "350", "duration": 249, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "360", "end": "388", "duration": 28, "dosis": null, "dosis_unit": "mg/kg"}, {"type": "Targeted Molecular therapy", "name": "Tarceva", "start": "393", "end": "434", "duration": 41, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "VP-16", "start": "360", "end": "388", "duration": 28, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temodar", "start": "21", "end": "77", "duration": 56, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "111", "end": "350", "duration": 239, "dosis": null, "dosis_unit": "mg/kg"}, {"type": "Targeted Molecular therapy", "name": "Rapamycin", "start": "393", "end": "434", "duration": 41, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "21", "end": "77", "duration": 56, "dosis": "6660", "dosis_unit": "cGy"}]}, {"uuid": "e2c45fe8-aeb2-4e50-880e-d0828c4ba6b7", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "65", "days_to_last_known_alive": "", "days_to_last_followup": "71", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "29", "end": "66", "duration": 37, "dosis": "75", "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "29", "end": "70", "duration": 41, "dosis": "60", "dosis_unit": "cGy"}]}, {"uuid": "0805dbc1-b513-40ce-9fc4-afab9ae6e5b8", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": "", "days_to_last_followup": "151", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "20", "end": "63", "duration": 43, "dosis": "75", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "20", "end": "63", "duration": 43, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "6be41a30-b8c9-4351-9b15-9c94ff9cbbe0", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "82", "age_at_initial_pathologic_diagnosis": "71", "days_to_last_known_alive": "", "days_to_last_followup": "31", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": null, "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "ce8bdabf-294f-48b5-8ae6-0efb1108c8c9", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "350", "age_at_initial_pathologic_diagnosis": "59", "days_to_last_known_alive": "", "days_to_last_followup": "350", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "3", "end": "7", "duration": 4, "dosis": "300", "dosis_unit": "mg"}, {"type": "Hormone Therapy", "name": "Dexamethasone", "start": "-11", "end": "350", "duration": 361, "dosis": "4", "dosis_unit": "mg"}, {"type": "Hormone Therapy", "name": "Oxcarbazepine", "start": "-11", "end": "350", "duration": 361, "dosis": "600", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "1", "end": "2", "duration": 1, "dosis": "140", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "71", "end": "102", "duration": 31, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "5a9e0bd9-2306-4df8-b18c-dd1ded6797e9", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "65", "days_to_last_known_alive": "", "days_to_last_followup": "455", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 8, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "15", "end": "81", "duration": 66, "dosis": "140", "dosis_unit": "mg/day"}, {"type": "Chemotherapy", "name": "Irinotecan", "start": "477", "end": "728", "duration": 251, "dosis": "125", "dosis_unit": "mg/m2"}, {"type": "Targeted Molecular therapy", "name": "Bevacizumab", "start": "203", "end": "799", "duration": 596, "dosis": "10", "dosis_unit": "mg/kg"}, {"type": "Targeted Molecular therapy", "name": "Bevacizumab", "start": "1043", "end": "1435", "duration": 392, "dosis": "10", "dosis_unit": "mg/kg"}, {"type": "Targeted Molecular therapy", "name": "Cilengitide", "start": "84", "end": "192", "duration": 108, "dosis": "2000", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "84", "end": "192", "duration": 108, "dosis": "390", "dosis_unit": "mg/day"}, {"type": "Targeted Molecular therapy", "name": "Cilengitide", "start": "15", "end": "81", "duration": 66, "dosis": "2000", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "1324", "end": "1383", "duration": 59, "dosis": "100", "dosis_unit": "mg/m2"}], "qty_radiation": 2, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "15", "end": "56", "duration": 41, "dosis": "6000", "dosis_unit": "cGy"}, {"type": "OTHER", "start": "1267", "end": "1277", "duration": 10, "dosis": "3200", "dosis_unit": "cGy"}]}, {"uuid": "37a2b703-43e9-4034-9ad6-f09599a015bb", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "63", "days_to_last_known_alive": "", "days_to_last_followup": "3", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "7cd74c96-f69c-4bfb-95f6-3fc098374e93", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "442", "age_at_initial_pathologic_diagnosis": "61", "days_to_last_known_alive": "", "days_to_last_followup": "442", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 5, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "49", "end": "96", "duration": 47, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Targeted Molecular therapy", "name": "AMG 102", "start": "177", "end": "343", "duration": 166, "dosis": null, "dosis_unit": "mg/kg"}, {"type": "Chemotherapy", "name": "VP 16", "start": "351", "end": "385", "duration": 34, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temodar", "start": "351", "end": "385", "duration": 34, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temodar", "start": "110", "end": "166", "duration": 56, "dosis": null, "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "49", "end": "96", "duration": 47, "dosis": "5940", "dosis_unit": "cGy"}]}, {"uuid": "7375974b-bbb5-4043-b96f-647ba997a453", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "489", "age_at_initial_pathologic_diagnosis": "63", "days_to_last_known_alive": "", "days_to_last_followup": "489", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 6, "drug_details": [{"type": "Chemotherapy", "name": "Cisplatin", "start": "10", "end": "59", "duration": 49, "dosis": "90", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Erlotinib", "start": "97", "end": "386", "duration": 289, "dosis": "150", "dosis_unit": "mg"}, {"type": "Hormone Therapy", "name": "Phenytoin Sodium", "start": "-6", "end": "489", "duration": 495, "dosis": "300", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "60", "end": "380", "duration": 320, "dosis": "300", "dosis_unit": "mg"}, {"type": "Hormone Therapy", "name": "Dexamethasone", "start": "-6", "end": "489", "duration": 495, "dosis": "8", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Lumustine", "start": "11", "end": "11", "duration": 0, "dosis": "160", "dosis_unit": "mg"}], "qty_radiation": 2, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "55", "end": "60", "duration": 5, "dosis": "3000", "dosis_unit": "cGy"}, {"type": "EXTERNAL BEAM", "start": "29", "end": "36", "duration": 7, "dosis": "3000", "dosis_unit": "cGy"}]}, {"uuid": "e63e1246-c138-4bc0-932d-0ec292bc5f73", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "541", "age_at_initial_pathologic_diagnosis": "31", "days_to_last_known_alive": "", "days_to_last_followup": "541", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Hormone Therapy", "name": "Dexamethasone", "start": "0", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temodar", "start": "40", "end": "69", "duration": 29, "dosis": null, "dosis_unit": "mg"}, {"type": "Hormone Therapy", "name": "Dexamethasone", "start": "331", "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "27", "end": "69", "duration": 42, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "c34e3732-e8a5-4b51-8e77-fadb355b1a5c", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Glioblastoma Multiforme (GBM)", "days_to_death": "625", "age_at_initial_pathologic_diagnosis": "55", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "9a6f0c31-e66a-489a-8108-e421461ef4aa", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "626", "age_at_initial_pathologic_diagnosis": "75", "days_to_last_known_alive": "", "days_to_last_followup": "626", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 7, "drug_details": [{"type": "Chemotherapy", "name": "Temador", "start": "474", "end": "571", "duration": 97, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "474", "end": "571", "duration": 97, "dosis": null, "dosis_unit": "mg/kg"}, {"type": "Chemotherapy", "name": "Temador", "start": "16", "end": "64", "duration": 48, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "CPT-11", "start": "572", "end": "599", "duration": 27, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "572", "end": "599", "duration": 27, "dosis": null, "dosis_unit": "mg/kg"}, {"type": "Chemotherapy", "name": "Temador", "start": "95", "end": "473", "duration": 378, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Immunotherapy", "name": "ATTAC", "start": "115", "end": "473", "duration": 358, "dosis": null, "dosis_unit": "mL"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "16", "end": "64", "duration": 48, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "3ce3af11-38c7-41f0-a1ce-3989ac00c375", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "24", "age_at_initial_pathologic_diagnosis": "61", "days_to_last_known_alive": "", "days_to_last_followup": "24", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Hormone Therapy", "name": "Dexamethasone", "start": "0", "end": null, "duration": "", "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "19", "end": "22", "duration": 3, "dosis": "800", "dosis_unit": "cGy"}]}, {"uuid": "e8dcf2ae-6cd8-4a0e-9914-3175bcc86c57", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "448", "age_at_initial_pathologic_diagnosis": "36", "days_to_last_known_alive": "", "days_to_last_followup": "439", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 8, "drug_details": [{"type": "Chemotherapy", "name": "Hydroxyurea", "start": "407", "end": "433", "duration": 26, "dosis": null, "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Rad001", "start": "407", "end": "433", "duration": 26, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "CPT-11", "start": "260", "end": "348", "duration": 88, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Targeted Molecular therapy", "name": "Gleevac", "start": "407", "end": "433", "duration": 26, "dosis": null, "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "260", "end": "348", "duration": 88, "dosis": null, "dosis_unit": "mg/kg"}, {"type": "Chemotherapy", "name": "Temozolamide", "start": "29", "end": "75", "duration": 46, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "362", "end": "407", "duration": 45, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temozolamide", "start": "106", "end": "259", "duration": 153, "dosis": null, "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "29", "end": "75", "duration": 46, "dosis": "5940", "dosis_unit": "cGy"}]}, {"uuid": "7c8303be-0a49-4724-8811-cef78880906a", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "124", "age_at_initial_pathologic_diagnosis": "76", "days_to_last_known_alive": "", "days_to_last_followup": "124", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "cd13ebce-4a29-4b8c-a825-5c6d749a4fbf", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "291", "age_at_initial_pathologic_diagnosis": "68", "days_to_last_known_alive": "", "days_to_last_followup": "291", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "b081dd83-1519-4572-82c7-a5949730aed7", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "64", "days_to_last_known_alive": "", "days_to_last_followup": "218", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "45", "end": "92", "duration": 47, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "132182a2-af0c-476a-8144-8a30b053eb10", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "94", "age_at_initial_pathologic_diagnosis": "85", "days_to_last_known_alive": "", "days_to_last_followup": "94", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": null, "end": "70", "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": null, "start": null, "end": "82", "duration": "", "dosis": null, "dosis_unit": null}]}, {"uuid": "2ed53d9e-8053-4e1f-b3de-6a63b38af0b5", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "68", "days_to_last_known_alive": "", "days_to_last_followup": "137", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "83", "end": "109", "duration": 26, "dosis": "105", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "60", "end": "75", "duration": 15, "dosis": "105", "dosis_unit": "mg"}], "qty_radiation": 2, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "60", "end": "75", "duration": 15, "dosis": null, "dosis_unit": null}, {"type": "EXTERNAL BEAM", "start": "80", "end": "109", "duration": 29, "dosis": null, "dosis_unit": null}]}, {"uuid": "a18bd02d-a2a3-40ba-b44c-3ca441ac1791", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "771", "age_at_initial_pathologic_diagnosis": "49", "days_to_last_known_alive": "", "days_to_last_followup": "570", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "75f3a96f-a009-4eb1-a9fb-de3bc29f1b4e", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "59", "days_to_last_known_alive": "", "days_to_last_followup": "452", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "116", "end": "120", "duration": 4, "dosis": "150", "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temozolamide", "start": "25", "end": "68", "duration": 43, "dosis": "75", "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "144", "end": "351", "duration": 207, "dosis": "200", "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "25", "end": "68", "duration": 43, "dosis": "60", "dosis_unit": "cGy"}]}, {"uuid": "ba841049-6725-45dc-b08b-edb38f809322", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "1638", "age_at_initial_pathologic_diagnosis": "46", "days_to_last_known_alive": "", "days_to_last_followup": "1615", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 14, "drug_details": [{"type": "Chemotherapy", "name": "Temozolamide", "start": "1112", "end": "1174", "duration": 62, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Targeted Molecular therapy", "name": "Tarceva", "start": "1468", "end": "1526", "duration": 58, "dosis": null, "dosis_unit": "mg/kg"}, {"type": "Targeted Molecular therapy", "name": "ARIAD AP23573", "start": "621", "end": "670", "duration": 49, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "VP-16", "start": "120", "end": "489", "duration": 369, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "CPT-11", "start": "670", "end": "951", "duration": 281, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "CCNU", "start": "1224", "end": "1265", "duration": 41, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Cytoxan", "start": "1307", "end": "1468", "duration": 161, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "CCNU", "start": "951", "end": "1112", "duration": 161, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temozolamide", "start": "79", "end": "120", "duration": 41, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "1468", "end": "1526", "duration": 58, "dosis": null, "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Sirolimus", "start": "1468", "end": "1526", "duration": 58, "dosis": null, "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "1529", "end": "1616", "duration": 87, "dosis": null, "dosis_unit": "mg/kg"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "1307", "end": "1468", "duration": 161, "dosis": null, "dosis_unit": "mg/kg"}, {"type": "Chemotherapy", "name": "VP-16", "start": "1529", "end": "1616", "duration": 87, "dosis": null, "dosis_unit": "mg/m2"}], "qty_radiation": 2, "radiation_details": [{"type": "EXTERNAL BEAM", "start": null, "end": null, "duration": "", "dosis": "1800", "dosis_unit": "cGy"}, {"type": "EXTERNAL BEAM", "start": "79", "end": "120", "duration": 41, "dosis": "5940", "dosis_unit": "cGy"}]}, {"uuid": "10c6e233-e035-4995-8ebb-367bf499cae0", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "36", "days_to_last_known_alive": "", "days_to_last_followup": "214", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "123", "end": "128", "duration": 5, "dosis": "360", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "78", "end": "89", "duration": 11, "dosis": "180", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "39", "end": "70", "duration": 31, "dosis": "180", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "166", "end": "170", "duration": 4, "dosis": "480", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "39", "end": "89", "duration": 50, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "47b814bb-6b9e-46fc-a380-4e3a7685e564", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Treated primary GBM", "days_to_death": "1077", "age_at_initial_pathologic_diagnosis": "20", "days_to_last_known_alive": "", "days_to_last_followup": "1077", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "509", "end": "569", "duration": 60, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Thalidomide", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "CPT 11", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "139", "end": "182", "duration": 43, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "794f46df-ee17-4dc6-920b-7dc7dd713bad", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "53", "days_to_last_known_alive": "", "days_to_last_followup": "145", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": null, "end": null, "duration": "", "dosis": "75", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": "cGy"}]}, {"uuid": "d8237936-d593-4d5d-83c3-555efe8bcf13", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "48", "days_to_last_known_alive": "", "days_to_last_followup": "143", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Tarceva", "start": "250", "end": null, "duration": "", "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Avastin", "start": "105", "end": null, "duration": "", "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "7", "end": "55", "duration": 48, "dosis": "5040", "dosis_unit": "cGy"}]}, {"uuid": "307ddefb-2ff1-4b2a-9394-4e63de8a6325", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "30", "age_at_initial_pathologic_diagnosis": "59", "days_to_last_known_alive": "", "days_to_last_followup": "30", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Hormone Therapy", "name": "Dexamethasone", "start": "0", "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "28", "end": "28", "duration": 0, "dosis": "1800", "dosis_unit": "cGy"}]}, {"uuid": "9b02f27a-5de9-434d-9f78-0f8919438095", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "2362", "age_at_initial_pathologic_diagnosis": "43", "days_to_last_known_alive": "", "days_to_last_followup": "2362", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 5, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "72", "end": "191", "duration": 119, "dosis": null, "dosis_unit": "mg/m2/day"}, {"type": "Chemotherapy", "name": "Celebrex", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "6 Thiguanine", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Xeloda", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "CCNU", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "27", "end": "68", "duration": 41, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "d9e05c9f-3a9e-4f37-86ef-c0994c883a0d", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": "", "days_to_last_followup": "217", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "111", "end": "195", "duration": 84, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "32", "end": "79", "duration": 47, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "26", "end": "79", "duration": 53, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "e117b7fd-d14c-4cb7-a38c-4c030e4e4b14", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "335", "age_at_initial_pathologic_diagnosis": "62", "days_to_last_known_alive": "", "days_to_last_followup": "237", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 4, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temodar", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Avastin", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": null, "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 2, "radiation_details": [{"type": null, "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": null, "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}]}, {"uuid": "83da823e-60e4-4023-a4d7-9d4dad4f6ab0", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "27", "days_to_last_known_alive": "", "days_to_last_followup": "1757", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "eb871047-9394-4857-8b25-2582a20c3f78", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "56", "days_to_last_known_alive": "", "days_to_last_followup": "263", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "80", "end": "231", "duration": 151, "dosis": "150", "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Irinotecan", "start": "238", "end": "323", "duration": 85, "dosis": "125", "dosis_unit": "mg/m2"}, {"type": "Targeted Molecular therapy", "name": "Bevacizumab", "start": "238", "end": "323", "duration": 85, "dosis": "10", "dosis_unit": "mg/kg"}], "qty_radiation": 1, "radiation_details": [{"type": "OTHER", "start": "311", "end": "323", "duration": 12, "dosis": "3200", "dosis_unit": "cGy"}]}, {"uuid": "553382db-0cd2-435e-948b-7ebea3aec5f2", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "209", "age_at_initial_pathologic_diagnosis": "61", "days_to_last_known_alive": "", "days_to_last_followup": "209", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "b8c732d3-e962-4e46-86d1-7297cfa8cc68", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "485", "age_at_initial_pathologic_diagnosis": "62", "days_to_last_known_alive": "", "days_to_last_followup": "485", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 8, "drug_details": [{"type": "Chemotherapy", "name": "Gliadel Wafers", "start": "285", "end": "285", "duration": 0, "dosis": null, "dosis_unit": "{Wafer}"}, {"type": "Targeted Molecular therapy", "name": "Bevacizumab Avastin", "start": "301", "end": null, "duration": "", "dosis": null, "dosis_unit": "mg/kg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "96", "end": "100", "duration": 4, "dosis": null, "dosis_unit": "mg/day"}, {"type": "Chemotherapy", "name": "Gliadel Wafer", "start": "0", "end": "0", "duration": 0, "dosis": null, "dosis_unit": "{Wafer}"}, {"type": "Chemotherapy", "name": "Metronomic Temodar", "start": "161", "end": "273", "duration": 112, "dosis": null, "dosis_unit": "mg/day"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "301", "end": null, "duration": "", "dosis": null, "dosis_unit": "mg/kg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "26", "end": "65", "duration": 39, "dosis": "160", "dosis_unit": "mg/day"}, {"type": "Chemotherapy", "name": "Gliadel Wafer", "start": "285", "end": "285", "duration": 0, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "OTHER", "start": "313", "end": "313", "duration": 0, "dosis": "146", "dosis_unit": "cGy"}]}, {"uuid": "6c2fa917-7f7c-4db0-8532-076c217bd16e", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "42", "days_to_last_known_alive": "", "days_to_last_followup": "258", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 5, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "11", "end": "272", "duration": 261, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "11", "end": "272", "duration": 261, "dosis": null, "dosis_unit": "mg"}, {"type": "Immunotherapy", "name": "Dendriticcell Vaccine", "start": "105", "end": "132", "duration": 27, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "11", "end": "272", "duration": 261, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "11", "end": "272", "duration": 261, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "12", "end": "52", "duration": 40, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "7d8c6244-171b-467c-bb18-a37b5ae8a229", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "747", "age_at_initial_pathologic_diagnosis": "30", "days_to_last_known_alive": "", "days_to_last_followup": "685", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 7, "drug_details": [{"type": "Chemotherapy", "name": "Carboplatin", "start": "582", "end": "582", "duration": 0, "dosis": null, "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Thalomid", "start": "531", "end": "572", "duration": 41, "dosis": null, "dosis_unit": "mg/day"}, {"type": "Targeted Molecular therapy", "name": "Enzastaurin", "start": "638", "end": "671", "duration": 33, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temodor", "start": "25", "end": "68", "duration": 43, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temodor", "start": "88", "end": "498", "duration": 410, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "BCNU", "start": "531", "end": "531", "duration": 0, "dosis": null, "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Tamoxifen", "start": "573", "end": "607", "duration": 34, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "25", "end": "68", "duration": 43, "dosis": null, "dosis_unit": "cGy"}]}, {"uuid": "541b4bcc-68ec-4165-9193-2a469355d235", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Treated primary GBM", "days_to_death": "604", "age_at_initial_pathologic_diagnosis": "66", "days_to_last_known_alive": "", "days_to_last_followup": "604", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Gliadel Wafer", "start": "1", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temozolomide", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "16", "end": "63", "duration": 47, "dosis": "6480", "dosis_unit": "cGy"}]}, {"uuid": "7cc785f3-49b1-423e-bf68-1653ee94ea19", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "543", "age_at_initial_pathologic_diagnosis": "58", "days_to_last_known_alive": "", "days_to_last_followup": "543", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 6, "drug_details": [{"type": "Chemotherapy", "name": "Gliadel Wafers", "start": "0", "end": null, "duration": "", "dosis": null, "dosis_unit": "{Wafer}"}, {"type": "Hormone Therapy", "name": "Dexamethasone", "start": "0", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temodar", "start": "20", "end": "450", "duration": 430, "dosis": null, "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "378", "end": "478", "duration": 100, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "20", "end": "450", "duration": 430, "dosis": null, "dosis_unit": null}, {"type": "Hormone Therapy", "name": "Dexamethasone", "start": "140", "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "29", "end": "70", "duration": 41, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "702f4297-0fe9-4d08-8d93-fc889f5ae44a", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "394", "age_at_initial_pathologic_diagnosis": "54", "days_to_last_known_alive": "", "days_to_last_followup": "320", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "74", "end": "280", "duration": 206, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "74", "end": "122", "duration": 48, "dosis": "6120", "dosis_unit": "cGy"}]}, {"uuid": "ca3ea301-1af2-4708-96ac-acb90b665167", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "123", "age_at_initial_pathologic_diagnosis": "69", "days_to_last_known_alive": "", "days_to_last_followup": "83", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Tipifarnib (R115777)", "start": "15", "end": "22", "duration": 7, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "51", "end": "78", "duration": 27, "dosis": "5900", "dosis_unit": "cGy"}]}, {"uuid": "3e3c90a0-d757-4596-8b86-b7036ff9fa07", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "53", "days_to_last_known_alive": "", "days_to_last_followup": "286", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 8, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "29", "end": "66", "duration": 37, "dosis": "75", "dosis_unit": "mg/m2"}, {"type": "Targeted Molecular therapy", "name": "A4QN", "start": "25", "end": "66", "duration": 41, "dosis": "150", "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Erlotinib (Tarceva)", "start": "309", "end": "370", "duration": 61, "dosis": "150", "dosis_unit": "mg/day"}, {"type": "Targeted Molecular therapy", "name": "A4QN", "start": "25", "end": "60", "duration": 35, "dosis": "750", "dosis_unit": "mg/m2"}, {"type": "Targeted Molecular therapy", "name": "AT 101", "start": "175", "end": "279", "duration": 104, "dosis": "20", "dosis_unit": "mg/day"}, {"type": "Targeted Molecular therapy", "name": "Bevacizumab", "start": "412", "end": "412", "duration": 0, "dosis": "10", "dosis_unit": "mg/kg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "95", "end": "127", "duration": 32, "dosis": "150", "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Irintotecan", "start": "384", "end": "412", "duration": 28, "dosis": "125", "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "25", "end": "66", "duration": 41, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "f8259ceb-6075-42b7-ac33-276c1d434abb", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Treated primary GBM", "days_to_death": "254", "age_at_initial_pathologic_diagnosis": "28", "days_to_last_known_alive": "", "days_to_last_followup": "254", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temozomide", "start": "21", "end": "143", "duration": 122, "dosis": null, "dosis_unit": "mg/m2/day"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "11", "end": "69", "duration": 58, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "115efbab-6e49-40e7-a82a-6d3957fd2e65", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "28", "age_at_initial_pathologic_diagnosis": "61", "days_to_last_known_alive": "", "days_to_last_followup": "28", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Hormone Therapy", "name": "Dexamethasone", "start": "17", "end": "28", "duration": 11, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Gliadel wafer", "start": "17", "end": null, "duration": "", "dosis": null, "dosis_unit": "{Wafer}"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "a43488c4-d8c5-4bb9-9109-5dd1c5b1c4a6", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "1977", "age_at_initial_pathologic_diagnosis": "29", "days_to_last_known_alive": "", "days_to_last_followup": "1977", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "1536", "end": "1786", "duration": 250, "dosis": null, "dosis_unit": "mg/m2/day"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "1536", "end": "1786", "duration": 250, "dosis": null, "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "1536", "end": "1581", "duration": 45, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "183a483b-0858-4f13-b1d1-80eabad88541", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "179", "age_at_initial_pathologic_diagnosis": "51", "days_to_last_known_alive": "", "days_to_last_followup": "179", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Hormone Therapy", "name": "Dexamethasone", "start": "0", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "42", "end": "46", "duration": 4, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "BCNU", "start": "42", "end": "46", "duration": 4, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "b8ec4a48-ca99-423d-a996-a4913c7c055e", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "781", "age_at_initial_pathologic_diagnosis": "47", "days_to_last_known_alive": "", "days_to_last_followup": "769", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 13, "drug_details": [{"type": "Targeted Molecular therapy", "name": "Avastin", "start": "621", "end": "671", "duration": 50, "dosis": null, "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Sirolimus", "start": "406", "end": "433", "duration": 27, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Hydroxyurea", "start": "461", "end": "492", "duration": 31, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Hydroxyurea", "start": "160", "end": "391", "duration": 231, "dosis": null, "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Gleevac", "start": "160", "end": "391", "duration": 231, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Cytoxan", "start": "675", "end": "727", "duration": 52, "dosis": null, "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Erlotinib", "start": "406", "end": "433", "duration": 27, "dosis": null, "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Gleevac", "start": "96", "end": "127", "duration": 31, "dosis": null, "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "438", "end": "602", "duration": 164, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "CPT 11", "start": "621", "end": "671", "duration": 50, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "24", "end": "59", "duration": 35, "dosis": null, "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "675", "end": "727", "duration": 52, "dosis": null, "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "438", "end": "602", "duration": 164, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "24", "end": "75", "duration": 51, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "a42f8804-3076-4101-907e-ac303922960d", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "97", "age_at_initial_pathologic_diagnosis": "63", "days_to_last_known_alive": "", "days_to_last_followup": "97", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "19", "end": "61", "duration": 42, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "5b9115a9-0ec1-4e79-9b67-723d5d531049", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "419", "age_at_initial_pathologic_diagnosis": "65", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "28", "end": "59", "duration": 31, "dosis": null, "dosis_unit": "mg/m2/day"}, {"type": "Targeted Molecular therapy", "name": "SAHA", "start": "259", "end": "300", "duration": 41, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}]}, {"uuid": "21f25d93-fdba-4a5a-a29a-117ee6491cb7", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "230", "age_at_initial_pathologic_diagnosis": "64", "days_to_last_known_alive": "", "days_to_last_followup": "168", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "27", "end": "69", "duration": 42, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "102", "end": "198", "duration": 96, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "27", "end": "69", "duration": 42, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "29d25533-117c-4312-b9f7-777f376ec8fc", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "98", "age_at_initial_pathologic_diagnosis": "54", "days_to_last_known_alive": "", "days_to_last_followup": "67", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Tipfarnib (R115777)", "start": "3", "end": "33", "duration": 30, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "59", "end": "66", "duration": 7, "dosis": "0951", "dosis_unit": "cGy"}]}, {"uuid": "502b9533-0bfa-4b71-a0b2-a04036f1201f", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "1987", "age_at_initial_pathologic_diagnosis": "40", "days_to_last_known_alive": "", "days_to_last_followup": "1637", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Targeted Molecular therapy", "name": "Thalidomide", "start": "72", "end": "581", "duration": 509, "dosis": null, "dosis_unit": "mg/day"}, {"type": "Chemotherapy", "name": "Temodor", "start": "72", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temodor", "start": "1594", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "Thalidomide", "start": "1594", "end": null, "duration": "", "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "84", "end": "126", "duration": 42, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "7a41a316-a803-4876-b815-989d6c3def22", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "239", "age_at_initial_pathologic_diagnosis": "59", "days_to_last_known_alive": "", "days_to_last_followup": "164", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "cf83d875-8bc8-4e20-8c4a-a8bc7b8a4e17", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "146", "age_at_initial_pathologic_diagnosis": "76", "days_to_last_known_alive": "", "days_to_last_followup": "146", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": null, "end": "145", "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": null, "end": "60", "duration": "", "dosis": "5064", "dosis_unit": "cGy"}]}, {"uuid": "db3e4a49-c666-4d1d-bb4d-73637150ed7f", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "811", "age_at_initial_pathologic_diagnosis": "74", "days_to_last_known_alive": "", "days_to_last_followup": "734", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 7, "drug_details": [{"type": "Chemotherapy", "name": "CCNU", "start": "96", "end": "179", "duration": 83, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "CPT-11", "start": "605", "end": "649", "duration": 44, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temozolamide", "start": "501", "end": "597", "duration": 96, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "VP-16", "start": "215", "end": "238", "duration": 23, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "VP-16", "start": "649", "end": "734", "duration": 85, "dosis": null, "dosis_unit": "mg"}, {"type": "Hormone Therapy", "name": "Tamoxiten", "start": "238", "end": "353", "duration": 115, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "VP-16", "start": "238", "end": "353", "duration": 115, "dosis": null, "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "25", "end": "67", "duration": 42, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "80fd6457-4ab4-402a-9f40-fe404270b4b5", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "136", "age_at_initial_pathologic_diagnosis": "72", "days_to_last_known_alive": "", "days_to_last_followup": "7", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "48207a14-eb18-416a-8533-987a011ad53b", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "535", "age_at_initial_pathologic_diagnosis": "58", "days_to_last_known_alive": "", "days_to_last_followup": "535", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "3b4c04ff-6590-4882-b1f4-5eea92995c10", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "432", "age_at_initial_pathologic_diagnosis": "57", "days_to_last_known_alive": "", "days_to_last_followup": "432", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Procarbazine", "start": "93", "end": "182", "duration": 89, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Vincristine", "start": "93", "end": "182", "duration": 89, "dosis": null, "dosis_unit": "mg/m2/day"}, {"type": "Chemotherapy", "name": "CCNU", "start": "93", "end": "182", "duration": 89, "dosis": null, "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "37", "end": "82", "duration": 45, "dosis": "6000", "dosis_unit": null}]}, {"uuid": "e8fd51eb-71d5-4b7c-b887-2d7fa10f2dd1", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "63", "days_to_last_known_alive": "", "days_to_last_followup": "1228", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "93", "end": "670", "duration": 577, "dosis": "200", "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "1311", "end": "1646", "duration": 335, "dosis": "75", "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "23", "end": "72", "duration": 49, "dosis": "75", "dosis_unit": "mg/m2"}], "qty_radiation": 2, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "23", "end": "72", "duration": 49, "dosis": "6100", "dosis_unit": "cGy"}, {"type": "OTHER", "start": "1286", "end": "1300", "duration": 14, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "97512809-0332-4f62-9e7f-cfe74c587449", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "1062", "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": "", "days_to_last_followup": "316", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 7, "drug_details": [{"type": "Chemotherapy", "name": "CCNU", "start": "163", "end": "203", "duration": 40, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "VP-16", "start": "291", "end": "350", "duration": 59, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Gliadel Wafers", "start": "0", "end": "0", "duration": 0, "dosis": null, "dosis_unit": "{Wafer}"}, {"type": "Chemotherapy", "name": "Temozolamide", "start": "21", "end": "84", "duration": 63, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temozolamide", "start": "228", "end": "291", "duration": 63, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "VP-16", "start": "443", "end": "571", "duration": 128, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "CCNU", "start": "84", "end": "129", "duration": 45, "dosis": null, "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "19", "end": "60", "duration": 41, "dosis": "5800", "dosis_unit": "cGy"}]}, {"uuid": "1718a5e5-2aae-412a-84df-7a43ad37439a", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "829", "age_at_initial_pathologic_diagnosis": "57", "days_to_last_known_alive": "", "days_to_last_followup": "829", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "d5b65891-aee5-43b5-9166-0a6b2a7eb212", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "666", "age_at_initial_pathologic_diagnosis": "48", "days_to_last_known_alive": "", "days_to_last_followup": "666", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 8, "drug_details": [{"type": "Chemotherapy", "name": "Irinotecan", "start": "538", "end": "552", "duration": 14, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Avastin", "start": "566", "end": "580", "duration": 14, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Avastin", "start": "594", "end": "608", "duration": 14, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Irinotecan", "start": "594", "end": "608", "duration": 14, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "120", "end": "273", "duration": 153, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "35", "end": "81", "duration": 46, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Avastin", "start": "538", "end": "552", "duration": 14, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "368", "end": "372", "duration": 4, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "35", "end": "81", "duration": 46, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "7e77ecac-8a5f-4a46-a31c-4018eb233f99", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "307", "age_at_initial_pathologic_diagnosis": "76", "days_to_last_known_alive": "", "days_to_last_followup": "298", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "25", "end": "67", "duration": 42, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "a0d7c743-e8b9-4e2e-8073-addc0856f402", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "244", "age_at_initial_pathologic_diagnosis": "76", "days_to_last_known_alive": "", "days_to_last_followup": "244", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "50", "end": "94", "duration": 44, "dosis": "165", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "50", "end": "94", "duration": 44, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "68a1648a-8f83-47a0-8de7-92fddffdca02", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "106", "age_at_initial_pathologic_diagnosis": "46", "days_to_last_known_alive": "", "days_to_last_followup": "106", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "-260", "end": "-124", "duration": 136, "dosis": null, "dosis_unit": "mg/m2/day"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "-314", "end": "-271", "duration": 43, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "cccc6472-c5d3-4e28-8ec3-a0a1c883b38f", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "678", "age_at_initial_pathologic_diagnosis": "50", "days_to_last_known_alive": "", "days_to_last_followup": "594", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 7, "drug_details": [{"type": "Chemotherapy", "name": "CCNU", "start": "491", "end": "548", "duration": 57, "dosis": null, "dosis_unit": "mg"}, {"type": "Immunotherapy", "name": "IL-13 with Pseudomonas Exotoxin", "start": "288", "end": "293", "duration": 5, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodor", "start": "91", "end": "264", "duration": 173, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Immunotherapy", "name": "HSPPC-96 Vaccine", "start": "341", "end": "467", "duration": 126, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodor", "start": "33", "end": "75", "duration": 42, "dosis": null, "dosis_unit": "mg/day"}, {"type": "Targeted Molecular therapy", "name": "Tarceva", "start": "33", "end": "75", "duration": 42, "dosis": null, "dosis_unit": "mg/day"}, {"type": "Targeted Molecular therapy", "name": "Tarceva", "start": "91", "end": "264", "duration": 173, "dosis": null, "dosis_unit": "mg/day"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "33", "end": "75", "duration": 42, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "e011d63c-7a57-4892-837d-df8122bc3c5a", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "49", "days_to_last_known_alive": "", "days_to_last_followup": "237", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Avastin", "start": "43", "end": "223", "duration": 180, "dosis": "510", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "6", "end": null, "duration": "", "dosis": "250", "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "e76ead6e-e9d2-4183-a921-ee6a30d0a3a4", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "705", "age_at_initial_pathologic_diagnosis": "56", "days_to_last_known_alive": "", "days_to_last_followup": "705", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "28", "end": "74", "duration": 46, "dosis": null, "dosis_unit": "ug/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "28", "end": "74", "duration": 46, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "68b82ba9-ef02-46a0-bd4b-23b378178fea", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "211", "age_at_initial_pathologic_diagnosis": "86", "days_to_last_known_alive": "", "days_to_last_followup": "3", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "432d4bf9-5725-469c-acbf-1f9d0f640490", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "600", "age_at_initial_pathologic_diagnosis": "50", "days_to_last_known_alive": "", "days_to_last_followup": "600", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "23", "end": "358", "duration": 335, "dosis": null, "dosis_unit": "mg/m2/day"}, {"type": "Chemotherapy", "name": "Bevacizumab", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "CPT 11", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "23", "end": "68", "duration": 45, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "d7df6775-b415-490c-8bfb-b840d6e31945", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "15", "age_at_initial_pathologic_diagnosis": "65", "days_to_last_known_alive": "", "days_to_last_followup": "15", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "274f3d56-47eb-44db-a429-e55a541bafcb", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "53", "days_to_last_known_alive": "", "days_to_last_followup": "282", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 8, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "21", "end": "63", "duration": 42, "dosis": "75", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "XL 184", "start": "119", "end": "148", "duration": 29, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Avastin", "start": "171", "end": null, "duration": "", "dosis": "6", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "irinotecan", "start": "171", "end": null, "duration": "", "dosis": "125", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozlomide", "start": "348", "end": "471", "duration": 123, "dosis": "25", "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Irinotecan", "start": "171", "end": "325", "duration": 154, "dosis": "125", "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Carboplatin", "start": "478", "end": "492", "duration": 14, "dosis": "6", "dosis_unit": "AUC"}, {"type": "Targeted Molecular therapy", "name": "Bevacizumab", "start": "171", "end": "492", "duration": 321, "dosis": "10", "dosis_unit": "mg/kg"}], "qty_radiation": 2, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "21", "end": "63", "duration": 42, "dosis": "60", "dosis_unit": "cGy"}, {"type": "OTHER", "start": "352", "end": "358", "duration": 6, "dosis": "3200", "dosis_unit": "cGy"}]}, {"uuid": "23275eb9-a5a2-4be7-8d5e-a53354368b72", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "182", "age_at_initial_pathologic_diagnosis": "23", "days_to_last_known_alive": "", "days_to_last_followup": "182", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "30", "end": "69", "duration": 39, "dosis": "75", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "95", "end": "100", "duration": 5, "dosis": "200", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "26", "end": "69", "duration": 43, "dosis": "60", "dosis_unit": "cGy"}]}, {"uuid": "31ad2809-8007-488b-bab8-10bef856e2b6", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "175", "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": "", "days_to_last_followup": "136", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "b7671ef7-506f-4710-9ddf-35200e31d3c3", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "76", "age_at_initial_pathologic_diagnosis": "62", "days_to_last_known_alive": "", "days_to_last_followup": "76", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "-112", "end": "0", "duration": 112, "dosis": null, "dosis_unit": "mg/m2/day"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "-112", "end": "0", "duration": 112, "dosis": null, "dosis_unit": "mg/m2/day"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "-112", "end": "-67", "duration": 45, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "199c1104-8ba7-4ef2-ac3f-a0b1ba97e2e9", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "43", "days_to_last_known_alive": "", "days_to_last_followup": "466", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "53", "end": "94", "duration": 41, "dosis": "75", "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temodar", "start": "95", "end": "466", "duration": 371, "dosis": "150", "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "53", "end": "94", "duration": 41, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "2be096ff-2e4f-4c42-b857-c95a26cb691a", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "59", "days_to_last_known_alive": "", "days_to_last_followup": "351", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 5, "drug_details": [{"type": "Chemotherapy", "name": "Gliadel wafer carmustine", "start": "231", "end": null, "duration": "", "dosis": null, "dosis_unit": "{Wafer}"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "105", "end": "195", "duration": 90, "dosis": "350", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "31", "end": "77", "duration": 46, "dosis": "140", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "345", "end": null, "duration": "", "dosis": "800", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "359", "end": "387", "duration": 28, "dosis": "850", "dosis_unit": "mg"}], "qty_radiation": 2, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "31", "end": "77", "duration": 46, "dosis": "6000", "dosis_unit": "cGy"}, {"type": "OTHER", "start": "366", "end": "368", "duration": 2, "dosis": "2400", "dosis_unit": "cGy"}]}, {"uuid": "f00b5337-e56c-4456-b04e-866997537084", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "484", "age_at_initial_pathologic_diagnosis": "51", "days_to_last_known_alive": "", "days_to_last_followup": "484", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 5, "drug_details": [{"type": "Chemotherapy", "name": "CCNU", "start": "107", "end": "137", "duration": 30, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Procarbazine", "start": "107", "end": "137", "duration": 30, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Vincristine", "start": "107", "end": "137", "duration": 30, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Carboplatin", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "VP-16", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "45", "end": "90", "duration": 45, "dosis": "6000", "dosis_unit": null}]}, {"uuid": "e4892140-c662-425c-a85b-37592797bcf6", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "701", "age_at_initial_pathologic_diagnosis": "50", "days_to_last_known_alive": "", "days_to_last_followup": "701", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 13, "drug_details": [{"type": "Chemotherapy", "name": "CPT 11", "start": "182", "end": "210", "duration": 28, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Carmustine", "start": "567", "end": "570", "duration": 3, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Etoposide", "start": "659", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Carboplatin", "start": "659", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temodar", "start": "526", "end": "567", "duration": 41, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "140", "end": "142", "duration": 2, "dosis": null, "dosis_unit": null}, {"type": "Hormone Therapy", "name": "Dexamethasone", "start": "127", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Streptozocin", "start": "567", "end": "570", "duration": 3, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Thalidomide", "start": "574", "end": "651", "duration": 77, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Carmustine", "start": "140", "end": "142", "duration": 2, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Procarbazine", "start": "308", "end": "357", "duration": 49, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "6-Mercaptopurine", "start": "567", "end": "570", "duration": 3, "dosis": null, "dosis_unit": "mg"}, {"type": "Hormone Therapy", "name": "Dexamethasone", "start": "0", "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "56", "end": "101", "duration": 45, "dosis": "5940", "dosis_unit": "cGy"}]}, {"uuid": "147d118b-0e50-4bec-b6c4-59a130dd0b32", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "310", "age_at_initial_pathologic_diagnosis": "68", "days_to_last_known_alive": "", "days_to_last_followup": "310", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "13", "end": "154", "duration": 141, "dosis": null, "dosis_unit": "mg/m2/day"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "13", "end": "154", "duration": 141, "dosis": null, "dosis_unit": "mg/m2/day"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "13", "end": "62", "duration": 49, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "cb1f1934-2c3e-4ded-85ea-4e0fa7cde3d3", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "223", "age_at_initial_pathologic_diagnosis": "82", "days_to_last_known_alive": "", "days_to_last_followup": "5", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "cef8c282-e770-4a8c-baf1-8b49a51771b4", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "126", "age_at_initial_pathologic_diagnosis": "68", "days_to_last_known_alive": "", "days_to_last_followup": "104", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Targeted Molecular therapy", "name": "Avastin", "start": "62", "end": "104", "duration": 42, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temodor", "start": "61", "end": "101", "duration": 40, "dosis": null, "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "60", "end": "101", "duration": 41, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "ac34f184-bde5-420e-83a9-3bf8273a6b60", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Treated primary GBM", "days_to_death": "1615", "age_at_initial_pathologic_diagnosis": "35", "days_to_last_known_alive": "", "days_to_last_followup": "1615", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "152", "end": "701", "duration": 549, "dosis": null, "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "33", "end": "75", "duration": 42, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "60ff9172-b6bc-43b6-b86a-7d4f2ceb8df6", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "64", "days_to_last_known_alive": "", "days_to_last_followup": "493", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Accutane", "start": "130", "end": "230", "duration": 100, "dosis": "40", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "24", "end": "66", "duration": 42, "dosis": "75", "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temodar", "start": "67", "end": "440", "duration": 373, "dosis": "150", "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "24", "end": "66", "duration": 42, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "336289e7-5d39-4bc7-bc46-b75299add3fd", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "864", "age_at_initial_pathologic_diagnosis": "55", "days_to_last_known_alive": "", "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "5f4c9a36-afc1-4a1f-bd4d-a65c5d621daa", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "127", "age_at_initial_pathologic_diagnosis": "57", "days_to_last_known_alive": "", "days_to_last_followup": "119", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temodor", "start": "35", "end": "103", "duration": 68, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "35", "end": "77", "duration": 42, "dosis": null, "dosis_unit": null}]}, {"uuid": "9df93378-21c1-4ed1-9ebc-7b6db6cc9d26", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "558", "age_at_initial_pathologic_diagnosis": "56", "days_to_last_known_alive": "", "days_to_last_followup": "558", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "88", "end": "148", "duration": 60, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "CIS Retinoic Acid", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "21", "end": "67", "duration": 46, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "5c200eae-fd69-485b-8222-e6e468c2f5d8", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "103", "age_at_initial_pathologic_diagnosis": "59", "days_to_last_known_alive": "", "days_to_last_followup": "29", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "f764bd8f-f6b6-43ff-baab-b06121c81ed3", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "735", "age_at_initial_pathologic_diagnosis": "61", "days_to_last_known_alive": "", "days_to_last_followup": "684", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "250", "end": "463", "duration": 213, "dosis": "150", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "CI 980", "start": "36", "end": "97", "duration": 61, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Carmustine", "start": "586", "end": "586", "duration": 0, "dosis": null, "dosis_unit": "meq"}], "qty_radiation": 2, "radiation_details": [{"type": "OTHER", "start": "215", "end": "215", "duration": 0, "dosis": "800", "dosis_unit": "cGy"}, {"type": "EXTERNAL BEAM", "start": "128", "end": "159", "duration": 31, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "03e12ee3-f5c1-4f10-bf95-515f9ead180b", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "56", "days_to_last_known_alive": "", "days_to_last_followup": "165", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "30", "end": "71", "duration": 41, "dosis": "135", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Avastin", "start": "55", "end": "165", "duration": 110, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temodar", "start": "123", "end": "155", "duration": 32, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "30", "end": "75", "duration": 45, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "95a2e4b4-30f7-4f57-829e-cd707a6ec8d7", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "16", "age_at_initial_pathologic_diagnosis": "55", "days_to_last_known_alive": "", "days_to_last_followup": "6", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "4944dab1-ca78-4edc-8bb5-c42956be9473", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "74", "days_to_last_known_alive": "", "days_to_last_followup": "218", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Irinotecan", "start": "78", "end": null, "duration": "", "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Avastin", "start": "78", "end": null, "duration": "", "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "6", "end": "53", "duration": 47, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "14", "end": "58", "duration": 44, "dosis": "6000", "dosis_unit": null}]}, {"uuid": "aa527649-6fe0-4896-a301-fa55222efb3f", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "143", "age_at_initial_pathologic_diagnosis": "76", "days_to_last_known_alive": "", "days_to_last_followup": "143", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "959a7b14-0adb-4ea9-b919-ec9889ca4b67", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "54", "age_at_initial_pathologic_diagnosis": "83", "days_to_last_known_alive": "", "days_to_last_followup": "54", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "afabd0a7-76bd-41af-b22b-7a16fea3e551", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "422", "age_at_initial_pathologic_diagnosis": "63", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "31", "end": "81", "duration": 50, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "31", "end": "81", "duration": 50, "dosis": "6120", "dosis_unit": "cGy"}]}, {"uuid": "1fe1a148-5671-49e4-8269-97dfdf610176", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "78", "days_to_last_known_alive": "", "days_to_last_followup": "86", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "21", "end": "69", "duration": 48, "dosis": "160", "dosis_unit": "mg"}], "qty_radiation": 2, "radiation_details": [{"type": "OTHER", "start": "10", "end": "10", "duration": 0, "dosis": "1500", "dosis_unit": "cGy"}, {"type": "EXTERNAL BEAM", "start": "25", "end": "69", "duration": 44, "dosis": null, "dosis_unit": null}]}, {"uuid": "98ac13e9-789b-4990-9221-4cf932d590cc", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "612", "age_at_initial_pathologic_diagnosis": "38", "days_to_last_known_alive": "", "days_to_last_followup": "612", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "-9", "end": "34", "duration": 43, "dosis": null, "dosis_unit": "mg/m2/day"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "-9", "end": "34", "duration": 43, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "5ac58d3d-bfe2-4fe0-8f2b-be7349ed658a", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "111", "age_at_initial_pathologic_diagnosis": "75", "days_to_last_known_alive": "", "days_to_last_followup": "80", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "14", "end": "45", "duration": 31, "dosis": null, "dosis_unit": "mg/m2"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "cf888ed8-18c3-451c-96e1-5865401d13e2", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "72", "days_to_last_known_alive": "", "days_to_last_followup": "259", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "27", "end": "57", "duration": 30, "dosis": "75", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Bevacizumab", "start": "934", "end": null, "duration": "", "dosis": "10", "dosis_unit": "mg/kg"}, {"type": "Targeted Molecular therapy", "name": "R04929097", "start": "885", "end": "931", "duration": 46, "dosis": "20", "dosis_unit": "mg/day"}], "qty_radiation": 2, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "27", "end": "57", "duration": 30, "dosis": "46", "dosis_unit": "cGy"}, {"type": "OTHER", "start": "566", "end": "576", "duration": 10, "dosis": "3200", "dosis_unit": "cGy"}]}, {"uuid": "0c67110c-18e0-4e0e-9481-a498f73ef49e", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "419", "age_at_initial_pathologic_diagnosis": "64", "days_to_last_known_alive": "", "days_to_last_followup": "419", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Gliadel BCNU", "start": "0", "end": null, "duration": "", "dosis": null, "dosis_unit": "{Wafer}"}, {"type": "Chemotherapy", "name": "Temodar", "start": "15", "end": "410", "duration": 395, "dosis": null, "dosis_unit": "mg"}, {"type": "Hormone Therapy", "name": "Dexamethasone", "start": "0", "end": null, "duration": "", "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "28", "end": "67", "duration": 39, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "a94583e3-a753-4f41-ad65-4dc5e493bc7a", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "1010", "age_at_initial_pathologic_diagnosis": "10", "days_to_last_known_alive": "", "days_to_last_followup": "929", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 14, "drug_details": [{"type": "Chemotherapy", "name": "CCNG", "start": "288", "end": "330", "duration": 42, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temodor", "start": "521", "end": "691", "duration": 170, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "VP-16", "start": "358", "end": "453", "duration": 95, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temodor", "start": "453", "end": "484", "duration": 31, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "VP-16", "start": "819", "end": "926", "duration": 107, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temodor", "start": "484", "end": "521", "duration": 37, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Hormone Therapy", "name": "Tamoxiten", "start": "521", "end": "691", "duration": 170, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodor", "start": "143", "end": "169", "duration": 26, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "CCNG", "start": "229", "end": "287", "duration": 58, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Hormone Therapy", "name": "Tamoxifen", "start": "453", "end": "484", "duration": 31, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodor", "start": "179", "end": "206", "duration": 27, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Hormone Therapy", "name": "Tamoxifen", "start": "484", "end": "521", "duration": 37, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodor", "start": "331", "end": "358", "duration": 27, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Hormone Therapy", "name": "Tamoxifen", "start": "358", "end": "453", "duration": 95, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "67", "end": "112", "duration": 45, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "988e9df9-691a-40fc-b665-0f1e5140785c", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "38", "days_to_last_known_alive": "", "days_to_last_followup": "1642", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 4, "drug_details": [{"type": "Targeted Molecular therapy", "name": "Bevcizumab", "start": "2572", "end": "2614", "duration": 42, "dosis": "10", "dosis_unit": "mg/kg"}, {"type": "Chemotherapy", "name": "MEDT 575", "start": "2530", "end": null, "duration": "", "dosis": "25", "dosis_unit": "mg/kg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "51", "end": "95", "duration": 44, "dosis": "200", "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "113", "end": "751", "duration": 638, "dosis": "200", "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "51", "end": "95", "duration": 44, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "e0dd8752-7cb7-4543-876d-f673eade6a8d", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "157", "age_at_initial_pathologic_diagnosis": "63", "days_to_last_known_alive": "", "days_to_last_followup": "128", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 4, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "68", "end": null, "duration": "", "dosis": "100", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "68", "end": null, "duration": "", "dosis": "100", "dosis_unit": "mg"}], "qty_radiation": 2, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "16", "end": "29", "duration": 13, "dosis": "3000", "dosis_unit": "cGy"}, {"type": "EXTERNAL BEAM", "start": "16", "end": "29", "duration": 13, "dosis": "3000", "dosis_unit": "cGy"}]}, {"uuid": "b9ef6482-ba32-4308-956c-e79071970287", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "515", "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": "", "days_to_last_followup": "515", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 6, "drug_details": [{"type": "Chemotherapy", "name": "Gliadel wafer", "start": "0", "end": "0", "duration": 0, "dosis": "5", "dosis_unit": "{Wafer}"}, {"type": "Chemotherapy", "name": "Temodar", "start": "94", "end": "98", "duration": 4, "dosis": "330", "dosis_unit": "mg/day"}, {"type": "Chemotherapy", "name": "Temodar", "start": "124", "end": "341", "duration": 217, "dosis": "425", "dosis_unit": "mg/day"}, {"type": "Chemotherapy", "name": "Temodar", "start": "22", "end": "65", "duration": 43, "dosis": "165", "dosis_unit": "mg/day"}, {"type": "Chemotherapy", "name": "Temodar", "start": "94", "end": "98", "duration": 4, "dosis": "330", "dosis_unit": "mg/day"}, {"type": "Chemotherapy", "name": "Motexafin Gadolinium", "start": "23", "end": "65", "duration": 42, "dosis": "05", "dosis_unit": "mg/kg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "23", "end": "65", "duration": 42, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "4afc956c-3cb0-4c96-a183-010c623313d9", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "54", "days_to_last_known_alive": "", "days_to_last_followup": "793", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "29", "end": "71", "duration": 42, "dosis": "5400", "dosis_unit": "cGy"}]}, {"uuid": "e580820c-28ab-4a82-8cce-d26f85ca3130", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "130", "age_at_initial_pathologic_diagnosis": "75", "days_to_last_known_alive": "", "days_to_last_followup": "107", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Targeted Molecular therapy", "name": "Thalidomide", "start": "41", "end": "64", "duration": 23, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodor", "start": "35", "end": "90", "duration": 55, "dosis": null, "dosis_unit": "mg/day"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "35", "end": "84", "duration": 49, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "e9427d97-7b64-4dbf-b09b-089ce5496929", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "889", "age_at_initial_pathologic_diagnosis": "32", "days_to_last_known_alive": "", "days_to_last_followup": "104", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temodor", "start": "446", "end": "629", "duration": 183, "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "Tarceva", "start": "678", "end": "838", "duration": 160, "dosis": null, "dosis_unit": "mg/day"}], "qty_radiation": 2, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "40", "end": "79", "duration": 39, "dosis": "6540", "dosis_unit": "cGy"}, {"type": "IMPLANTS", "start": "0", "end": "0", "duration": 0, "dosis": "021", "dosis_unit": "mCi"}]}, {"uuid": "bbf0f347-7d7d-431b-8cce-55965dbf199e", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "104", "age_at_initial_pathologic_diagnosis": "47", "days_to_last_known_alive": "", "days_to_last_followup": "78", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "CAI (NABTT 9712)", "start": "13", "end": "74", "duration": 61, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "13", "end": "74", "duration": 61, "dosis": null, "dosis_unit": "cGy"}]}, {"uuid": "e7fe06a6-67b0-4c04-b437-657ef31d43f4", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "77", "age_at_initial_pathologic_diagnosis": "66", "days_to_last_known_alive": "", "days_to_last_followup": "77", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "0be008f5-011e-4e0f-ab8d-3131a1da7309", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "45", "age_at_initial_pathologic_diagnosis": "44", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "249a9c76-1d6e-40c1-b4e3-938d5c55a47b", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Treated primary GBM", "days_to_death": "457", "age_at_initial_pathologic_diagnosis": "59", "days_to_last_known_alive": "", "days_to_last_followup": "457", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 5, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "278", "end": "429", "duration": 151, "dosis": "380", "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temodar", "start": "34", "end": "75", "duration": 41, "dosis": "140", "dosis_unit": null}, {"type": "Chemotherapy", "name": "Gliadel Wafer", "start": "252", "end": "252", "duration": 0, "dosis": "5", "dosis_unit": "{Wafer}"}, {"type": "Chemotherapy", "name": "Temodar", "start": "103", "end": "107", "duration": 4, "dosis": "290", "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temodar", "start": "131", "end": "192", "duration": 61, "dosis": "380", "dosis_unit": null}], "qty_radiation": 2, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "34", "end": "75", "duration": 41, "dosis": "5400", "dosis_unit": "cGy"}, {"type": "OTHER", "start": "275", "end": "275", "duration": 0, "dosis": "1200", "dosis_unit": "cGy"}]}, {"uuid": "2f71701f-c0cb-475d-aa3e-a9ebc85ce2d0", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "33", "days_to_last_known_alive": "", "days_to_last_followup": "539", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "104", "end": "108", "duration": 4, "dosis": "330", "dosis_unit": "mg/day"}, {"type": "Chemotherapy", "name": "Temodar", "start": "21", "end": "69", "duration": 48, "dosis": "160", "dosis_unit": "mg/day"}, {"type": "Chemotherapy", "name": "Temodar", "start": "130", "end": "260", "duration": 130, "dosis": "440", "dosis_unit": "mg/day"}], "qty_radiation": 2, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "34", "end": "75", "duration": 41, "dosis": "6000", "dosis_unit": "cGy"}, {"type": "OTHER", "start": "347", "end": "351", "duration": 4, "dosis": "8000", "dosis_unit": "cGy"}]}, {"uuid": "499da6d6-98e5-4bd4-ac6c-f6df59ce7eb7", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "71", "days_to_last_known_alive": "", "days_to_last_followup": "375", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "288", "end": "319", "duration": 31, "dosis": "75", "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Irinotecan", "start": "106", "end": "263", "duration": 157, "dosis": "125", "dosis_unit": "mg/m2"}, {"type": "Targeted Molecular therapy", "name": "Bevacizumab", "start": "96", "end": "333", "duration": 237, "dosis": "10", "dosis_unit": "mg/kg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "23", "end": "65", "duration": 42, "dosis": "75", "dosis_unit": "mg/m2"}], "qty_radiation": 2, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "23", "end": "65", "duration": 42, "dosis": "6000", "dosis_unit": "cGy"}, {"type": "OTHER", "start": "280", "end": "291", "duration": 11, "dosis": "3600", "dosis_unit": "cGy"}]}, {"uuid": "e85f1b05-cf4f-45b5-bb0e-1f42ae087585", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "422", "age_at_initial_pathologic_diagnosis": "50", "days_to_last_known_alive": "", "days_to_last_followup": "422", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "af7483e3-1a7a-41d8-8773-e6356b0f9dfd", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "3667", "age_at_initial_pathologic_diagnosis": "64", "days_to_last_known_alive": "", "days_to_last_followup": "15", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "79de16ae-b38d-43d3-9b0f-885b0050eb6a", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Treated primary GBM", "days_to_death": "511", "age_at_initial_pathologic_diagnosis": "61", "days_to_last_known_alive": "", "days_to_last_followup": "511", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "72", "end": "102", "duration": 30, "dosis": "150", "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temodar", "start": "28", "end": "71", "duration": 43, "dosis": "75", "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "28", "end": "71", "duration": 43, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "e53196ef-c933-4e53-b354-ee0bbe33e606", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "424", "age_at_initial_pathologic_diagnosis": "54", "days_to_last_known_alive": "", "days_to_last_followup": "389", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Carmustine", "start": "160", "end": "191", "duration": 31, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Gliadel wafer", "start": "235", "end": "235", "duration": 0, "dosis": "8", "dosis_unit": "{Wafer}"}, {"type": "Chemotherapy", "name": "Procarbazine", "start": "373", "end": null, "duration": "", "dosis": "100", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "CI 980", "start": "12", "end": "89", "duration": 77, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 2, "radiation_details": [{"type": "OTHER", "start": "321", "end": "321", "duration": 0, "dosis": "1500", "dosis_unit": "cGy"}, {"type": "EXTERNAL BEAM", "start": "98", "end": "145", "duration": 47, "dosis": "5940", "dosis_unit": "cGy"}]}, {"uuid": "d9bd3bd7-723d-4975-b2d5-b6f9002ac0d2", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "164", "age_at_initial_pathologic_diagnosis": "58", "days_to_last_known_alive": "", "days_to_last_followup": "164", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "22", "end": "69", "duration": 47, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "96", "end": "96", "duration": 0, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "22", "end": "69", "duration": 47, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "c9c4be81-6615-4000-acc1-076b0db16896", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "382", "age_at_initial_pathologic_diagnosis": "63", "days_to_last_known_alive": "", "days_to_last_followup": "17", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "dee3f789-1eee-4697-b163-8c6af7c05287", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "327", "age_at_initial_pathologic_diagnosis": "69", "days_to_last_known_alive": "", "days_to_last_followup": "327", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "16", "end": "57", "duration": 41, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "89", "end": "93", "duration": 4, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "16", "end": "57", "duration": 41, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "94f18c1f-23bc-4d45-8390-c018ce4bd2ba", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "627", "age_at_initial_pathologic_diagnosis": "50", "days_to_last_known_alive": "", "days_to_last_followup": "627", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Gliadel Wafer", "start": "0", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "AE 788", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "22", "end": "57", "duration": 35, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "d3bfd1ea-7522-4fd3-a2bc-82ef74e714cf", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "298", "age_at_initial_pathologic_diagnosis": "77", "days_to_last_known_alive": "", "days_to_last_followup": "294", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "e6852c5f-af6f-43c2-b756-55874a4c9b4f", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "1433", "age_at_initial_pathologic_diagnosis": "36", "days_to_last_known_alive": "", "days_to_last_followup": "1433", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "CCNU", "start": "105", "end": "329", "duration": 224, "dosis": null, "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "18", "end": "56", "duration": 38, "dosis": "6000", "dosis_unit": null}]}, {"uuid": "3e2a859b-dbed-462a-939c-771d6be99c12", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "254", "age_at_initial_pathologic_diagnosis": "51", "days_to_last_known_alive": "", "days_to_last_followup": "254", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Targeted Molecular therapy", "name": "Avastin", "start": "213", "end": "235", "duration": 22, "dosis": "10", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "96", "end": "218", "duration": 122, "dosis": "200", "dosis_unit": "mg/m2"}], "qty_radiation": 2, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "27", "end": "68", "duration": 41, "dosis": "6000", "dosis_unit": "cGy"}, {"type": "OTHER", "start": "151", "end": "151", "duration": 0, "dosis": "1800", "dosis_unit": "cGy"}]}, {"uuid": "e7efc7f0-5aac-46ed-b481-627473fe0356", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Glioblastoma Multiforme (GBM)", "days_to_death": "287", "age_at_initial_pathologic_diagnosis": "74", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Carmustine", "start": "70", "end": "162", "duration": 92, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "18", "end": "63", "duration": 45, "dosis": "6100", "dosis_unit": "cGy"}]}, {"uuid": "76035747-609f-4a2d-95d7-eefa335e258b", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "213", "age_at_initial_pathologic_diagnosis": "74", "days_to_last_known_alive": "", "days_to_last_followup": "213", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "42", "end": "88", "duration": 46, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "50411d13-7445-4130-aaef-142902142a71", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "111", "age_at_initial_pathologic_diagnosis": "76", "days_to_last_known_alive": "", "days_to_last_followup": "111", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "0e413118-a654-4e56-b71e-22399d775a49", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "77", "days_to_last_known_alive": "", "days_to_last_followup": "145", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "33", "end": null, "duration": "", "dosis": "75", "dosis_unit": "mg/m2"}, {"type": "Targeted Molecular therapy", "name": "Cilenaitide", "start": "26", "end": null, "duration": "", "dosis": "2000", "dosis_unit": "mg/day"}], "qty_radiation": 2, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "33", "end": "74", "duration": 41, "dosis": "1600", "dosis_unit": "cGy"}, {"type": "EXTERNAL BEAM", "start": "33", "end": "62", "duration": 29, "dosis": "4400", "dosis_unit": "cGy"}]}, {"uuid": "cb1bad7f-bc4e-4064-93ba-d46dc3666eeb", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "235", "age_at_initial_pathologic_diagnosis": "69", "days_to_last_known_alive": "", "days_to_last_followup": "235", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": null, "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "e1fc083f-7f65-4c16-b839-8bbe30c18cab", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "65", "days_to_last_known_alive": "", "days_to_last_followup": "391", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "232", "end": "275", "duration": 43, "dosis": "75", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Bevacozimab", "start": "359", "end": null, "duration": "", "dosis": "10", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "277", "end": "308", "duration": 31, "dosis": "150", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "308", "end": "338", "duration": 30, "dosis": "75", "dosis_unit": "mg/day"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "232", "end": "275", "duration": 43, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "6cf8ab88-4fd2-4a70-9484-d301e0d2f56a", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "111", "age_at_initial_pathologic_diagnosis": "76", "days_to_last_known_alive": "", "days_to_last_followup": "77", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "e04560e1-25ca-4834-b91f-2da0361d7a7d", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "71", "days_to_last_known_alive": "", "days_to_last_followup": "358", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "31", "end": "277", "duration": 246, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 2, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "79", "end": "79", "duration": 0, "dosis": "140", "dosis_unit": "cGy"}, {"type": "EXTERNAL BEAM", "start": "31", "end": "70", "duration": 39, "dosis": "460", "dosis_unit": "cGy"}]}, {"uuid": "4731acf2-2403-4bf6-ae62-b67f15c3b247", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "51", "days_to_last_known_alive": "", "days_to_last_followup": "132", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "55", "end": "99", "duration": 44, "dosis": "140", "dosis_unit": "mg/day"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "132", "end": null, "duration": "", "dosis": "10", "dosis_unit": "mg/kg"}], "qty_radiation": 2, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "55", "end": "87", "duration": 32, "dosis": "4500", "dosis_unit": "cGy"}, {"type": "EXTERNAL BEAM", "start": "91", "end": "99", "duration": 8, "dosis": "1400", "dosis_unit": "cGy"}]}, {"uuid": "7e31ed56-0607-4ca8-871f-0867cac1b8ba", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Treated primary GBM", "days_to_death": "705", "age_at_initial_pathologic_diagnosis": "40", "days_to_last_known_alive": "", "days_to_last_followup": "705", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "33", "end": "338", "duration": 305, "dosis": null, "dosis_unit": "mg/m2/day"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "33", "end": "338", "duration": 305, "dosis": null, "dosis_unit": "mg/m2/day"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "33", "end": "76", "duration": 43, "dosis": "6180", "dosis_unit": "cGy"}]}, {"uuid": "089f879e-1f0f-4201-bf2d-a086794d27c3", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "55", "days_to_last_known_alive": "", "days_to_last_followup": "581", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "68", "end": "280", "duration": 212, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "68", "end": "98", "duration": 30, "dosis": null, "dosis_unit": null}]}, {"uuid": "3f75e162-9a63-497f-aa3f-591461eec0f0", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "133", "age_at_initial_pathologic_diagnosis": "65", "days_to_last_known_alive": "", "days_to_last_followup": "133", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}]}, {"uuid": "a0dce149-d989-4c31-a3a4-2d7b0b220ace", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "61", "days_to_last_known_alive": "", "days_to_last_followup": "232", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Immunotherapy", "name": "Dendriticcell Vaccine", "start": "114", "end": "142", "duration": 28, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "14", "end": "208", "duration": 194, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "14", "end": "208", "duration": 194, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "14", "end": "208", "duration": 194, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "14", "end": "58", "duration": 44, "dosis": "5940", "dosis_unit": "cGy"}]}, {"uuid": "5aeca719-9e82-4281-b957-3e1bfcef54ca", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "290", "age_at_initial_pathologic_diagnosis": "75", "days_to_last_known_alive": "", "days_to_last_followup": "290", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "95", "end": "145", "duration": 50, "dosis": "140", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "166", "end": "166", "duration": 0, "dosis": "800", "dosis_unit": "mg"}], "qty_radiation": 2, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "167", "end": "169", "duration": 2, "dosis": "1800", "dosis_unit": "cGy"}, {"type": "EXTERNAL BEAM", "start": "95", "end": "145", "duration": 50, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "d023cb51-3084-45d4-ac87-48334db51eeb", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "467", "age_at_initial_pathologic_diagnosis": "78", "days_to_last_known_alive": "", "days_to_last_followup": "426", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 6, "drug_details": [{"type": "Targeted Molecular therapy", "name": "Avastin", "start": "195", "end": "278", "duration": 83, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "278", "end": "383", "duration": 105, "dosis": null, "dosis_unit": "mg/kg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "102", "end": "172", "duration": 70, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "CPT-11", "start": "195", "end": "278", "duration": 83, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Gliadel wafers", "start": "28", "end": "28", "duration": 0, "dosis": null, "dosis_unit": "{Wafer}"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}]}, {"uuid": "8ebdea05-b470-4d0d-8ae2-e67022209518", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "58", "days_to_last_known_alive": "", "days_to_last_followup": "557", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 7, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "96", "end": "462", "duration": 366, "dosis": "200", "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Irinotecan", "start": "816", "end": "907", "duration": 91, "dosis": "125", "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Lomustine", "start": "725", "end": "767", "duration": 42, "dosis": "160", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "18", "end": "60", "duration": 42, "dosis": "75", "dosis_unit": "mg/m2"}, {"type": "Targeted Molecular therapy", "name": "Bevacizumab", "start": "816", "end": "1153", "duration": 337, "dosis": "10", "dosis_unit": "mg/kg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "919", "end": "980", "duration": 61, "dosis": "75", "dosis_unit": "mg/m2"}, {"type": "Targeted Molecular therapy", "name": "Cediranib/Placebo", "start": "725", "end": "808", "duration": 83, "dosis": "20", "dosis_unit": "mg/day"}], "qty_radiation": 2, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "18", "end": "60", "duration": 42, "dosis": "6000", "dosis_unit": "cGy"}, {"type": "OTHER", "start": "928", "end": "938", "duration": 10, "dosis": "3200", "dosis_unit": "cGy"}]}, {"uuid": "91b15999-a9e8-46ac-a265-070e7afbb990", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "61", "days_to_last_known_alive": "", "days_to_last_followup": "273", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Hydrochoroquine", "start": "41", "end": "124", "duration": 83, "dosis": "600", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "41", "end": "112", "duration": 71, "dosis": "160", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "41", "end": "84", "duration": 43, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "2824f5b6-b0a9-4531-81d6-31a1235dff58", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "40", "days_to_last_known_alive": "", "days_to_last_followup": "104", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Hormone Therapy", "name": "Dexamethasone", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "19", "end": "67", "duration": 48, "dosis": "75", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "96", "end": null, "duration": "", "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "19", "end": "67", "duration": 48, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "a96dec05-76cb-4ee2-9104-f7ec11d85baa", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "134", "age_at_initial_pathologic_diagnosis": "69", "days_to_last_known_alive": "", "days_to_last_followup": "134", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "7728972c-ac85-414c-b78f-4e43d0c42cdf", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "69", "days_to_last_known_alive": "", "days_to_last_followup": "679", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 5, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomode", "start": "122", "end": "178", "duration": 56, "dosis": "150", "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Irinotecan", "start": "203", "end": "704", "duration": 501, "dosis": "125", "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "55", "end": "94", "duration": 39, "dosis": "75", "dosis_unit": "mg/m2"}, {"type": "Targeted Molecular therapy", "name": "Bevacizumab", "start": "203", "end": "704", "duration": 501, "dosis": "10", "dosis_unit": "mg/kg"}, {"type": "Targeted Molecular therapy", "name": "Cilengitide", "start": "55", "end": "178", "duration": 123, "dosis": "500", "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "55", "end": "94", "duration": 39, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "5573f50b-c296-4ae6-9a94-3de935a86510", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Treated primary GBM", "days_to_death": "691", "age_at_initial_pathologic_diagnosis": "59", "days_to_last_known_alive": "", "days_to_last_followup": "691", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "69", "end": "404", "duration": 335, "dosis": null, "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "36", "end": "62", "duration": 26, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "96be6b68-26b8-4453-9194-872ae1745d5c", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "73", "days_to_last_known_alive": "", "days_to_last_followup": "236", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "112", "end": "196", "duration": 84, "dosis": "320", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "40", "end": "81", "duration": 41, "dosis": "160", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "40", "end": "82", "duration": 42, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "661c6329-7f2f-4875-8319-594f056f1a39", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "596", "age_at_initial_pathologic_diagnosis": "14", "days_to_last_known_alive": "", "days_to_last_followup": "561", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 2, "radiation_details": [{"type": "IMPLANTS", "start": "171", "end": "171", "duration": 0, "dosis": null, "dosis_unit": null}, {"type": "EXTERNAL BEAM", "start": "10", "end": "40", "duration": 30, "dosis": null, "dosis_unit": null}]}, {"uuid": "3f4e30b9-7fa5-4b7d-b3ab-2c8f93ad966d", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "274", "age_at_initial_pathologic_diagnosis": "57", "days_to_last_known_alive": "", "days_to_last_followup": "168", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Vincristine", "start": "126", "end": "176", "duration": 50, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Procarbazine", "start": "126", "end": "176", "duration": 50, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Lomustine", "start": "126", "end": "176", "duration": 50, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "OTHER", "start": "104", "end": "115", "duration": 11, "dosis": null, "dosis_unit": "cGy"}]}, {"uuid": "66f915f1-1044-414d-97e9-5adcacdc882b", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "318", "age_at_initial_pathologic_diagnosis": "61", "days_to_last_known_alive": "", "days_to_last_followup": "263", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "BCNU", "start": "144", "end": "236", "duration": 92, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Targeted Molecular therapy", "name": "CI980", "start": "9", "end": "52", "duration": 43, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Gliadel Wafer", "start": "257", "end": "257", "duration": 0, "dosis": null, "dosis_unit": "{Wafer}"}, {"type": "Chemotherapy", "name": "Carmustine", "start": "175", "end": "205", "duration": 30, "dosis": "80", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "72", "end": "120", "duration": 48, "dosis": "5944", "dosis_unit": "cGy"}]}, {"uuid": "0df79698-2294-401f-8d21-1045beb28b77", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "53", "days_to_last_known_alive": "", "days_to_last_followup": "198", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "51", "end": "70", "duration": 19, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Avastin", "start": "51", "end": "70", "duration": 19, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temodar", "start": "202", "end": "604", "duration": 402, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "51", "end": "94", "duration": 43, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "7d097fb7-51aa-4b33-bb7d-74cd73341ff0", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "146", "age_at_initial_pathologic_diagnosis": "17", "days_to_last_known_alive": "", "days_to_last_followup": "146", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "99", "end": "126", "duration": 27, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "27", "end": "63", "duration": 36, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "27", "end": "63", "duration": 36, "dosis": "5940", "dosis_unit": "cGy"}]}, {"uuid": "1c969739-c647-4a27-a2cb-7afc2964459d", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Glioblastoma Multiforme (GBM)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "47", "days_to_last_known_alive": "", "days_to_last_followup": "260", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "35", "end": "235", "duration": 200, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Lomustine", "start": "511", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "511", "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "23", "end": "65", "duration": 42, "dosis": "60", "dosis_unit": "Gy"}]}, {"uuid": "52639573-0436-49d8-b4e0-23c9c8e8a924", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "225", "age_at_initial_pathologic_diagnosis": "72", "days_to_last_known_alive": "", "days_to_last_followup": "151", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "123", "end": "148", "duration": 25, "dosis": "3270", "dosis_unit": "cGy"}]}, {"uuid": "2fed891c-f08d-41e4-9e2d-7d25ce3ead07", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "454", "age_at_initial_pathologic_diagnosis": "72", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 4, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "9", "end": "448", "duration": 439, "dosis": "140", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "9", "end": "448", "duration": 439, "dosis": "140", "dosis_unit": "mg"}], "qty_radiation": 2, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "9", "end": "52", "duration": 43, "dosis": "6000", "dosis_unit": "cGy"}, {"type": "EXTERNAL BEAM", "start": "9", "end": "52", "duration": 43, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "35b1d7a1-7b59-4e73-bd02-5f1259f3e3d0", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "318", "age_at_initial_pathologic_diagnosis": "57", "days_to_last_known_alive": "", "days_to_last_followup": "181", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "CCNU", "start": "92", "end": "191", "duration": 99, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temodar", "start": "21", "end": "68", "duration": 47, "dosis": null, "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "21", "end": "68", "duration": 47, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "858a2a4e-8c4c-433c-8079-0c0f63105eff", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "703", "age_at_initial_pathologic_diagnosis": "39", "days_to_last_known_alive": "", "days_to_last_followup": "703", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 10, "drug_details": [{"type": "Chemotherapy", "name": "Etoposide", "start": "411", "end": "480", "duration": 69, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Gliadel", "start": "153", "end": null, "duration": "", "dosis": null, "dosis_unit": "{Wafer}"}, {"type": "Targeted Molecular therapy", "name": "Erlotinib", "start": "382", "end": "504", "duration": 122, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "59", "end": "101", "duration": 42, "dosis": null, "dosis_unit": "mg"}, {"type": "Hormone Therapy", "name": "Dexamethasone", "start": "0", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "BCNU", "start": "501", "end": "566", "duration": 65, "dosis": null, "dosis_unit": "mg"}, {"type": "Hormone Therapy", "name": "Dexamethasone", "start": "19", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "20", "end": "34", "duration": 14, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Vincristin", "start": "411", "end": "480", "duration": 69, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "411", "end": "480", "duration": 69, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "60", "end": "101", "duration": 41, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "ac256683-9e1c-44cd-a811-b239dd1d7fd8", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "82", "age_at_initial_pathologic_diagnosis": "53", "days_to_last_known_alive": "", "days_to_last_followup": "82", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "39d26191-1e2c-45e8-8246-7cf49382cbf9", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "468", "age_at_initial_pathologic_diagnosis": "59", "days_to_last_known_alive": "", "days_to_last_followup": "468", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "28", "end": "67", "duration": 39, "dosis": "170", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": null, "end": null, "duration": "", "dosis": "200", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "28", "end": "67", "duration": 39, "dosis": "600", "dosis_unit": "cGy"}]}, {"uuid": "040eae7f-6db9-4542-9c48-1ae58ca3da6e", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "386", "age_at_initial_pathologic_diagnosis": "68", "days_to_last_known_alive": "", "days_to_last_followup": "386", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "126", "end": "139", "duration": 13, "dosis": "150", "dosis_unit": "mg/day"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "126", "end": "156", "duration": 30, "dosis": "4500", "dosis_unit": "cGy"}]}, {"uuid": "c8158832-7a43-4358-a0da-534bef1a9f49", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "438", "age_at_initial_pathologic_diagnosis": "81", "days_to_last_known_alive": "", "days_to_last_followup": "438", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Hormone Therapy", "name": "Dexamethasone", "start": "-7", "end": "438", "duration": 445, "dosis": "8", "dosis_unit": "mg"}, {"type": "Hormone Therapy", "name": "Valproic acid", "start": "-7", "end": "438", "duration": 445, "dosis": "1000", "dosis_unit": "mg"}], "qty_radiation": 2, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "36", "end": "38", "duration": 2, "dosis": "2250", "dosis_unit": "cGy"}, {"type": "EXTERNAL BEAM", "start": "14", "end": "16", "duration": 2, "dosis": "2250", "dosis_unit": "cGy"}]}, {"uuid": "0fbb2265-e107-4792-9925-6de587447a9d", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "505", "age_at_initial_pathologic_diagnosis": "66", "days_to_last_known_alive": "", "days_to_last_followup": "505", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Hormone Therapy", "name": "Dexamethasone", "start": "-8", "end": "505", "duration": 513, "dosis": "8", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "6", "end": "103", "duration": 97, "dosis": "200", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "4", "end": "98", "duration": 94, "dosis": "140", "dosis_unit": "mg"}, {"type": "Hormone Therapy", "name": "Oxcarbazepine", "start": "-8", "end": "505", "duration": 513, "dosis": "600", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "39", "end": "84", "duration": 45, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "2c39a12a-475e-455d-b814-dc0f99b82743", "tumor_tissue_site": null, "pathologic_stage": "", "histological_type": null, "days_to_death": null, "age_at_initial_pathologic_diagnosis": null, "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": null, "ethnicity": null, "race": null, "vital_status": null, "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "3b113b1b-ea15-4d1b-a6ad-8fd7074c2c21", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "67", "days_to_last_known_alive": "", "days_to_last_followup": "268", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "87", "end": "179", "duration": 92, "dosis": "200", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "261", "end": null, "duration": "", "dosis": "10", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "21", "end": "63", "duration": 42, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "8f190695-d699-4dfe-929b-b5b6a90766ec", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "2729", "age_at_initial_pathologic_diagnosis": "28", "days_to_last_known_alive": "", "days_to_last_followup": "2729", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "352", "end": "443", "duration": 91, "dosis": null, "dosis_unit": "mg/m2/day"}, {"type": "Chemotherapy", "name": "CIS Retinoic Acid", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "16", "end": "57", "duration": 41, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "253109e8-3948-4297-809c-eedd4334857f", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "74", "days_to_last_known_alive": "", "days_to_last_followup": "167", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "60", "end": "103", "duration": 43, "dosis": "60", "dosis_unit": "cGy"}]}, {"uuid": "829c06bf-fe62-4682-8e04-3e006c884047", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "63", "days_to_last_known_alive": "", "days_to_last_followup": "139", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "70", "end": null, "duration": "", "dosis": "200", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "13", "end": "42", "duration": 29, "dosis": "75", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "13", "end": "28", "duration": 15, "dosis": "3600", "dosis_unit": "cGy"}]}, {"uuid": "c067c84a-8d14-42ad-a15d-bc1e4431459e", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "482", "age_at_initial_pathologic_diagnosis": "57", "days_to_last_known_alive": "", "days_to_last_followup": "482", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "71c0c022-9ae0-4828-8579-6a635a363feb", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "562", "age_at_initial_pathologic_diagnosis": "40", "days_to_last_known_alive": "", "days_to_last_followup": "562", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 9, "drug_details": [{"type": "Targeted Molecular therapy", "name": "06-BG", "start": "-1", "end": "0", "duration": 1, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "CPT-11", "start": "363", "end": "433", "duration": 70, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Targeted Molecular therapy", "name": "06-BG", "start": "300", "end": "341", "duration": 41, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "BCNU", "start": "300", "end": "341", "duration": 41, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "VP-16", "start": "502", "end": "543", "duration": 41, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "CPT-11", "start": "342", "end": "363", "duration": 21, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "216", "end": "272", "duration": 56, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "CPT-11", "start": "433", "end": "502", "duration": 69, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Hormone Therapy", "name": "Tamoxifen", "start": "502", "end": "543", "duration": 41, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "21", "end": "68", "duration": 47, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "3393d0f8-28e6-4353-8d47-d7ab406bdfa4", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "78", "days_to_last_known_alive": "", "days_to_last_followup": "37", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "65646e28-7648-40ad-8cfc-b85add6a5765", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "65", "days_to_last_known_alive": "", "days_to_last_followup": "48", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "ce6261e1-8614-4749-9d31-1b0a925338d4", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "269", "age_at_initial_pathologic_diagnosis": "80", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "c64e7dc3-0a87-43a0-9af2-33f04e280a06", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "98", "age_at_initial_pathologic_diagnosis": "80", "days_to_last_known_alive": "", "days_to_last_followup": "98", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "f809f2cf-803a-4a34-bf59-fb09753fd0ac", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "33", "age_at_initial_pathologic_diagnosis": "83", "days_to_last_known_alive": "", "days_to_last_followup": "33", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "f36bda90-5cd1-4ae6-88f0-10a7dc10bd8b", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Glioblastoma Multiforme (GBM)", "days_to_death": "592", "age_at_initial_pathologic_diagnosis": "45", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Taxol", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Carmustine", "start": "335", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Procarbazine", "start": "495", "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 2, "radiation_details": [{"type": "External", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": "cGy"}, {"type": "External", "start": "504", "end": null, "duration": "", "dosis": null, "dosis_unit": null}]}, {"uuid": "8a5e570a-c11a-4df9-aa9f-9d5a0a7f78f9", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "232", "age_at_initial_pathologic_diagnosis": "75", "days_to_last_known_alive": "", "days_to_last_followup": "167", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "CCNU", "start": "117", "end": "158", "duration": 41, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temodar", "start": "37", "end": "94", "duration": 57, "dosis": null, "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "37", "end": "94", "duration": 57, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "6d7a9ffa-c82c-49ed-8f99-13c5febb0a06", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "3524", "age_at_initial_pathologic_diagnosis": "66", "days_to_last_known_alive": "", "days_to_last_followup": "3310", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "BCNU", "start": "2577", "end": "2850", "duration": 273, "dosis": null, "dosis_unit": null}], "qty_radiation": 3, "radiation_details": [{"type": "OTHER", "start": "120", "end": "120", "duration": 0, "dosis": null, "dosis_unit": null}, {"type": "OTHER", "start": "2122", "end": "2122", "duration": 0, "dosis": "1550", "dosis_unit": "cGy"}, {"type": "EXTERNAL BEAM", "start": "82", "end": "113", "duration": 31, "dosis": null, "dosis_unit": null}]}, {"uuid": "fdae9fcd-b96f-4cc9-80b6-28a23f5ca15c", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "44", "days_to_last_known_alive": "", "days_to_last_followup": "242", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Hormone Therapy", "name": "Dexamethasone", "start": "0", "end": null, "duration": "", "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "34", "end": "242", "duration": 208, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "34", "end": "78", "duration": 44, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "9c65354a-0c6c-4b28-95a1-4e006d15fb4c", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Glioblastoma Multiforme (GBM)", "days_to_death": "466", "age_at_initial_pathologic_diagnosis": "47", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "26", "end": "64", "duration": 38, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "81", "end": "256", "duration": 175, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "ABT-888", "start": "81", "end": "256", "duration": 175, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cabozantinib", "start": "293", "end": "455", "duration": 162, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "26", "end": "64", "duration": 38, "dosis": "60", "dosis_unit": "Gy"}]}, {"uuid": "67c4e27e-9721-4c52-8af0-e7a08a34ef40", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "99", "age_at_initial_pathologic_diagnosis": "65", "days_to_last_known_alive": "", "days_to_last_followup": "99", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Hormone Therapy", "name": "Dexamethasone", "start": "0", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Gliadel Wafers", "start": "0", "end": null, "duration": "", "dosis": null, "dosis_unit": "{Wafer}"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "7f73b155-0dbc-4af9-8843-a33d96772649", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "78", "days_to_last_known_alive": "", "days_to_last_followup": "204", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "13", "end": "17", "duration": 4, "dosis": "100", "dosis_unit": null}]}, {"uuid": "b4682ebb-60a5-4e21-a0c6-5b716284c491", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "77", "days_to_last_known_alive": "", "days_to_last_followup": "6", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "73e12b6e-0276-464a-96d5-24d1a95b2113", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "82", "days_to_last_known_alive": "", "days_to_last_followup": "270", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Gliadel Wafer", "start": "0", "end": "0", "duration": 0, "dosis": null, "dosis_unit": "{Wafer}"}, {"type": "Chemotherapy", "name": "Temodar", "start": "17", "end": "59", "duration": 42, "dosis": "200", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "108", "end": null, "duration": "", "dosis": "200", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "17", "end": "59", "duration": 42, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "64211996-6fb9-4c25-923d-c03d656c90cf", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "343", "age_at_initial_pathologic_diagnosis": "71", "days_to_last_known_alive": "", "days_to_last_followup": "275", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 4, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temodar", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": null, "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 3, "radiation_details": [{"type": null, "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": null, "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": null, "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}]}, {"uuid": "b370fd21-7854-4d84-957a-7d0d370ac926", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "753", "age_at_initial_pathologic_diagnosis": "52", "days_to_last_known_alive": "", "days_to_last_followup": "753", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 6, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "22", "end": "182", "duration": 160, "dosis": "350", "dosis_unit": "mg"}, {"type": "Hormone Therapy", "name": "Dexamethasone", "start": "55", "end": "753", "duration": 698, "dosis": "8", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Fotemustine", "start": "627", "end": "700", "duration": 73, "dosis": "180", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "PC2", "start": "627", "end": "700", "duration": 73, "dosis": "300", "dosis_unit": "mg"}, {"type": "Hormone Therapy", "name": "Levenracetam", "start": "55", "end": "753", "duration": 698, "dosis": "1500", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "20", "end": "107", "duration": 87, "dosis": "160", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "38", "end": "82", "duration": 44, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "5088cea4-caa2-4b32-997c-123b7b5eea37", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "638", "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": "", "days_to_last_followup": "638", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Avastin", "start": "510", "end": "580", "duration": 70, "dosis": "990", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "102", "end": null, "duration": "", "dosis": "100", "dosis_unit": "mg"}], "qty_radiation": 2, "radiation_details": [{"type": "RADIOISOTOPE", "start": "250", "end": "250", "duration": 0, "dosis": "35", "dosis_unit": "cGy"}, {"type": "EXTERNAL BEAM", "start": "-278", "end": "67", "duration": 345, "dosis": "60", "dosis_unit": "cGy"}]}, {"uuid": "76c8e9ae-e98d-4595-a588-99cafcf70d87", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "323", "age_at_initial_pathologic_diagnosis": "62", "days_to_last_known_alive": "", "days_to_last_followup": "323", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "CCNU", "start": "123", "end": "165", "duration": 42, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "VP-16", "start": "203", "end": "259", "duration": 56, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "CPT-11", "start": "271", "end": "296", "duration": 25, "dosis": null, "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "35", "end": "86", "duration": 51, "dosis": "6120", "dosis_unit": "cGy"}]}, {"uuid": "f8ae4d54-7038-4fd8-bef4-932bbf59851e", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "1068", "age_at_initial_pathologic_diagnosis": "63", "days_to_last_known_alive": "", "days_to_last_followup": "1065", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Cisplatain", "start": "5", "end": "370", "duration": 365, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "BCNU", "start": "5", "end": "370", "duration": 365, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "5", "end": "5", "duration": 0, "dosis": null, "dosis_unit": null}]}, {"uuid": "c5ad24bc-f81f-4eba-833a-52318969d570", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "327", "age_at_initial_pathologic_diagnosis": "68", "days_to_last_known_alive": "", "days_to_last_followup": "327", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "7e789f3c-a1de-4e83-990f-37a5046f34f6", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "164", "age_at_initial_pathologic_diagnosis": "69", "days_to_last_known_alive": "", "days_to_last_followup": "164", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Hormone Therapy", "name": "Dexamethasone", "start": "0", "end": "15", "duration": 15, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "d7da0175-b624-456b-a29c-b1cbeebc0bc5", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "41", "age_at_initial_pathologic_diagnosis": "78", "days_to_last_known_alive": "", "days_to_last_followup": "41", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Hormone Therapy", "name": "Dexamethasone", "start": "0", "end": "41", "duration": 41, "dosis": null, "dosis_unit": "mg/day"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "8757744e-148f-4271-92b8-b7623acba53e", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "20", "age_at_initial_pathologic_diagnosis": "70", "days_to_last_known_alive": "", "days_to_last_followup": "20", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "e4c4ad3f-4d96-49b9-a621-059e89a3fc7d", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "394", "age_at_initial_pathologic_diagnosis": "58", "days_to_last_known_alive": "", "days_to_last_followup": "394", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "21", "end": "63", "duration": 42, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "97", "end": "250", "duration": 153, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Avastin", "start": "363", "end": "377", "duration": 14, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "269", "end": "328", "duration": 59, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "21", "end": "63", "duration": 42, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "fccf56aa-e168-46a1-b3a4-8dbfb5e19dee", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "1818", "age_at_initial_pathologic_diagnosis": "47", "days_to_last_known_alive": "", "days_to_last_followup": "1807", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 28, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "72", "end": "119", "duration": 47, "dosis": "200", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "1583", "end": "1611", "duration": 28, "dosis": "10", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "1639", "end": "1722", "duration": 83, "dosis": "10", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "1142", "end": "1180", "duration": 38, "dosis": "75", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Accutane", "start": "1611", "end": "1639", "duration": 28, "dosis": "80", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Hydroxyuerea", "start": "1583", "end": "1611", "duration": 28, "dosis": "500", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Rapamycin", "start": "1583", "end": "1611", "duration": 28, "dosis": "5", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "06BG", "start": "1150", "end": "1154", "duration": 4, "dosis": "120", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "CCNU", "start": "134", "end": "179", "duration": 45, "dosis": "110", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "CPT 11", "start": "1194", "end": "1583", "duration": 389, "dosis": "125", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "1639", "end": "1722", "duration": 83, "dosis": "150", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Acctuane", "start": "1639", "end": "1722", "duration": 83, "dosis": "80", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Rapamycin", "start": "891", "end": "1030", "duration": 139, "dosis": "5", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Tarceva", "start": "1611", "end": "1639", "duration": 28, "dosis": "150", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "1765", "end": "1806", "duration": 41, "dosis": "10", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "1611", "end": "1639", "duration": 28, "dosis": "10", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "1030", "end": "1142", "duration": 112, "dosis": "50", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "1194", "end": "1583", "duration": 389, "dosis": "10", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Tarceva", "start": "1583", "end": "1611", "duration": 28, "dosis": "150", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "861", "end": "891", "duration": 30, "dosis": "200", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "CPT 11", "start": "1639", "end": "1722", "duration": 83, "dosis": "125", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "06BG", "start": "1150", "end": "1154", "duration": 4, "dosis": "30", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Gliadel Wafer", "start": "37", "end": "37", "duration": 0, "dosis": "8", "dosis_unit": "{Wafer}"}, {"type": "Chemotherapy", "name": "Hydroxyurea", "start": "1611", "end": "1639", "duration": 28, "dosis": "500", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Tarceva", "start": "891", "end": "1030", "duration": 139, "dosis": "150", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Rapamycin", "start": "1611", "end": "1639", "duration": 28, "dosis": "5", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "179", "end": "486", "duration": 307, "dosis": "200", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Chloroquine", "start": "1639", "end": "1722", "duration": 83, "dosis": "500", "dosis_unit": "mg"}], "qty_radiation": 2, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "891", "end": "891", "duration": 0, "dosis": "1800", "dosis_unit": "cGy"}, {"type": "EXTERNAL BEAM", "start": "72", "end": "119", "duration": 47, "dosis": "5940", "dosis_unit": "cGy"}]}, {"uuid": "cc2b004b-fc01-429e-906f-710877918fca", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "632", "age_at_initial_pathologic_diagnosis": "58", "days_to_last_known_alive": "", "days_to_last_followup": "632", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 7, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "90", "end": "94", "duration": 4, "dosis": "270", "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temodar", "start": "488", "end": "550", "duration": 62, "dosis": "160", "dosis_unit": "mg/day"}, {"type": "Chemotherapy", "name": "Temodar", "start": "20", "end": "62", "duration": 42, "dosis": "140", "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temodar", "start": "120", "end": "403", "duration": 283, "dosis": "360", "dosis_unit": "mg/m2"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "488", "end": "550", "duration": 62, "dosis": "600", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "620", "end": "620", "duration": 0, "dosis": null, "dosis_unit": "mg/kg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "620", "end": "632", "duration": 12, "dosis": "140", "dosis_unit": "mg/day"}], "qty_radiation": 3, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "21", "end": "62", "duration": 41, "dosis": "6000", "dosis_unit": "cGy"}, {"type": "EXTERNAL BEAM", "start": "501", "end": "518", "duration": 17, "dosis": "3900", "dosis_unit": "cGy"}, {"type": "RADIOISOTOPE", "start": "21", "end": "62", "duration": 41, "dosis": "354", "dosis_unit": null}]}, {"uuid": "156dede1-a383-49d0-9391-3b660cf998d6", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "358", "age_at_initial_pathologic_diagnosis": "44", "days_to_last_known_alive": "", "days_to_last_followup": "279", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "CRA", "start": "92", "end": "278", "duration": 186, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Celebrex", "start": "92", "end": "278", "duration": 186, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Cis Retinoic Acid", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Celebrex", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "49", "end": "80", "duration": 31, "dosis": "4500", "dosis_unit": "cGy"}]}, {"uuid": "6ddfcede-377c-448c-8b11-9afc6674014d", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "52", "days_to_last_known_alive": "", "days_to_last_followup": "415", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "29", "end": "70", "duration": 41, "dosis": "140", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "29", "end": "70", "duration": 41, "dosis": "140", "dosis_unit": "mg"}, {"type": null, "name": "Temodar", "start": "29", "end": "70", "duration": 41, "dosis": null, "dosis_unit": null}], "qty_radiation": 3, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "30", "end": "72", "duration": 42, "dosis": "6000", "dosis_unit": "cGy"}, {"type": "EXTERNAL BEAM", "start": "30", "end": "72", "duration": 42, "dosis": "6000", "dosis_unit": "cGy"}, {"type": "External", "start": "30", "end": "72", "duration": 42, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "9611d7d9-569e-46cb-8d4a-a64c627fdf89", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "914", "age_at_initial_pathologic_diagnosis": "33", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 9, "drug_details": [{"type": "Hormone Therapy", "name": "Dexamethasone", "start": "-7", "end": "914", "duration": 921, "dosis": "24", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Fotemustine", "start": "247", "end": "399", "duration": 152, "dosis": "160", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Bevacizumab", "start": "655", "end": "760", "duration": 105, "dosis": "800", "dosis_unit": "mg"}, {"type": "Hormone Therapy", "name": "Valproic Acid", "start": "-7", "end": "914", "duration": 921, "dosis": "900", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "472", "end": "562", "duration": 90, "dosis": "200", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "PCB", "start": "245", "end": "399", "duration": 154, "dosis": "500", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Irinotecan", "start": "655", "end": "760", "duration": 105, "dosis": "200", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "48", "end": "90", "duration": 42, "dosis": "140", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "120", "end": "181", "duration": 61, "dosis": "200", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "48", "end": "90", "duration": 42, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "a0cdcf40-f421-4f4e-8525-4fd1508c3891", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "975", "age_at_initial_pathologic_diagnosis": "58", "days_to_last_known_alive": "", "days_to_last_followup": "975", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 8, "drug_details": [{"type": "Targeted Molecular therapy", "name": "Avastin", "start": "659", "end": "832", "duration": 173, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Carboplatin", "start": "659", "end": "832", "duration": 173, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "344", "end": "529", "duration": 185, "dosis": null, "dosis_unit": "mg"}, {"type": "Hormone Therapy", "name": "Dexamethasone", "start": "316", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Hormone Therapy", "name": "Prednisone", "start": "316", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "Sovatenib", "start": "619", "end": "633", "duration": 14, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Arsenic Trioxide", "start": "57", "end": "66", "duration": 9, "dosis": null, "dosis_unit": "mg"}, {"type": "Hormone Therapy", "name": "Dexamethasone", "start": "333", "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "28", "end": "67", "duration": 39, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "eda3313d-c626-4287-a65d-340af38df2f2", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Glioblastoma Multiforme (GBM)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "61", "days_to_last_known_alive": "", "days_to_last_followup": "124", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "30", "end": "72", "duration": 42, "dosis": "18", "dosis_unit": null}]}, {"uuid": "4c18f144-eb16-4f54-8a96-3bedd16a7eb2", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "57", "days_to_last_known_alive": "", "days_to_last_followup": "1788", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 5, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "127", "end": "961", "duration": 834, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "22", "end": "65", "duration": 43, "dosis": null, "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "1024", "end": "1233", "duration": 209, "dosis": null, "dosis_unit": "mg"}, {"type": "Hormone Therapy", "name": "Dexamethasone", "start": "0", "end": null, "duration": "", "dosis": null, "dosis_unit": "mg"}, {"type": "Hormone Therapy", "name": "Dexamethasone", "start": "826", "end": null, "duration": "", "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "22", "end": "65", "duration": 43, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "3ea7d69e-8a79-4cdc-b5a7-e951b579fe7d", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "50", "days_to_last_known_alive": "", "days_to_last_followup": "2", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "14", "end": "642", "duration": 628, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "3", "end": "64", "duration": 61, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "7eb0c4e6-ea0f-4aa3-8552-d5c4efe3e678", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "278", "age_at_initial_pathologic_diagnosis": "70", "days_to_last_known_alive": "", "days_to_last_followup": "111", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "28", "end": "41", "duration": 13, "dosis": "3000", "dosis_unit": "cGy"}]}, {"uuid": "791cde77-3851-424a-9579-6518381b6747", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "61", "days_to_last_known_alive": "", "days_to_last_followup": "279", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "89", "end": "454", "duration": 365, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "18", "end": "60", "duration": 42, "dosis": "6000", "dosis_unit": null}]}, {"uuid": "dfb5b94e-1563-479e-af81-364b6a69e7df", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "233", "age_at_initial_pathologic_diagnosis": "40", "days_to_last_known_alive": "", "days_to_last_followup": "197", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Carmustine (BCNU)", "start": "138", "end": "138", "duration": 0, "dosis": "200", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "18", "end": "79", "duration": 61, "dosis": null, "dosis_unit": "cGy"}]}, {"uuid": "371a2a70-f910-4609-8511-08d6080c0fa9", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "56", "days_to_last_known_alive": "", "days_to_last_followup": "164", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "34", "end": "80", "duration": 46, "dosis": "145", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Avastin", "start": "56", "end": "265", "duration": 209, "dosis": "745-835", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "111", "end": "248", "duration": 137, "dosis": "300-400", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "34", "end": "80", "duration": 46, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "36c6c556-04ad-494b-a605-53d8dc3e1c05", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "142", "age_at_initial_pathologic_diagnosis": "37", "days_to_last_known_alive": "", "days_to_last_followup": "142", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "7c16424e-48b1-47ae-82d1-c07f499a0aec", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "64", "age_at_initial_pathologic_diagnosis": "73", "days_to_last_known_alive": "", "days_to_last_followup": "62", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "53ee575e-a330-47ed-b68c-fe9a5314af6d", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "147", "age_at_initial_pathologic_diagnosis": "66", "days_to_last_known_alive": "", "days_to_last_followup": "147", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "11", "end": null, "duration": "", "dosis": "140", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "42", "end": "89", "duration": 47, "dosis": "5940", "dosis_unit": "cGy"}]}, {"uuid": "6892af8c-8137-474b-b0e8-0e673bdb91a0", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "22", "age_at_initial_pathologic_diagnosis": "67", "days_to_last_known_alive": "", "days_to_last_followup": "11", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "ffad60b1-e26b-47d9-9cd6-6960346d9c20", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "54", "days_to_last_known_alive": "", "days_to_last_followup": "1126", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 8, "drug_details": [{"type": "Targeted Molecular therapy", "name": "Arsenic Trioxide (ATO)", "start": "19", "end": "56", "duration": 37, "dosis": "0.25", "dosis_unit": "mg/kg"}, {"type": "Targeted Molecular therapy", "name": "Bevacizumab", "start": "1664", "end": null, "duration": "", "dosis": "10", "dosis_unit": "mg/kg"}, {"type": "Chemotherapy", "name": "Lomustine", "start": "2259", "end": null, "duration": "", "dosis": "110", "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "98", "end": "249", "duration": 151, "dosis": "200", "dosis_unit": "mg/m2"}, {"type": "Targeted Molecular therapy", "name": "Bevacizumab", "start": "739", "end": "1397", "duration": 658, "dosis": "10", "dosis_unit": "mg/kg"}, {"type": "Chemotherapy", "name": "Irinotecan", "start": "739", "end": "1397", "duration": 658, "dosis": "125", "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "1986", "end": "2228", "duration": 242, "dosis": "75", "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "XL184", "start": "1502", "end": "1636", "duration": 134, "dosis": "75", "dosis_unit": "mg/day"}], "qty_radiation": 2, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "18", "end": "57", "duration": 39, "dosis": "6000", "dosis_unit": "cGy"}, {"type": "OTHER", "start": "1670", "end": "1677", "duration": 7, "dosis": "3200", "dosis_unit": "cGy"}]}, {"uuid": "ea962df2-f4da-4e90-8109-bd1292b553c0", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "405", "age_at_initial_pathologic_diagnosis": "46", "days_to_last_known_alive": "", "days_to_last_followup": "359", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "0a5593bc-7377-4328-9787-1068214f5b4f", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Glioblastoma Multiforme (GBM)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "69", "days_to_last_known_alive": "", "days_to_last_followup": "44", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "56", "end": "105", "duration": 49, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "56", "end": "105", "duration": 49, "dosis": "55", "dosis_unit": "Gy"}]}, {"uuid": "7ac48793-2513-4ed8-957b-df693dc585a7", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "546", "age_at_initial_pathologic_diagnosis": "52", "days_to_last_known_alive": "", "days_to_last_followup": "458", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 5, "drug_details": [{"type": "Chemotherapy", "name": "Temador", "start": "261", "end": "320", "duration": 59, "dosis": null, "dosis_unit": "mg/day"}, {"type": "Targeted Molecular therapy", "name": "Tarceva", "start": "261", "end": "320", "duration": 59, "dosis": null, "dosis_unit": "mg/day"}, {"type": "Chemotherapy", "name": "BCNU", "start": "345", "end": "390", "duration": 45, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Poly LCLC", "start": "28", "end": "253", "duration": 225, "dosis": null, "dosis_unit": "mL"}, {"type": "Chemotherapy", "name": "cis retinoic acid", "start": "345", "end": "393", "duration": 48, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "35", "end": "97", "duration": 62, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "f709f0e6-c9d4-449d-ac90-a2fab0ddf618", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "815", "age_at_initial_pathologic_diagnosis": "61", "days_to_last_known_alive": "", "days_to_last_followup": "815", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "94", "end": "275", "duration": 181, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "35", "end": "78", "duration": 43, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "073e82d1-b4ff-429a-a224-66582ff1092f", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "454", "age_at_initial_pathologic_diagnosis": "53", "days_to_last_known_alive": "", "days_to_last_followup": "452", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 10, "drug_details": [{"type": "Chemotherapy", "name": "Temozolamide", "start": "22", "end": "68", "duration": 46, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temozolamide", "start": "89", "end": "147", "duration": 58, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "CCNU", "start": "147", "end": "232", "duration": 85, "dosis": null, "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "250", "end": "329", "duration": 79, "dosis": null, "dosis_unit": "mg/kg"}, {"type": "Targeted Molecular therapy", "name": "Tarceva", "start": "355", "end": "385", "duration": 30, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "329", "end": "352", "duration": 23, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Targeted Molecular therapy", "name": "Rapamcyin", "start": "355", "end": "385", "duration": 30, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "VP-16", "start": "250", "end": "329", "duration": 79, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "VP-16", "start": "329", "end": "352", "duration": 23, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Targeted Molecular therapy", "name": "Rapamycin", "start": "355", "end": "385", "duration": 30, "dosis": null, "dosis_unit": "mg/day"}], "qty_radiation": 4, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "239", "end": "258", "duration": 19, "dosis": "3500", "dosis_unit": "cGy"}, {"type": "EXTERNAL BEAM", "start": "363", "end": "363", "duration": 0, "dosis": "1800", "dosis_unit": "cGy"}, {"type": "EXTERNAL BEAM", "start": "22", "end": "68", "duration": 46, "dosis": "5940", "dosis_unit": "cGy"}, {"type": "EXTERNAL BEAM", "start": "363", "end": "363", "duration": 0, "dosis": "1500", "dosis_unit": "cGy"}]}, {"uuid": "6a0b644f-89e0-43b2-9763-1faa01b63a33", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "463", "age_at_initial_pathologic_diagnosis": "76", "days_to_last_known_alive": "", "days_to_last_followup": "351", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 8, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "186", "end": "240", "duration": 54, "dosis": "200", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "186", "end": "240", "duration": 54, "dosis": "10", "dosis_unit": "mg/kg"}, {"type": "Immunotherapy", "name": "ATTAC", "start": "240", "end": "350", "duration": 110, "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "240", "end": "347", "duration": 107, "dosis": "10", "dosis_unit": "mg/kg"}, {"type": "Immunotherapy", "name": "ATTAC", "start": "186", "end": "245", "duration": 59, "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": null, "end": null, "duration": "", "dosis": "10", "dosis_unit": "mg/kg"}, {"type": "Chemotherapy", "name": "Temodar", "start": null, "end": null, "duration": "", "dosis": "200", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "240", "end": "350", "duration": 110, "dosis": "200", "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "577438d4-3fb6-4b3a-b7ca-062a3e325e42", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "503", "age_at_initial_pathologic_diagnosis": "36", "days_to_last_known_alive": "", "days_to_last_followup": "503", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "0b09371f-3f38-4005-8b06-6cc165ffc26a", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "880", "age_at_initial_pathologic_diagnosis": "74", "days_to_last_known_alive": "", "days_to_last_followup": "880", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Hormone Therapy", "name": "Dexamethasone", "start": "0", "end": "281", "duration": 281, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "22", "end": "72", "duration": 50, "dosis": "5940", "dosis_unit": "cGy"}]}, {"uuid": "ef2b79e8-8362-4840-8607-71c30338dbad", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "399", "age_at_initial_pathologic_diagnosis": "65", "days_to_last_known_alive": "", "days_to_last_followup": "396", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Carmustine (BCNU)", "start": "231", "end": "273", "duration": 42, "dosis": "200", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "81", "end": "175", "duration": 94, "dosis": "200", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "36", "end": "76", "duration": 40, "dosis": null, "dosis_unit": "cGy"}]}, {"uuid": "a4e32acd-69de-411c-ad3d-df187e8d9a65", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "34", "age_at_initial_pathologic_diagnosis": "78", "days_to_last_known_alive": "", "days_to_last_followup": "34", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Hormone Therapy", "name": "Dexamethasone", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "e68949bf-61e8-4d22-b835-bed2567ea7be", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "375", "age_at_initial_pathologic_diagnosis": "68", "days_to_last_known_alive": "", "days_to_last_followup": "359", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Procarbazine", "start": "293", "end": "293", "duration": 0, "dosis": "110", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Tamoxifen", "start": "293", "end": "293", "duration": 0, "dosis": "10", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Carmustine", "start": "263", "end": "293", "duration": 30, "dosis": "80", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Paclitaxel", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": null, "end": "123", "duration": "", "dosis": null, "dosis_unit": "cGy"}]}, {"uuid": "6d2c3aa1-3033-4bee-98a0-0f774578a437", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "58", "days_to_last_known_alive": "", "days_to_last_followup": "282", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Carmustine", "start": "254", "end": null, "duration": "", "dosis": "360", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "88", "end": "227", "duration": 139, "dosis": "100", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "22", "end": "65", "duration": 43, "dosis": "60", "dosis_unit": "cGy"}]}, {"uuid": "87654485-a0ba-43db-bb13-b993037de7d8", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "1143", "age_at_initial_pathologic_diagnosis": "49", "days_to_last_known_alive": "", "days_to_last_followup": "1084", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 15, "drug_details": [{"type": "Chemotherapy", "name": "Hyrdroxyurea", "start": "689", "end": "733", "duration": 44, "dosis": null, "dosis_unit": "mg/day"}, {"type": "Targeted Molecular therapy", "name": "Rapamycin", "start": "736", "end": "860", "duration": 124, "dosis": null, "dosis_unit": "mg/day"}, {"type": "Chemotherapy", "name": "CCNU", "start": "736", "end": "860", "duration": 124, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Targeted Molecular therapy", "name": "Thalidomide", "start": "93", "end": "136", "duration": 43, "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "Gleevac", "start": "689", "end": "733", "duration": 44, "dosis": null, "dosis_unit": "mg/day"}, {"type": "Chemotherapy", "name": "Temodar", "start": "93", "end": "136", "duration": 43, "dosis": null, "dosis_unit": "mg"}, {"type": "Immunotherapy", "name": "Interferon Alpha", "start": "736", "end": "860", "duration": 124, "dosis": null, "dosis_unit": null}, {"type": "Immunotherapy", "name": "IL-13 Pseudomonas exotoxin", "start": "184", "end": "188", "duration": 4, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "29", "end": "71", "duration": 42, "dosis": null, "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Cytoxan", "start": "1097", "end": "1112", "duration": 15, "dosis": null, "dosis_unit": "mg/day"}, {"type": "Chemotherapy", "name": "VP-16", "start": "875", "end": "985", "duration": 110, "dosis": null, "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Sorafenib", "start": "1007", "end": "1084", "duration": 77, "dosis": null, "dosis_unit": "mg/day"}, {"type": "Targeted Molecular therapy", "name": "Irinotecan", "start": "471", "end": "688", "duration": 217, "dosis": null, "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Tarveca", "start": "1007", "end": "1084", "duration": 77, "dosis": null, "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "471", "end": "688", "duration": 217, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "29", "end": "71", "duration": 42, "dosis": "6005", "dosis_unit": "cGy"}]}, {"uuid": "06c2f2fe-258e-4c57-abb2-77050b68721c", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "661", "age_at_initial_pathologic_diagnosis": "58", "days_to_last_known_alive": "", "days_to_last_followup": "658", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 9, "drug_details": [{"type": "Chemotherapy", "name": "CPT 11", "start": "368", "end": "460", "duration": 92, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Targeted Molecular therapy", "name": "Tarceva", "start": "460", "end": "551", "duration": 91, "dosis": null, "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "119", "end": "204", "duration": 85, "dosis": null, "dosis_unit": "mg/kg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "232", "end": "367", "duration": 135, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temodar", "start": "46", "end": "96", "duration": 50, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temodar", "start": "551", "end": "637", "duration": 86, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temodar", "start": "205", "end": "232", "duration": 27, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Targeted Molecular therapy", "name": "Rapamycin", "start": "460", "end": "551", "duration": 91, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "119", "end": "204", "duration": 85, "dosis": null, "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "46", "end": "96", "duration": 50, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "657a771a-4959-44e9-af63-5cd46460e065", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "1233", "age_at_initial_pathologic_diagnosis": "56", "days_to_last_known_alive": "", "days_to_last_followup": "1008", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 6, "drug_details": [{"type": "Hormone Therapy", "name": "Dexamethasone", "start": "-5", "end": "1233", "duration": 1238, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Procarbazine", "start": "352", "end": "540", "duration": 188, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "15", "end": "168", "duration": 153, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Fotemustine", "start": "352", "end": "540", "duration": 188, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomoide", "start": "15", "end": "168", "duration": 153, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "352", "end": "662", "duration": 310, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "27", "end": "64", "duration": 37, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "4aa405d2-e37d-415a-8a48-693424a1f6f1", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Glioblastoma Multiforme (GBM)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "64", "days_to_last_known_alive": "", "days_to_last_followup": "164", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "34", "end": "76", "duration": 42, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "113", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Lomustine", "start": "342", "end": "419", "duration": 77, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Procarbazine", "start": "342", "end": "420", "duration": 78, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "34", "end": "76", "duration": 42, "dosis": "60", "dosis_unit": "Gy"}]}, {"uuid": "609afc66-8b5a-4667-9053-a47b4880c2eb", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "2201", "age_at_initial_pathologic_diagnosis": "43", "days_to_last_known_alive": "", "days_to_last_followup": "2145", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 9, "drug_details": [{"type": "Chemotherapy", "name": "Procarbazine", "start": "1294", "end": "1628", "duration": 334, "dosis": "50", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Tamoxifen", "start": "1294", "end": "1779", "duration": 485, "dosis": "20", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Lomustine", "start": "168", "end": "348", "duration": 180, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Vincristine", "start": "168", "end": "348", "duration": 180, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Gliadel Wafer", "start": "1267", "end": "1267", "duration": 0, "dosis": null, "dosis_unit": "{Wafer}"}, {"type": "Chemotherapy", "name": "Procarbazine", "start": "168", "end": "348", "duration": 180, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "9 immunoamino camptnetecin", "start": "379", "end": "471", "duration": 92, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Hyroxyurea", "start": "75", "end": "149", "duration": 74, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Irinotecan", "start": "1845", "end": "2114", "duration": 269, "dosis": "125", "dosis_unit": "mg"}], "qty_radiation": 2, "radiation_details": [{"type": "OTHER", "start": "1809", "end": "1809", "duration": 0, "dosis": "4000", "dosis_unit": "cGy"}, {"type": "EXTERNAL BEAM", "start": "75", "end": "149", "duration": 74, "dosis": "5940", "dosis_unit": "cGy"}]}, {"uuid": "c07b95e1-bf50-4cc0-8b44-d30b94574c70", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "5", "age_at_initial_pathologic_diagnosis": "51", "days_to_last_known_alive": "", "days_to_last_followup": "5", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "5fcd18ca-b155-4148-a20f-991df154b94a", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "28", "age_at_initial_pathologic_diagnosis": "43", "days_to_last_known_alive": "", "days_to_last_followup": "28", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "4c6bd9f6-da20-4581-b42f-e2c5b1d358da", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "206", "age_at_initial_pathologic_diagnosis": "58", "days_to_last_known_alive": "", "days_to_last_followup": "195", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temodor", "start": "86", "end": "140", "duration": 54, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodor", "start": "17", "end": "57", "duration": 40, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "17", "end": "57", "duration": 40, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "5f2102dd-11b1-4660-9ceb-7a966f435e4e", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "1179", "age_at_initial_pathologic_diagnosis": "38", "days_to_last_known_alive": "", "days_to_last_followup": "1179", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 9, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "350", "end": "390", "duration": 40, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "258", "end": "350", "duration": 92, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Targeted Molecular therapy", "name": "81C6", "start": "34", "end": "76", "duration": 42, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "CCNU", "start": "181", "end": "258", "duration": 77, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "CPT-11", "start": "390", "end": "434", "duration": 44, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Targeted Molecular therapy", "name": "MABI131", "start": "34", "end": "76", "duration": 42, "dosis": null, "dosis_unit": "mCi"}, {"type": "Chemotherapy", "name": "CCNU", "start": "137", "end": "181", "duration": 44, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "466", "end": "615", "duration": 149, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Hormone Therapy", "name": "Tamoxifen", "start": "615", "end": "746", "duration": 131, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "76", "end": "127", "duration": 51, "dosis": "5940", "dosis_unit": "cGy"}]}, {"uuid": "b8e11f25-01bb-47ab-ace1-8e5ce08bf709", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Glioblastoma Multiforme (GBM)", "days_to_death": "78", "age_at_initial_pathologic_diagnosis": "53", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "8", "end": "45", "duration": 37, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "8", "end": "45", "duration": 37, "dosis": "41.1", "dosis_unit": "Gy"}]}, {"uuid": "c21a76de-a185-414e-a70a-14db69d47fea", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "457", "age_at_initial_pathologic_diagnosis": "66", "days_to_last_known_alive": "", "days_to_last_followup": "378", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Carmustine (BCNU)", "start": "119", "end": "331", "duration": 212, "dosis": "200", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Tamoxifen", "start": "331", "end": "453", "duration": 122, "dosis": "10", "dosis_unit": "mg/day"}, {"type": "Chemotherapy", "name": "CI-980", "start": "18", "end": "52", "duration": 34, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "66", "end": "109", "duration": 43, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "82c26d71-c11a-4046-bbf6-60202ade3a15", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "39", "age_at_initial_pathologic_diagnosis": "79", "days_to_last_known_alive": "", "days_to_last_followup": "39", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "f6682817-fd6e-4fa3-8ee9-f09a19de946a", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Treated primary GBM", "days_to_death": "516", "age_at_initial_pathologic_diagnosis": "52", "days_to_last_known_alive": "", "days_to_last_followup": "516", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "68", "end": "282", "duration": 214, "dosis": null, "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "38", "end": "85", "duration": 47, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "adada823-910e-485d-9b84-7f60e3a8849d", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "121", "age_at_initial_pathologic_diagnosis": "67", "days_to_last_known_alive": "", "days_to_last_followup": "109", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "21", "end": "64", "duration": 43, "dosis": "75", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "21", "end": "64", "duration": 43, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "90d0acd1-2bf0-4462-b3e8-0a4ac6b47532", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "63", "days_to_last_known_alive": "", "days_to_last_followup": "205", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Immunotherapy", "name": "Tumor Vaccine", "start": "107", "end": "135", "duration": 28, "dosis": "1.1", "dosis_unit": "mL"}, {"type": "Chemotherapy", "name": "Temodar", "start": "27", "end": "72", "duration": 45, "dosis": "100", "dosis_unit": "mg/m2"}, {"type": "Targeted Molecular therapy", "name": "BIBW 2992", "start": "177", "end": null, "duration": "", "dosis": "40", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "27", "end": "69", "duration": 42, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "b835382a-4f86-44f5-a5a5-cbe290fff9ce", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "296", "age_at_initial_pathologic_diagnosis": "52", "days_to_last_known_alive": "", "days_to_last_followup": "277", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "CCNU", "start": "82", "end": "127", "duration": 45, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temodar", "start": "33", "end": "74", "duration": 41, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "CPT-11", "start": "140", "end": "275", "duration": 135, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "140", "end": "275", "duration": 135, "dosis": null, "dosis_unit": "mg/kg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "33", "end": "74", "duration": 41, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "20d3be49-8fa4-4dfb-88f1-34369ff85001", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "548", "age_at_initial_pathologic_diagnosis": "74", "days_to_last_known_alive": "", "days_to_last_followup": "478", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 5, "drug_details": [{"type": "Targeted Molecular therapy", "name": "Tarceva", "start": "94", "end": "106", "duration": 12, "dosis": null, "dosis_unit": "mg/day"}, {"type": "Chemotherapy", "name": "Temodar", "start": "29", "end": "76", "duration": 47, "dosis": null, "dosis_unit": "mg/m2/day"}, {"type": "Targeted Molecular therapy", "name": "Tarceva", "start": "29", "end": "76", "duration": 47, "dosis": null, "dosis_unit": "mg/day"}, {"type": "Chemotherapy", "name": "Temodar", "start": "95", "end": "427", "duration": 332, "dosis": null, "dosis_unit": null}, {"type": "Immunotherapy", "name": "HSPPC-96 Vaccine", "start": "113", "end": "125", "duration": 12, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "29", "end": "76", "duration": 47, "dosis": "5940", "dosis_unit": "cGy"}]}, {"uuid": "03ee086c-a93f-4afe-ac72-a7838c484837", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Glioblastoma Multiforme (GBM)", "days_to_death": "621", "age_at_initial_pathologic_diagnosis": "57", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 7, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "34", "end": "65", "duration": 31, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "36", "end": "320", "duration": 284, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cilengitide", "start": "36", "end": "320", "duration": 284, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Irinotecan", "start": "337", "end": "407", "duration": 70, "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "Bevacizumab", "start": "337", "end": "589", "duration": 252, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "435", "end": "511", "duration": 76, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Carboplatin", "start": "547", "end": "589", "duration": 42, "dosis": null, "dosis_unit": null}], "qty_radiation": 2, "radiation_details": [{"type": "External", "start": "34", "end": "65", "duration": 31, "dosis": "6000", "dosis_unit": "cGy"}, {"type": null, "start": "420", "end": "432", "duration": 12, "dosis": "3600", "dosis_unit": "cGy"}]}, {"uuid": "5f7ea4ba-14d1-4536-9a87-f30619127146", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "360", "age_at_initial_pathologic_diagnosis": "47", "days_to_last_known_alive": "", "days_to_last_followup": "360", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "CI-980", "start": "25", "end": "44", "duration": 19, "dosis": "4.0", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Gliadel wafer", "start": "221", "end": "221", "duration": 0, "dosis": "8", "dosis_unit": "{Wafer}"}, {"type": "Chemotherapy", "name": "Carmustine", "start": "149", "end": "210", "duration": 61, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "121", "end": "149", "duration": 28, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "27fb73b3-99f2-4872-8595-d51b8dd08ef1", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "177", "age_at_initial_pathologic_diagnosis": "64", "days_to_last_known_alive": "", "days_to_last_followup": "177", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "CCNU", "start": "105", "end": "147", "duration": 42, "dosis": null, "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "33", "end": "77", "duration": 44, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "99e59e20-47ac-43c1-9664-1698ffb32d64", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "515", "age_at_initial_pathologic_diagnosis": "54", "days_to_last_known_alive": "", "days_to_last_followup": "515", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "1b949d43-c8cf-4a7f-9bb9-96074280f8e6", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "100", "age_at_initial_pathologic_diagnosis": "68", "days_to_last_known_alive": "", "days_to_last_followup": "95", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "29", "end": "78", "duration": 49, "dosis": "75", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "-152", "end": "78", "duration": 230, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "39d661ff-4fe9-4095-bd46-70b703b86de4", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "59", "days_to_last_known_alive": "", "days_to_last_followup": "95", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": null, "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "cc513d1c-eecf-4452-9f61-9857b42eaca3", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Glioblastoma Multiforme (GBM)", "days_to_death": "57", "age_at_initial_pathologic_diagnosis": "78", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "0bb1dfe7-ffb7-47cc-9e55-c5f7744c6970", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "49", "age_at_initial_pathologic_diagnosis": "64", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "424b5f0d-7919-436c-a3ff-d43407aafe45", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "593", "age_at_initial_pathologic_diagnosis": "69", "days_to_last_known_alive": "", "days_to_last_followup": "593", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "4e92295f-59be-48f1-bb9a-d21245b7f100", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "98", "age_at_initial_pathologic_diagnosis": "56", "days_to_last_known_alive": "", "days_to_last_followup": "98", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Targeted Molecular therapy", "name": "Avastin", "start": "45", "end": "73", "duration": 28, "dosis": "10", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "45", "end": "80", "duration": 35, "dosis": "75", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "45", "end": "77", "duration": 32, "dosis": "3780", "dosis_unit": "cGy"}]}, {"uuid": "a5fe65c0-39ee-4d93-a19c-b66eccef7c2a", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "114", "age_at_initial_pathologic_diagnosis": "58", "days_to_last_known_alive": "", "days_to_last_followup": "114", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "949014b7-581a-4ff1-b78a-5aa0198612b2", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "73", "days_to_last_known_alive": "", "days_to_last_followup": "280", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "19", "end": "159", "duration": 140, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "19", "end": "159", "duration": 140, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "19", "end": "159", "duration": 140, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "19", "end": "63", "duration": 44, "dosis": "5940", "dosis_unit": "cGy"}]}, {"uuid": "6bd0e316-520d-4119-9519-6f96eb0c0d73", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "53", "age_at_initial_pathologic_diagnosis": "71", "days_to_last_known_alive": "", "days_to_last_followup": "53", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "45", "end": "52", "duration": 7, "dosis": "0900", "dosis_unit": "cGy"}]}, {"uuid": "a0a8e445-c017-4072-92c8-05064ff92a8e", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "216", "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": "", "days_to_last_followup": "216", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Temador", "start": "26", "end": "185", "duration": 159, "dosis": null, "dosis_unit": "mg"}, {"type": "Hormone Therapy", "name": "Dexamethasone", "start": "172", "end": "216", "duration": 44, "dosis": null, "dosis_unit": null}, {"type": "Hormone Therapy", "name": "Dexamethasone", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Gliadel", "start": "0", "end": null, "duration": "", "dosis": null, "dosis_unit": "{Wafer}"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "26", "end": "69", "duration": 43, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "d4d6bab4-c2fc-4fcc-a5c1-231588e4c910", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "121", "age_at_initial_pathologic_diagnosis": "78", "days_to_last_known_alive": "", "days_to_last_followup": "121", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "b33857f5-6900-489e-82bc-58f3eefb203f", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "300", "age_at_initial_pathologic_diagnosis": "59", "days_to_last_known_alive": "", "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "207", "end": "207", "duration": 0, "dosis": null, "dosis_unit": "mg"}, {"type": "Hormone Therapy", "name": "Dexamethasone", "start": "0", "end": "300", "duration": 300, "dosis": null, "dosis_unit": "mg/day"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "23", "end": "207", "duration": 184, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "54", "end": "54", "duration": 0, "dosis": null, "dosis_unit": null}]}, {"uuid": "f5b8c005-40b1-4d14-9764-d70daa58541f", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "88", "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": "", "days_to_last_followup": "88", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Hormone Therapy", "name": "Dexamethasone", "start": "0", "end": null, "duration": "", "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "ca3b2977-3abb-407d-aa79-f39d38790bd5", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "372", "age_at_initial_pathologic_diagnosis": "40", "days_to_last_known_alive": "", "days_to_last_followup": "372", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "anti neopastons", "start": "23", "end": "176", "duration": 153, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}]}, {"uuid": "3fdb57c9-1916-488d-bcf2-f5417c4931f3", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "105", "age_at_initial_pathologic_diagnosis": "67", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Dead", "qty_follow_ups": 4, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "24", "end": "66", "duration": 42, "dosis": "140", "dosis_unit": "mg/day"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "24", "end": "66", "duration": 42, "dosis": "5800", "dosis_unit": "cGy"}]}, {"uuid": "4552640c-a012-4c00-8199-b918f94523a6", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "1151", "age_at_initial_pathologic_diagnosis": "31", "days_to_last_known_alive": "", "days_to_last_followup": "1057", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "BCNU", "start": "875", "end": "933", "duration": 58, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temodar", "start": "560", "end": "843", "duration": 283, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Hormone Therapy", "name": null, "start": "878", "end": "933", "duration": 55, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "BCNU", "start": "933", "end": "1065", "duration": 132, "dosis": null, "dosis_unit": "mg/m2"}], "qty_radiation": 3, "radiation_details": [{"type": "OTHER", "start": "857", "end": "857", "duration": 0, "dosis": "1500", "dosis_unit": "cGy"}, {"type": "EXTERNAL BEAM", "start": "49", "end": "95", "duration": 46, "dosis": "5940", "dosis_unit": "cGy"}, {"type": "EXTERNAL BEAM", "start": "467", "end": "522", "duration": 55, "dosis": "5940", "dosis_unit": "cGy"}]}, {"uuid": "2aaa6afa-c5f0-4957-b03b-3b730d72cb44", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "231", "age_at_initial_pathologic_diagnosis": "56", "days_to_last_known_alive": "", "days_to_last_followup": "231", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Hormone Therapy", "name": "Oxcarbazepine", "start": "-6", "end": "231", "duration": 237, "dosis": "600", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "58", "end": "119", "duration": 61, "dosis": "300", "dosis_unit": "mg"}, {"type": "Hormone Therapy", "name": "Dexamethasone", "start": "-6", "end": "231", "duration": 237, "dosis": "4", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Gliadel Wafer", "start": "-6", "end": "-6", "duration": 0, "dosis": "8", "dosis_unit": "{Wafer}"}], "qty_radiation": 2, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "82", "end": "86", "duration": 4, "dosis": "3000", "dosis_unit": "cGy"}, {"type": "EXTERNAL BEAM", "start": "54", "end": "61", "duration": 7, "dosis": "3000", "dosis_unit": "cGy"}]}, {"uuid": "afc396f5-8179-4595-a132-2033ccc62ba5", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Glioblastoma Multiforme (GBM)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "51", "days_to_last_known_alive": "", "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "2382c3ab-9cfe-4c60-9b36-c8526364bd36", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "385", "age_at_initial_pathologic_diagnosis": "48", "days_to_last_known_alive": "", "days_to_last_followup": "385", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Avastin", "start": "312", "end": "347", "duration": 35, "dosis": "10", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "112", "end": "264", "duration": 152, "dosis": "280", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "42", "end": "85", "duration": 43, "dosis": "140", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "42", "end": "85", "duration": 43, "dosis": "140", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "42", "end": "85", "duration": 43, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "a927406b-0612-41b8-9385-5ac109c70937", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "72", "days_to_last_known_alive": "", "days_to_last_followup": "298", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 6, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "11", "end": null, "duration": "", "dosis": "1800", "dosis_unit": "mg/m2/day"}, {"type": "Chemotherapy", "name": "Temodar", "start": "11", "end": null, "duration": "", "dosis": "140", "dosis_unit": "mg/m2/day"}, {"type": "Chemotherapy", "name": "Temodar", "start": "9", "end": "50", "duration": 41, "dosis": null, "dosis_unit": null}], "qty_radiation": 3, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "11", "end": null, "duration": "", "dosis": "6000", "dosis_unit": "cGy"}, {"type": "EXTERNAL BEAM", "start": "11", "end": null, "duration": "", "dosis": "6000", "dosis_unit": "cGy"}, {"type": "External", "start": "11", "end": "53", "duration": 42, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "ce09f0d6-c282-49cc-bc38-780e9f2b6335", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "60", "age_at_initial_pathologic_diagnosis": "66", "days_to_last_known_alive": "", "days_to_last_followup": "60", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Gliadel Wafer", "start": "0", "end": null, "duration": "", "dosis": null, "dosis_unit": "{Wafer}"}, {"type": "Hormone Therapy", "name": "Dexamethasone", "start": "0", "end": "60", "duration": 60, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "f3e254f2-d786-4279-a17b-2d590682b025", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "165", "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": "", "days_to_last_followup": "165", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 4, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "25", "end": "41", "duration": 16, "dosis": "123", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temoxolomide", "start": "25", "end": "41", "duration": 16, "dosis": "125", "dosis_unit": "mg"}], "qty_radiation": 2, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "26", "end": "67", "duration": 41, "dosis": "6000", "dosis_unit": "cGy"}, {"type": "EXTERNAL BEAM", "start": "26", "end": "67", "duration": 41, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "efd085ac-5874-4b22-808d-6f2fc34b2e36", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "6", "age_at_initial_pathologic_diagnosis": "63", "days_to_last_known_alive": "", "days_to_last_followup": "6", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "16f3d144-66f0-4a56-af39-3d11f711106a", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "65", "days_to_last_known_alive": "", "days_to_last_followup": "20", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "12", "end": "15", "duration": 3, "dosis": "800", "dosis_unit": "cGy"}]}, {"uuid": "2411aa2d-39de-4383-b2ec-d4c91350bd12", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "918", "age_at_initial_pathologic_diagnosis": "54", "days_to_last_known_alive": "", "days_to_last_followup": "918", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 6, "drug_details": [{"type": "Chemotherapy", "name": "Gliadel", "start": "0", "end": null, "duration": "", "dosis": null, "dosis_unit": "{Wafer}"}, {"type": "Hormone Therapy", "name": "Dexamethasone", "start": "291", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Hydroxyurea", "start": "309", "end": "900", "duration": 591, "dosis": null, "dosis_unit": "mg"}, {"type": "Hormone Therapy", "name": "Dexamethasone", "start": "0", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temodar", "start": "29", "end": "235", "duration": 206, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Gleevac", "start": "309", "end": "900", "duration": 591, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "29", "end": "78", "duration": 49, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "aea0ac7e-2aa7-4411-a8a9-40f35e62e613", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "782", "age_at_initial_pathologic_diagnosis": "46", "days_to_last_known_alive": "", "days_to_last_followup": "782", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "CCNU", "start": "99", "end": "230", "duration": 131, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "procarbazine", "start": "99", "end": "230", "duration": 131, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Vincristine", "start": "99", "end": "230", "duration": 131, "dosis": null, "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "37", "end": "82", "duration": 45, "dosis": "6000", "dosis_unit": null}]}, {"uuid": "3a7c52e7-3b08-4465-b433-7675bbd59021", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Glioblastoma Multiforme (GBM)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "21", "days_to_last_known_alive": "", "days_to_last_followup": "143", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "31", "end": "74", "duration": 43, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Lomustine", "start": "122", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Procarbazine", "start": "129", "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "31", "end": "74", "duration": 43, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "e59ea9f6-9e46-4a28-994b-c71e89e39c8f", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "77", "age_at_initial_pathologic_diagnosis": "44", "days_to_last_known_alive": "", "days_to_last_followup": "77", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "25", "end": "36", "duration": 11, "dosis": "160", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "27", "end": "36", "duration": 9, "dosis": "1260", "dosis_unit": "cGy"}]}, {"uuid": "1c685fbe-20f3-4851-bdcf-aed8221117dc", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "748", "age_at_initial_pathologic_diagnosis": "27", "days_to_last_known_alive": "", "days_to_last_followup": "748", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "92", "end": "418", "duration": 326, "dosis": null, "dosis_unit": "mg/m2/day"}, {"type": "Chemotherapy", "name": "Gleevec", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Hydroxyurea", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "28", "end": "75", "duration": 47, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "1e151e34-944e-4042-a408-a46ea8d2650d", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "2883", "age_at_initial_pathologic_diagnosis": "48", "days_to_last_known_alive": "", "days_to_last_followup": "2005", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 9, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "1488", "end": "1758", "duration": 270, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "VP-16", "start": "1873", "end": "1899", "duration": 26, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "CCNU", "start": "1758", "end": "1817", "duration": 59, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "CCNU", "start": "204", "end": "254", "duration": 50, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Targeted Molecular therapy", "name": "MAb I-131", "start": "22", "end": "22", "duration": 0, "dosis": null, "dosis_unit": "mCi"}, {"type": "Chemotherapy", "name": "CCNU", "start": "1817", "end": "1873", "duration": 56, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "CCNU", "start": "135", "end": "204", "duration": 69, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "VP-16", "start": "301", "end": "443", "duration": 142, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Targeted Molecular therapy", "name": "mu81c6", "start": "22", "end": "22", "duration": 0, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "70", "end": "114", "duration": 44, "dosis": "5940", "dosis_unit": "cGy"}]}, {"uuid": "9281607c-f0cd-461a-8ad6-0b100862406a", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "112", "age_at_initial_pathologic_diagnosis": "39", "days_to_last_known_alive": "", "days_to_last_followup": "112", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "50", "end": "95", "duration": 45, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "50", "end": "95", "duration": 45, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "f3175b8d-df05-4594-988d-a7de9d37084b", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "323", "age_at_initial_pathologic_diagnosis": "61", "days_to_last_known_alive": "", "days_to_last_followup": "323", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Procarbazine", "start": "84", "end": "115", "duration": 31, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Vincristine", "start": "84", "end": "115", "duration": 31, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "CCNU", "start": "84", "end": "115", "duration": 31, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "CIS Retinoic Acid", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "19", "end": "64", "duration": 45, "dosis": "5700", "dosis_unit": null}]}, {"uuid": "85afb1d9-0401-48ef-8dee-e2b785554ae0", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "378", "age_at_initial_pathologic_diagnosis": "63", "days_to_last_known_alive": "", "days_to_last_followup": "378", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "22", "end": null, "duration": "", "dosis": null, "dosis_unit": "mg"}, {"type": "Hormone Therapy", "name": "Dexamethasone", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Hormone Therapy", "name": "Dexamethasone", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "22", "end": "66", "duration": 44, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "c74d5b56-fd61-47d1-998d-c1849ee366e6", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "12", "age_at_initial_pathologic_diagnosis": "51", "days_to_last_known_alive": "", "days_to_last_followup": "12", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "f72f7aea-e831-4ad6-a42a-e1e983758fa8", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "74", "days_to_last_known_alive": "", "days_to_last_followup": "286", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "40", "end": "83", "duration": 43, "dosis": "110", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "205", "end": "205", "duration": 0, "dosis": "150", "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "40", "end": "83", "duration": 43, "dosis": "60", "dosis_unit": "cGy"}]}, {"uuid": "0f10f81c-4f96-450d-b49d-57c4c7d5fbae", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "380", "age_at_initial_pathologic_diagnosis": "75", "days_to_last_known_alive": "", "days_to_last_followup": "23", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "29", "end": "71", "duration": 42, "dosis": "59", "dosis_unit": "cGy"}]}, {"uuid": "d1c1c34a-9f05-4ae5-8cb1-ec1f2553f25d", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "620", "age_at_initial_pathologic_diagnosis": "67", "days_to_last_known_alive": "", "days_to_last_followup": "123", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "temozolomide", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "c7e3bb8b-8e91-46b3-b583-9fdf4920112a", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "346", "age_at_initial_pathologic_diagnosis": "57", "days_to_last_known_alive": "", "days_to_last_followup": "346", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "27", "end": null, "duration": "", "dosis": "150", "dosis_unit": "mg"}], "qty_radiation": 2, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "27", "end": "66", "duration": 39, "dosis": "60", "dosis_unit": "cGy"}, {"type": "EXTERNAL BEAM", "start": "182", "end": "192", "duration": 10, "dosis": "35", "dosis_unit": "cGy"}]}, {"uuid": "8bd595d5-825e-4ae5-9437-ba9746ce9314", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "232", "age_at_initial_pathologic_diagnosis": "70", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Hormone Therapy", "name": "Dexamethasone", "start": "0", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Hormone Therapy", "name": "Dexamethasone", "start": "82", "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "21", "end": "79", "duration": 58, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "b685b110-bff6-4b41-885f-a8e8ea9eda5b", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "635", "age_at_initial_pathologic_diagnosis": "61", "days_to_last_known_alive": "", "days_to_last_followup": "555", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 5, "drug_details": [{"type": "Immunotherapy", "name": "IL-13-PE38QQR Cytoxin", "start": "268", "end": "271", "duration": 3, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "22", "end": "65", "duration": 43, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Carboplatin", "start": "517", "end": "555", "duration": 38, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temodar", "start": "72", "end": "225", "duration": 153, "dosis": null, "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "LY317615", "start": "423", "end": "511", "duration": 88, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "22", "end": "65", "duration": 43, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "71b96491-9d33-4fa4-bc8f-1eea62a39cd9", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "36", "age_at_initial_pathologic_diagnosis": "72", "days_to_last_known_alive": "", "days_to_last_followup": "36", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "9a13d4f3-99b0-4c56-a065-8139a5587e8e", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "441", "age_at_initial_pathologic_diagnosis": "50", "days_to_last_known_alive": "", "days_to_last_followup": "441", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "f37cb842-0a90-4e71-809d-69a6850300fe", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "43", "days_to_last_known_alive": "", "days_to_last_followup": "953", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Motexafin Gadolinium", "start": "27", "end": "66", "duration": 39, "dosis": "340", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "94", "end": "872", "duration": 778, "dosis": "200", "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temodar", "start": "27", "end": "66", "duration": 39, "dosis": "140", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "27", "end": "66", "duration": 39, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "d2dd9249-a6b0-4013-b100-b040350db48c", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "29", "age_at_initial_pathologic_diagnosis": "49", "days_to_last_known_alive": "", "days_to_last_followup": "29", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Hormone Therapy", "name": "Dexamethasone", "start": "0", "end": null, "duration": "", "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "56780918-f492-485f-b355-3a80a0d90666", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "73", "days_to_last_known_alive": "", "days_to_last_followup": "534", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 6, "qty_drugs": 4, "drug_details": [{"type": "Targeted Molecular therapy", "name": "Avastin", "start": "498", "end": null, "duration": "", "dosis": "10", "dosis_unit": "mg/kg"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "152", "end": "498", "duration": 346, "dosis": "5", "dosis_unit": "mg/kg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "36", "end": "73", "duration": 37, "dosis": "120", "dosis_unit": "mg/day"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "96", "end": "131", "duration": 35, "dosis": "200", "dosis_unit": "mg/day"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "28", "end": "76", "duration": 48, "dosis": "5940", "dosis_unit": "cGy"}]}, {"uuid": "a40526d7-d605-454f-b78c-486d6d1b6302", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "36", "days_to_last_known_alive": "", "days_to_last_followup": "1618", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "CPT-11", "start": "9", "end": "130", "duration": 121, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temodar", "start": "9", "end": "130", "duration": 121, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "BCNU", "start": "9", "end": "130", "duration": 121, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "9", "end": "70", "duration": 61, "dosis": null, "dosis_unit": null}]}, {"uuid": "86e26a1b-c9ac-41ec-808b-8bd484a404ed", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "199", "age_at_initial_pathologic_diagnosis": "44", "days_to_last_known_alive": "", "days_to_last_followup": "199", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 5, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "28", "end": "73", "duration": 45, "dosis": null, "dosis_unit": "mg/m2/day"}, {"type": "Chemotherapy", "name": "Celebrex", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "CCNU", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "6 Thiguanine", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Xeloda", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "28", "end": "73", "duration": 45, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "0d5c3baf-8919-4545-ad04-21ad5d00b27b", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "50", "days_to_last_known_alive": "", "days_to_last_followup": "178", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "72", "end": "133", "duration": 61, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Avastin", "start": "150", "end": null, "duration": "", "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Irinotecan", "start": "150", "end": null, "duration": "", "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 2, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "16", "end": "58", "duration": 42, "dosis": "6000", "dosis_unit": null}, {"type": "OTHER", "start": "229", "end": "394", "duration": 165, "dosis": "3000", "dosis_unit": "cGy"}]}, {"uuid": "0d7f5313-5e5e-4398-8ee7-e741d535379d", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "782", "age_at_initial_pathologic_diagnosis": "50", "days_to_last_known_alive": "", "days_to_last_followup": "419", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Procarbazine", "start": "422", "end": "465", "duration": 43, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Carboplatin", "start": "486", "end": "605", "duration": 119, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "BCNU", "start": "69", "end": "419", "duration": 350, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Hydroxurea", "start": "10", "end": "54", "duration": 44, "dosis": null, "dosis_unit": "mg/m2"}], "qty_radiation": 3, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "10", "end": "54", "duration": 44, "dosis": "6400", "dosis_unit": "cGy"}, {"type": "OTHER", "start": "618", "end": "618", "duration": 0, "dosis": "2800", "dosis_unit": "cGy"}, {"type": "OTHER", "start": "63", "end": "63", "duration": 0, "dosis": "4000", "dosis_unit": "cGy"}]}, {"uuid": "4cf3bf84-f523-427b-b4c8-f683618a0580", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "342", "age_at_initial_pathologic_diagnosis": "54", "days_to_last_known_alive": "", "days_to_last_followup": "342", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Gliadel Wafer (BCNU)", "start": "118", "end": null, "duration": "", "dosis": null, "dosis_unit": "{Wafer}"}, {"type": "Chemotherapy", "name": "Temodar", "start": "44", "end": "75", "duration": 31, "dosis": null, "dosis_unit": "mg/day"}, {"type": "Hormone Therapy", "name": "Dexamethasone", "start": "119", "end": "224", "duration": 105, "dosis": null, "dosis_unit": "mg"}, {"type": "Hormone Therapy", "name": "Dexamethazone", "start": "0", "end": "118", "duration": 118, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "44", "end": "80", "duration": 36, "dosis": "5280", "dosis_unit": "cGy"}]}, {"uuid": "1a5f08a8-7185-4df0-8170-8edce56c5088", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "111", "age_at_initial_pathologic_diagnosis": "72", "days_to_last_known_alive": "", "days_to_last_followup": "106", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "a2234e30-a238-42b0-a557-c07f6605b93a", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "272", "age_at_initial_pathologic_diagnosis": "57", "days_to_last_known_alive": "", "days_to_last_followup": "272", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "28", "end": "152", "duration": 124, "dosis": null, "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "161", "end": "195", "duration": 34, "dosis": "4600", "dosis_unit": "cGy"}]}, {"uuid": "366976b7-aa59-498c-b5d2-e041825c5a6b", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "383", "age_at_initial_pathologic_diagnosis": "56", "days_to_last_known_alive": "", "days_to_last_followup": "383", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "127", "end": "131", "duration": 4, "dosis": "440", "dosis_unit": "mg/day"}, {"type": "Chemotherapy", "name": "Temodar", "start": "93", "end": "97", "duration": 4, "dosis": "330", "dosis_unit": "mg/day"}, {"type": "Chemotherapy", "name": "Temodar", "start": "24", "end": "65", "duration": 41, "dosis": "160", "dosis_unit": "mg/day"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "24", "end": "65", "duration": 41, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "c1a412a7-f7af-4b6e-a751-bc37afdcd5b2", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Treated primary GBM", "days_to_death": "1458", "age_at_initial_pathologic_diagnosis": "50", "days_to_last_known_alive": "", "days_to_last_followup": "1458", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temodar (escalation)", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "31", "end": "73", "duration": 42, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "90dffd80-3435-4baf-930a-ababb5c3950e", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "81", "days_to_last_known_alive": "", "days_to_last_followup": "181", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "19", "end": "58", "duration": 39, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "19", "end": "58", "duration": 39, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "8d6da2e1-1fcc-42a5-a787-6da8c205c063", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "96", "age_at_initial_pathologic_diagnosis": "77", "days_to_last_known_alive": "", "days_to_last_followup": "5", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "611d56f5-886e-430f-b3ea-cdad7bd7953e", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "485", "age_at_initial_pathologic_diagnosis": "49", "days_to_last_known_alive": "", "days_to_last_followup": "485", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Vincristine", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Procarbazine", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "CCNU", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "380", "end": "425", "duration": 45, "dosis": "6000", "dosis_unit": null}]}, {"uuid": "24851f84-c986-46ee-9bfa-90bf848e1793", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "138", "age_at_initial_pathologic_diagnosis": "78", "days_to_last_known_alive": "", "days_to_last_followup": "138", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "71", "end": "71", "duration": 0, "dosis": "200", "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "ABTC 0603 Hydroxychloroquine", "start": "14", "end": "23", "duration": 9, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "14", "end": "53", "duration": 39, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "f73d4cb6-6911-48fb-ad11-6f06ff3b0a88", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Treated primary GBM", "days_to_death": "476", "age_at_initial_pathologic_diagnosis": "52", "days_to_last_known_alive": "", "days_to_last_followup": "476", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "27", "end": "107", "duration": 80, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Bevacizumab", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "27", "end": "70", "duration": 43, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "cfc164e7-c321-4851-ab41-5700acae15ab", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "57", "days_to_last_known_alive": "", "days_to_last_followup": "241", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Cilengitide", "start": "24", "end": null, "duration": "", "dosis": "4000", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "101", "end": "105", "duration": 4, "dosis": "150", "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "129", "end": "245", "duration": 116, "dosis": "200", "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "31", "end": "70", "duration": 39, "dosis": "75", "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "31", "end": "70", "duration": 39, "dosis": "60", "dosis_unit": "cGy"}]}, {"uuid": "62bb6f78-3bb8-4084-990b-d3a3633832cc", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "144", "age_at_initial_pathologic_diagnosis": "58", "days_to_last_known_alive": "", "days_to_last_followup": "144", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "366ae3b2-cc06-4e57-85ea-225d83658c49", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Glioblastoma Multiforme (GBM)", "days_to_death": "114", "age_at_initial_pathologic_diagnosis": "73", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "5b42ed49-e3a3-40ed-8f99-65e928ff183e", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "452", "age_at_initial_pathologic_diagnosis": "49", "days_to_last_known_alive": "", "days_to_last_followup": "452", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "26", "end": "67", "duration": 41, "dosis": null, "dosis_unit": "mg/day"}, {"type": "Chemotherapy", "name": "Temodar", "start": "130", "end": "134", "duration": 4, "dosis": "250", "dosis_unit": "mg/day"}, {"type": "Chemotherapy", "name": "Gliadle Wafer", "start": "68", "end": "68", "duration": 0, "dosis": "5", "dosis_unit": "{Wafer}"}, {"type": "Chemotherapy", "name": "Avastin", "start": "222", "end": null, "duration": "", "dosis": null, "dosis_unit": "mg/kg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "26", "end": "67", "duration": 41, "dosis": "5800", "dosis_unit": "cGy"}]}, {"uuid": "a40b23c8-3215-47c3-8b70-c2ed107abb80", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "68", "age_at_initial_pathologic_diagnosis": "69", "days_to_last_known_alive": "", "days_to_last_followup": "68", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Hormone Therapy", "name": "Dexmethasone", "start": "15", "end": "41", "duration": 26, "dosis": null, "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": null, "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "4167d4bb-5145-419c-ba98-e0a58d4bf6a9", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Glioblastoma Multiforme (GBM)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "39", "days_to_last_known_alive": "", "days_to_last_followup": "206", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "72", "end": "114", "duration": 42, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temodar", "start": "154", "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "72", "end": "114", "duration": 42, "dosis": "5945", "dosis_unit": "cGy"}]}, {"uuid": "eedcad6f-b847-4f19-b173-5b1201f73a01", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "737", "age_at_initial_pathologic_diagnosis": "67", "days_to_last_known_alive": "", "days_to_last_followup": "555", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 5, "drug_details": [{"type": "Chemotherapy", "name": "Fotemustine", "start": "171", "end": "359", "duration": 188, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "171", "end": "596", "duration": 425, "dosis": null, "dosis_unit": "mg"}, {"type": "Hormone Therapy", "name": "Dexamethasone", "start": "-6", "end": "737", "duration": 743, "dosis": null, "dosis_unit": "mg/day"}, {"type": "Chemotherapy", "name": "Procarbazine", "start": "171", "end": "725", "duration": 554, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "171", "end": "596", "duration": 425, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "63", "end": "94", "duration": 31, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "db99f164-2257-4f41-bc74-80f2fc6b440f", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "127", "age_at_initial_pathologic_diagnosis": "64", "days_to_last_known_alive": "", "days_to_last_followup": "61", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "28c9c771-f113-44a6-99d5-be73e2f4cfb5", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Treated primary GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "40", "days_to_last_known_alive": "", "days_to_last_followup": "338", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 8, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "41", "end": "85", "duration": 44, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "503", "end": "553", "duration": 50, "dosis": "10", "dosis_unit": "mg/kg"}, {"type": "Chemotherapy", "name": "CCNU", "start": "503", "end": "532", "duration": 29, "dosis": "100", "dosis_unit": "mg/kg"}], "qty_radiation": 4, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "41", "end": "85", "duration": 44, "dosis": "6000", "dosis_unit": "cGy"}, {"type": "OTHER", "start": "556", "end": "556", "duration": 0, "dosis": "3900", "dosis_unit": "cGy"}, {"type": "OTHER", "start": "461", "end": "461", "duration": 0, "dosis": "1400", "dosis_unit": "cGy"}, {"type": "EXTERNAL BEAM", "start": "365", "end": "385", "duration": 20, "dosis": "3900", "dosis_unit": "cGy"}]}, {"uuid": "0b774101-e5ee-4717-ae25-940f6402edd9", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "77", "days_to_last_known_alive": "", "days_to_last_followup": "250", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "94", "end": null, "duration": "", "dosis": "200", "dosis_unit": "mg/m2/day"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "26", "end": "74", "duration": 48, "dosis": "150", "dosis_unit": "mg/day"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "26", "end": "74", "duration": 48, "dosis": "5940", "dosis_unit": "cGy"}]}, {"uuid": "45e58ce1-afa9-48bf-a0ba-4cb459b66b15", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": "", "days_to_last_followup": "260", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "86", "end": null, "duration": "", "dosis": "200", "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "48", "end": "90", "duration": 42, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "ef85fa21-268f-40e3-b360-597484e3f172", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "301", "age_at_initial_pathologic_diagnosis": "74", "days_to_last_known_alive": "", "days_to_last_followup": "301", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "09c1f6a7-0c2b-4db3-bfe6-4412d026c5de", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "121", "age_at_initial_pathologic_diagnosis": "75", "days_to_last_known_alive": "", "days_to_last_followup": "121", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "35", "end": "74", "duration": 39, "dosis": null, "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "35", "end": "74", "duration": 39, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "7f76f109-ef99-4776-aeab-51b5c346038a", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "1448", "age_at_initial_pathologic_diagnosis": "63", "days_to_last_known_alive": "", "days_to_last_followup": "1439", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Thalidomide", "start": "1032", "end": "1352", "duration": 320, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "28", "end": "452", "duration": 424, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "CPT 11", "start": "880", "end": "941", "duration": 61, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 3, "radiation_details": [{"type": "OTHER", "start": "830", "end": "833", "duration": 3, "dosis": "8000", "dosis_unit": "cGy"}, {"type": "EXTERNAL BEAM", "start": "28", "end": "67", "duration": 39, "dosis": "6000", "dosis_unit": "cGy"}, {"type": "OTHER", "start": "1367", "end": "1367", "duration": 0, "dosis": "2000", "dosis_unit": "cGy"}]}, {"uuid": "c7d022a2-ca98-4aac-9ed5-c88e1fa5ee59", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "178", "age_at_initial_pathologic_diagnosis": "57", "days_to_last_known_alive": "", "days_to_last_followup": "164", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Tamoxifen", "start": "48", "end": "140", "duration": 92, "dosis": null, "dosis_unit": "mg/day"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "48", "end": "83", "duration": 35, "dosis": "5900", "dosis_unit": "cGy"}]}, {"uuid": "ec16c9c5-12fc-4891-a4fd-42565ead8a4b", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "634", "age_at_initial_pathologic_diagnosis": "63", "days_to_last_known_alive": "", "days_to_last_followup": "634", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "16", "end": "36", "duration": 20, "dosis": null, "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "16", "end": "69", "duration": 53, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "e09e8c50-6e46-4d21-a9c4-76efc2727981", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "154", "age_at_initial_pathologic_diagnosis": "56", "days_to_last_known_alive": "", "days_to_last_followup": "154", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "25", "end": "66", "duration": 41, "dosis": "140", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "25", "end": "66", "duration": 41, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "a0d2a37d-394e-4579-8abe-1047ff62cf89", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "71", "age_at_initial_pathologic_diagnosis": "53", "days_to_last_known_alive": "", "days_to_last_followup": "71", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Pyrazinamide", "start": "24", "end": "50", "duration": 26, "dosis": "871", "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "317e73c0-5a9d-4e21-970a-3116718d4a87", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "395", "age_at_initial_pathologic_diagnosis": "49", "days_to_last_known_alive": "", "days_to_last_followup": "50", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Gliadel wafers", "start": "0", "end": "0", "duration": 0, "dosis": null, "dosis_unit": "{Wafer}"}, {"type": "Chemotherapy", "name": "Temodar", "start": "9", "end": "65", "duration": 56, "dosis": null, "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "24", "end": "65", "duration": 41, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "acf87dec-3b0a-4286-94b5-c5d7e495cf73", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "2791", "age_at_initial_pathologic_diagnosis": "45", "days_to_last_known_alive": "", "days_to_last_followup": "2791", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 6, "drug_details": [{"type": "Chemotherapy", "name": "VP-16", "start": "75", "end": "136", "duration": 61, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Targeted Molecular therapy", "name": "MAB I-131", "start": "26", "end": "47", "duration": 21, "dosis": null, "dosis_unit": "mCi"}, {"type": "Chemotherapy", "name": "CCNU", "start": "255", "end": "296", "duration": 41, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Targeted Molecular therapy", "name": "81c6", "start": "26", "end": "47", "duration": 21, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "CCNU", "start": "136", "end": "1643", "duration": 1507, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "VP-16", "start": "213", "end": "255", "duration": 42, "dosis": null, "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "47", "end": "91", "duration": 44, "dosis": "6400", "dosis_unit": "cGy"}]}, {"uuid": "893511a1-6de8-4b71-a344-bff86816ed4b", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "415", "age_at_initial_pathologic_diagnosis": "75", "days_to_last_known_alive": "", "days_to_last_followup": "315", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "da7051c8-73af-4170-88ec-0b7038f19179", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "203", "age_at_initial_pathologic_diagnosis": "54", "days_to_last_known_alive": "", "days_to_last_followup": "187", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 5, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "83", "end": "146", "duration": 63, "dosis": null, "dosis_unit": "mg"}, {"type": "Hormone Therapy", "name": "Dexamethasone", "start": "81", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "89", "end": "162", "duration": 73, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "19", "end": "61", "duration": 42, "dosis": null, "dosis_unit": "mg"}, {"type": "Hormone Therapy", "name": "Dexaethasone", "start": "0", "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "20", "end": "61", "duration": 41, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "05803cef-bb87-47c9-997d-3020779fdb8e", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "327", "age_at_initial_pathologic_diagnosis": "70", "days_to_last_known_alive": "", "days_to_last_followup": "327", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temodor", "start": "175", "end": null, "duration": "", "dosis": null, "dosis_unit": "mg/m2"}], "qty_radiation": 2, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "24", "end": "79", "duration": 55, "dosis": "6000", "dosis_unit": "cGy"}, {"type": "OTHER", "start": "152", "end": "152", "duration": 0, "dosis": "2000", "dosis_unit": "cGy"}]}, {"uuid": "ba8bc0c7-26f7-4f8e-9ac8-4764234a5f23", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "322", "age_at_initial_pathologic_diagnosis": "41", "days_to_last_known_alive": "", "days_to_last_followup": "322", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "4c15b967-46ae-4c62-bdb3-5dac4af26ec0", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "25", "days_to_last_known_alive": "", "days_to_last_followup": "400", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "146", "end": "150", "duration": 4, "dosis": "300", "dosis_unit": "mg/day"}, {"type": "Chemotherapy", "name": "Temodar", "start": "41", "end": "84", "duration": 43, "dosis": "140", "dosis_unit": "mg/day"}, {"type": "Chemotherapy", "name": "Temodar", "start": "174", "end": null, "duration": "", "dosis": "300", "dosis_unit": "mg/day"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "41", "end": "85", "duration": 44, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "2ff05ef1-8f6d-4ba1-b8ff-5a51864b7054", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "772", "age_at_initial_pathologic_diagnosis": "63", "days_to_last_known_alive": "", "days_to_last_followup": "772", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "942220df-980c-467c-8870-91c87c8a6569", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "59", "days_to_last_known_alive": "", "days_to_last_followup": "272", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "100", "end": "142", "duration": 42, "dosis": "160", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "171", "end": null, "duration": "", "dosis": "10", "dosis_unit": "mg/kg"}, {"type": "Targeted Molecular therapy", "name": "BSI-201", "start": "127", "end": "142", "duration": 15, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temodar", "start": "29", "end": "71", "duration": 42, "dosis": "160", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "29", "end": "71", "duration": 42, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "b15443b7-f511-42fc-ab94-e1adf8ae5432", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "42", "age_at_initial_pathologic_diagnosis": "52", "days_to_last_known_alive": "", "days_to_last_followup": "42", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Oxaliplatin", "start": "14", "end": "28", "duration": 14, "dosis": null, "dosis_unit": "mg"}, {"type": "Hormone Therapy", "name": "Dexamethasone", "start": "0", "end": "41", "duration": 41, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "c0248a4f-603c-4512-b197-1267de36a039", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "55", "days_to_last_known_alive": "", "days_to_last_followup": "228", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 3, "drug_details": [{"type": "Targeted Molecular therapy", "name": "Avastin", "start": "98", "end": null, "duration": "", "dosis": "10", "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "99", "end": null, "duration": "", "dosis": "120", "dosis_unit": "mg/day"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "21", "end": "65", "duration": 44, "dosis": "150", "dosis_unit": "mg/day"}], "qty_radiation": 2, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "95", "end": "95", "duration": 0, "dosis": "1000", "dosis_unit": "cGy"}, {"type": "EXTERNAL BEAM", "start": "21", "end": "65", "duration": 44, "dosis": "5760", "dosis_unit": "cGy"}]}, {"uuid": "f137d095-fb75-485a-9160-34fba6f9936b", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "76", "days_to_last_known_alive": "", "days_to_last_followup": "345", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "14", "end": "180", "duration": 166, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "14", "end": "180", "duration": 166, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "14", "end": "180", "duration": 166, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 2, "radiation_details": [{"type": "OTHER", "start": "78", "end": "78", "duration": 0, "dosis": "0020", "dosis_unit": "cGy"}, {"type": "EXTERNAL BEAM", "start": "14", "end": "57", "duration": 43, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "b96974b8-cef4-433a-8e8d-107f2d44dda8", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "476", "age_at_initial_pathologic_diagnosis": "75", "days_to_last_known_alive": "", "days_to_last_followup": "287", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "160", "end": "287", "duration": 127, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "33", "end": "82", "duration": 49, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "33", "end": "82", "duration": 49, "dosis": "6300", "dosis_unit": "cGy"}]}, {"uuid": "bb5c27e6-73d5-412b-9cca-6adb5bdc4792", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "372", "age_at_initial_pathologic_diagnosis": "51", "days_to_last_known_alive": "", "days_to_last_followup": "279", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 2, "radiation_details": [{"type": "OTHER", "start": "181", "end": "181", "duration": 0, "dosis": "3500", "dosis_unit": "cGy"}, {"type": "EXTERNAL BEAM", "start": "41", "end": "83", "duration": 42, "dosis": "5940", "dosis_unit": "mCi"}]}, {"uuid": "3e584195-a7f1-4ae0-87dd-c2d22896998c", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Treated primary GBM", "days_to_death": "393", "age_at_initial_pathologic_diagnosis": "57", "days_to_last_known_alive": "", "days_to_last_followup": "393", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "100", "end": "183", "duration": 83, "dosis": "150", "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temodar", "start": "57", "end": "99", "duration": 42, "dosis": "75", "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "57", "end": "99", "duration": 42, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "16584103-f7f4-4116-8c9c-67793cab1d04", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "99", "age_at_initial_pathologic_diagnosis": "69", "days_to_last_known_alive": "", "days_to_last_followup": "99", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "26", "end": "32", "duration": 6, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "26", "end": "74", "duration": 48, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "83d01b67-56be-4dd0-b516-bf6a1e6bd145", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Treated primary GBM", "days_to_death": "1489", "age_at_initial_pathologic_diagnosis": "51", "days_to_last_known_alive": "", "days_to_last_followup": "1489", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "53", "end": "388", "duration": 335, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Hydoxyurea", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Gleevec", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "20", "end": "63", "duration": 43, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "12d458d6-8c39-42d0-830b-c328966aeb1a", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "183", "age_at_initial_pathologic_diagnosis": "66", "days_to_last_known_alive": "", "days_to_last_followup": "183", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "15", "end": "182", "duration": 167, "dosis": null, "dosis_unit": "mg/m2/day"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "15", "end": "182", "duration": 167, "dosis": null, "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "15", "end": "63", "duration": 48, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "be7a846b-6456-4141-af23-0c7ab20150ad", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "440", "age_at_initial_pathologic_diagnosis": "26", "days_to_last_known_alive": "", "days_to_last_followup": "440", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "cae63804-4251-499d-b155-f6180c6b5d61", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "535", "age_at_initial_pathologic_diagnosis": "57", "days_to_last_known_alive": "", "days_to_last_followup": "302", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "30", "end": "71", "duration": 41, "dosis": "7000", "dosis_unit": "cGy"}]}, {"uuid": "c0f2f73e-0ccb-4c73-a46d-24efb2a1fc04", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "364", "age_at_initial_pathologic_diagnosis": "70", "days_to_last_known_alive": "", "days_to_last_followup": "364", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Hormone Therapy", "name": "Dexamethasone", "start": "0", "end": null, "duration": "", "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": null, "end": null, "duration": "", "dosis": "5600", "dosis_unit": "cGy"}]}, {"uuid": "bd32d4e5-6a24-4c98-bda0-66e1c9468ab5", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Treated primary GBM", "days_to_death": "2755", "age_at_initial_pathologic_diagnosis": "39", "days_to_last_known_alive": "", "days_to_last_followup": "2755", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "1939", "end": "2304", "duration": 365, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Celebrex", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Xeloda", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temozolomide", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "951", "end": "993", "duration": 42, "dosis": "5400", "dosis_unit": "cGy"}]}, {"uuid": "6a0aa64d-a03e-409e-a23b-d604582b3eca", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "139", "age_at_initial_pathologic_diagnosis": "66", "days_to_last_known_alive": "", "days_to_last_followup": "25", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": null, "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "0b39d410-1c0d-4657-9620-beb5372bbce5", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "135", "age_at_initial_pathologic_diagnosis": "81", "days_to_last_known_alive": "", "days_to_last_followup": "135", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "51", "end": "95", "duration": 44, "dosis": "120", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "51", "end": "95", "duration": 44, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "8a812396-a23f-426c-8b8b-62c23f268fed", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "45", "days_to_last_known_alive": "", "days_to_last_followup": "155", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "71", "end": null, "duration": "", "dosis": "150", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "20", "end": "64", "duration": 44, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "9946cd4d-b7fc-4bc0-bf4f-65b7f6e38b53", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Glioblastoma Multiforme (GBM)", "days_to_death": "347", "age_at_initial_pathologic_diagnosis": "44", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "24", "end": "68", "duration": 44, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "77", "end": "197", "duration": 120, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "PS341", "start": "258", "end": "289", "duration": 31, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "24", "end": "68", "duration": 44, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "a18dad74-a763-440e-9d3a-dccf1b8838c5", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "45", "days_to_last_known_alive": "", "days_to_last_followup": "187", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Carboplatin", "start": "196", "end": null, "duration": "", "dosis": "3", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Bevacizumab", "start": "196", "end": null, "duration": "", "dosis": "10", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "25", "end": "68", "duration": 43, "dosis": "75", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "ABT-888 Parp Inhibitor", "start": "88", "end": "88", "duration": 0, "dosis": "10", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "25", "end": "68", "duration": 43, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "2fa523a7-360e-4cc5-bea3-2f96352dd0b0", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "268", "age_at_initial_pathologic_diagnosis": "45", "days_to_last_known_alive": "", "days_to_last_followup": "268", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 5, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "13", "end": "85", "duration": 72, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "6 Thiguanine", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Celebrex", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Xeloda", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "CCNU", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "13", "end": "68", "duration": 55, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "b573dce3-84d9-4ee9-9582-d6b24d3e14c8", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "317", "age_at_initial_pathologic_diagnosis": "62", "days_to_last_known_alive": "", "days_to_last_followup": "313", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "4067616d-2d51-4d31-9014-122955c2298c", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "178", "age_at_initial_pathologic_diagnosis": "51", "days_to_last_known_alive": "", "days_to_last_followup": "161", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Oxaliplatin", "start": "14", "end": "60", "duration": 46, "dosis": "85", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "77", "end": "137", "duration": 60, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "6b692df6-5611-4cb8-acb4-f2c4def56687", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "541", "age_at_initial_pathologic_diagnosis": "51", "days_to_last_known_alive": "", "days_to_last_followup": "508", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Gliadel Wafer", "start": "0", "end": "0", "duration": 0, "dosis": "4", "dosis_unit": "{Wafer}"}, {"type": "Chemotherapy", "name": "Carmustine (BCNU)", "start": "64", "end": "64", "duration": 0, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "156", "end": "399", "duration": 243, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Tamoxifen", "start": "94", "end": "125", "duration": 31, "dosis": "10", "dosis_unit": "mg/day"}], "qty_radiation": 2, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "11", "end": "63", "duration": 52, "dosis": "5940", "dosis_unit": "cGy"}, {"type": "OTHER", "start": "436", "end": "436", "duration": 0, "dosis": "1800", "dosis_unit": "cGy"}]}, {"uuid": "cc547db8-817d-4e9a-9e02-3a19d1ce5c4a", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "48", "days_to_last_known_alive": "", "days_to_last_followup": "296", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "108", "end": null, "duration": "", "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "30", "end": "78", "duration": 48, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "30", "end": "78", "duration": 48, "dosis": "6120", "dosis_unit": "cGy"}]}, {"uuid": "53c1df8e-4b03-4e9e-862d-705bd004a6c2", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Glioblastoma Multiforme (GBM)", "days_to_death": "359", "age_at_initial_pathologic_diagnosis": "56", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "CI-980", "start": "33", "end": "63", "duration": 30, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Carmustine", "start": "190", "end": "242", "duration": 52, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "277", "end": "277", "duration": 0, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "86", "end": "128", "duration": 42, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "c7844ea8-a0d3-40b2-949a-3963a6d68156", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Glioblastoma Multiforme (GBM)", "days_to_death": "1537", "age_at_initial_pathologic_diagnosis": "21", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "BCNU", "start": "38", "end": "72", "duration": 34, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "CPT-11", "start": "38", "end": "72", "duration": 34, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "6", "end": "78", "duration": 72, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "3776fe70-aed7-46b5-ba93-fcdaf8501cae", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "454", "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": "", "days_to_last_followup": "399", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "29", "end": "71", "duration": 42, "dosis": "75", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "277", "end": "323", "duration": 46, "dosis": "10", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "88", "end": "277", "duration": 189, "dosis": "10", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "CPT 11", "start": "88", "end": "277", "duration": 189, "dosis": "340", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "29", "end": "71", "duration": 42, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "d68d0607-48e1-4813-a53d-7086532f6d8b", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "715", "age_at_initial_pathologic_diagnosis": "46", "days_to_last_known_alive": "", "days_to_last_followup": "715", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 8, "drug_details": [{"type": "Chemotherapy", "name": "BCNU", "start": "126", "end": "175", "duration": 49, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Targeted Molecular therapy", "name": "SCH6636", "start": "625", "end": "652", "duration": 27, "dosis": null, "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "SCH66336", "start": "625", "end": "625", "duration": 0, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "281", "end": "583", "duration": 302, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Targeted Molecular therapy", "name": "O6BG", "start": "190", "end": "281", "duration": 91, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "BCNU", "start": "190", "end": "281", "duration": 91, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "VP-16", "start": "588", "end": "624", "duration": 36, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "CPT-11", "start": "126", "end": "175", "duration": 49, "dosis": null, "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "23", "end": "73", "duration": 50, "dosis": "6020", "dosis_unit": "cGy"}]}, {"uuid": "d2750bac-657c-4476-bcba-5fec6de30ea2", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "575", "age_at_initial_pathologic_diagnosis": "62", "days_to_last_known_alive": "", "days_to_last_followup": "567", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "71", "end": "107", "duration": 36, "dosis": null, "dosis_unit": null}]}, {"uuid": "60abea71-cafc-400c-ad4a-84898e96d8a6", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "322", "age_at_initial_pathologic_diagnosis": "61", "days_to_last_known_alive": "", "days_to_last_followup": "322", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "0cc0eac7-3288-4ed4-a3af-c9f68ff5226f", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "386", "age_at_initial_pathologic_diagnosis": "77", "days_to_last_known_alive": "", "days_to_last_followup": "358", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 6, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "186", "end": "212", "duration": 26, "dosis": "150", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "43", "end": "85", "duration": 42, "dosis": "10", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "221", "end": "358", "duration": 137, "dosis": "150", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "CPT 11", "start": "221", "end": "358", "duration": 137, "dosis": "40", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "43", "end": "85", "duration": 42, "dosis": "75", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "221", "end": "358", "duration": 137, "dosis": "5", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "43", "end": "85", "duration": 42, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "085982d8-55ce-4a2d-bf7d-c3808a918a85", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "1561", "age_at_initial_pathologic_diagnosis": "63", "days_to_last_known_alive": "", "days_to_last_followup": "1561", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "740", "end": "786", "duration": 46, "dosis": null, "dosis_unit": "mg/m2/day"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "740", "end": "786", "duration": 46, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "8fa3187d-f732-411a-a812-eb1ee6c4a177", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "467", "age_at_initial_pathologic_diagnosis": "59", "days_to_last_known_alive": "", "days_to_last_followup": "97", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": null, "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temodor", "start": "39", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "EMD", "start": "39", "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "39", "end": "100", "duration": 61, "dosis": null, "dosis_unit": null}]}, {"uuid": "b755292a-358b-4724-8504-37b32be6cbd5", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "34", "days_to_last_known_alive": "", "days_to_last_followup": "316", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "104", "end": null, "duration": "", "dosis": "350", "dosis_unit": "mg"}, {"type": "Hormone Therapy", "name": "Levetiracetam", "start": "-15", "end": null, "duration": "", "dosis": "1000", "dosis_unit": "mg"}, {"type": "Hormone Therapy", "name": "Dexamethasone", "start": "-15", "end": null, "duration": "", "dosis": "2", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "43", "end": "74", "duration": 31, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "726c0ff1-4536-4222-812b-623153dcca64", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "357", "age_at_initial_pathologic_diagnosis": "58", "days_to_last_known_alive": "", "days_to_last_followup": "357", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "92bfdc17-acf4-4a46-be45-4e80080f1764", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "34", "days_to_last_known_alive": "", "days_to_last_followup": "1562", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "127", "end": "584", "duration": 457, "dosis": "200", "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "50", "end": "93", "duration": 43, "dosis": "75", "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "50", "end": "93", "duration": 43, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "8f89dc5b-d0c0-45e5-b551-7f1b3ad60cc7", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "26", "age_at_initial_pathologic_diagnosis": "89", "days_to_last_known_alive": "", "days_to_last_followup": "26", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "22", "end": "25", "duration": 3, "dosis": "160", "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "05e50f02-507f-48a7-a868-bbfc569332de", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "383", "age_at_initial_pathologic_diagnosis": "49", "days_to_last_known_alive": "", "days_to_last_followup": "383", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "34", "end": "204", "duration": 170, "dosis": null, "dosis_unit": "mg/m2/day"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "16", "end": "57", "duration": 41, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "4e0ce5b3-27e7-4658-b8a7-003af90fa221", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "427", "age_at_initial_pathologic_diagnosis": "36", "days_to_last_known_alive": "", "days_to_last_followup": "427", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "1", "end": "153", "duration": 152, "dosis": "350", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Doxorubicin", "start": "35", "end": "106", "duration": 71, "dosis": "4", "dosis_unit": "mg"}, {"type": "Hormone Therapy", "name": "Dexamethasone", "start": "-6", "end": "427", "duration": 433, "dosis": "4", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "CDDP", "start": "-1", "end": "148", "duration": 149, "dosis": "160", "dosis_unit": "mg"}], "qty_radiation": 2, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "68", "end": "72", "duration": 4, "dosis": "3000", "dosis_unit": "cGy"}, {"type": "EXTERNAL BEAM", "start": "40", "end": "44", "duration": 4, "dosis": "3000", "dosis_unit": "cGy"}]}, {"uuid": "81916571-d55d-4e39-a027-6f7da595a6d1", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "61", "days_to_last_known_alive": "", "days_to_last_followup": "240", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Irinotecan", "start": "97", "end": "380", "duration": 283, "dosis": "125", "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "429", "end": "429", "duration": 0, "dosis": "75", "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Bevacizumab", "start": "97", "end": "436", "duration": 339, "dosis": "10", "dosis_unit": "mg/kg"}], "qty_radiation": 1, "radiation_details": [{"type": "OTHER", "start": "411", "end": "420", "duration": 9, "dosis": "3200", "dosis_unit": "cGy"}]}, {"uuid": "ad43052c-9ac0-4bf9-904b-8b2f0d885ce2", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "276", "age_at_initial_pathologic_diagnosis": "51", "days_to_last_known_alive": "", "days_to_last_followup": "276", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 5, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "21", "end": "62", "duration": 41, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Tarceva", "start": "216", "end": "229", "duration": 13, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Tarceva", "start": "230", "end": "236", "duration": 6, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "142", "end": "234", "duration": 92, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "89", "end": "93", "duration": 4, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "21", "end": "62", "duration": 41, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "be40e1a5-0f6c-4f3e-8b36-82e7bcbe51f6", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "45", "days_to_last_known_alive": "", "days_to_last_followup": "160", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "29", "end": null, "duration": "", "dosis": "75", "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "26", "end": "75", "duration": 49, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "451fe1e8-9327-4a4c-9110-1e986eb56eab", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "1300", "age_at_initial_pathologic_diagnosis": "47", "days_to_last_known_alive": "", "days_to_last_followup": "1300", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "118", "end": "656", "duration": 538, "dosis": null, "dosis_unit": "mg/m2/day"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Sarasar", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "38", "end": "82", "duration": 44, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "5ecf926b-aa17-4498-95c4-ccaf84ba21d4", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Treated primary GBM", "days_to_death": "557", "age_at_initial_pathologic_diagnosis": "54", "days_to_last_known_alive": "", "days_to_last_followup": "557", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 5, "drug_details": [{"type": "Chemotherapy", "name": "CCNU", "start": "297", "end": "359", "duration": 62, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Xeloda", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "6 Thiguanine", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Celebrex", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "CCNU", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "69", "end": "115", "duration": 46, "dosis": "5600", "dosis_unit": "cGy"}]}, {"uuid": "5daedd8c-941e-4a8f-8bb4-91e6d2da7fe0", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "1785", "age_at_initial_pathologic_diagnosis": "34", "days_to_last_known_alive": "", "days_to_last_followup": "1770", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Accutane", "start": null, "end": "1754", "duration": "", "dosis": null, "dosis_unit": "mg/day"}, {"type": "Chemotherapy", "name": "Procarbazine/CCNU/Vincristine", "start": "1086", "end": "1359", "duration": 273, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "16", "end": "58", "duration": 42, "dosis": "5400", "dosis_unit": "cGy"}]}, {"uuid": "c6cc0d86-ef75-40ed-bd68-69e13143c0d9", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Glioblastoma Multiforme (GBM)", "days_to_death": "191", "age_at_initial_pathologic_diagnosis": "72", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "2f8527aa-d8c0-4a82-a216-86cadb225b20", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "54", "days_to_last_known_alive": "", "days_to_last_followup": "7", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "48", "end": "115", "duration": 67, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "48", "end": "87", "duration": 39, "dosis": null, "dosis_unit": "cGy"}]}, {"uuid": "13f2ad8a-09bf-4aaf-93a3-8db634c6596f", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "153", "age_at_initial_pathologic_diagnosis": "74", "days_to_last_known_alive": "", "days_to_last_followup": "153", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "48", "end": "80", "duration": 32, "dosis": "60", "dosis_unit": "cGy"}]}, {"uuid": "d4c83bb4-5b36-43f2-bbfe-e080eff93db2", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "480", "age_at_initial_pathologic_diagnosis": "62", "days_to_last_known_alive": "", "days_to_last_followup": "480", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 5, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "0", "end": "161", "duration": 161, "dosis": "300", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "-2", "end": "150", "duration": 152, "dosis": "60", "dosis_unit": "mg"}, {"type": "Hormone Therapy", "name": "Dexamethasone", "start": "-12", "end": "480", "duration": 492, "dosis": "8", "dosis_unit": "mg"}, {"type": "Hormone Therapy", "name": "Levetiracetam", "start": "-12", "end": "480", "duration": 492, "dosis": "1000", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "445", "end": "465", "duration": 20, "dosis": "140", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "14", "end": "47", "duration": 33, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "6a2af770-7a6e-4571-a1e4-6b4af792ab79", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "485", "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": "", "days_to_last_followup": "485", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Hormone Therapy", "name": "Dexamethasone", "start": "282", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Gliadel", "start": "448", "end": null, "duration": "", "dosis": null, "dosis_unit": "{Wafer}"}, {"type": "Hormone Therapy", "name": "Dexamethasone", "start": "8", "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "54", "end": "78", "duration": 24, "dosis": "5400", "dosis_unit": "cGy"}]}, {"uuid": "1db94b8c-8c90-4382-88a9-763c1fb5da1f", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "113", "age_at_initial_pathologic_diagnosis": "73", "days_to_last_known_alive": "", "days_to_last_followup": "113", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "f0d013b5-4a22-42d8-ae7b-62536ba21e43", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "142", "age_at_initial_pathologic_diagnosis": "76", "days_to_last_known_alive": "", "days_to_last_followup": "142", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Gliadel Wafer", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": "{Wafer}"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "7d922c2c-25df-4cc7-b6d0-355ff527f69e", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "76", "days_to_last_known_alive": "", "days_to_last_followup": "145", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "100", "end": null, "duration": "", "dosis": "150", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "27", "end": "60", "duration": 33, "dosis": "75", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Vandetanib", "start": "22", "end": "77", "duration": 55, "dosis": "100", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "27", "end": "70", "duration": 43, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "25b7e4e6-df72-4583-9369-b5bd25eb8b53", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "189", "age_at_initial_pathologic_diagnosis": "36", "days_to_last_known_alive": "", "days_to_last_followup": "189", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Carboxy amido triazole", "start": "32", "end": "147", "duration": 115, "dosis": null, "dosis_unit": "mg"}, {"type": "Hormone Therapy", "name": "Dexamethasone", "start": "-1", "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "32", "end": "75", "duration": 43, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "e92a41c4-3c52-4c58-9ae2-fc1b9e5791c1", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "519", "age_at_initial_pathologic_diagnosis": "63", "days_to_last_known_alive": "", "days_to_last_followup": "519", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Avastin", "start": "320", "end": "374", "duration": 54, "dosis": "890", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "24", "end": "213", "duration": 189, "dosis": "210", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "25", "end": "65", "duration": 40, "dosis": "60", "dosis_unit": "cGy"}]}, {"uuid": "fe7d139a-508a-4ac5-91ff-fc64b7510fd7", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "71", "days_to_last_known_alive": "", "days_to_last_followup": "866", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 8, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "1244", "end": "1337", "duration": 93, "dosis": "75", "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "88", "end": "300", "duration": 212, "dosis": "200", "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Sorafenib", "start": "334", "end": "949", "duration": 615, "dosis": "200", "dosis_unit": "mg/day"}, {"type": "Chemotherapy", "name": "Etoposide", "start": "1342", "end": "1342", "duration": 0, "dosis": "75", "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Erlotinib", "start": "334", "end": "949", "duration": 615, "dosis": "75", "dosis_unit": "mg/day"}, {"type": "Targeted Molecular therapy", "name": "Bevacizumab", "start": "965", "end": "1342", "duration": 377, "dosis": "10", "dosis_unit": "mg/kg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "27", "end": "68", "duration": 41, "dosis": "75", "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Irinotecan", "start": "965", "end": "1230", "duration": 265, "dosis": "125", "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "25", "end": "68", "duration": 43, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "c2d3fad2-071e-4b38-be2a-88fbf96a5c9d", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "72", "days_to_last_known_alive": "", "days_to_last_followup": "242", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "32", "end": "75", "duration": 43, "dosis": "135", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "103", "end": "107", "duration": 4, "dosis": "270", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "32", "end": "75", "duration": 43, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "44fb7a3b-ceb1-4285-baa0-adda16150b42", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "357", "age_at_initial_pathologic_diagnosis": "54", "days_to_last_known_alive": "", "days_to_last_followup": "342", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "BS1-201", "start": "95", "end": "154", "duration": 59, "dosis": "9.5", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "95", "end": "154", "duration": 59, "dosis": "200", "dosis_unit": "mg/dL"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "154", "end": "337", "duration": 183, "dosis": "10", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "35", "end": "69", "duration": 34, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "acce5f54-f3c1-47b0-9a5e-db20358ed981", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "313", "age_at_initial_pathologic_diagnosis": "62", "days_to_last_known_alive": "", "days_to_last_followup": "280", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "CAI NABIT 9712", "start": "19", "end": "144", "duration": 125, "dosis": "250", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Procarbazine", "start": "235", "end": "270", "duration": 35, "dosis": "170", "dosis_unit": "mg/day"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "155", "end": "217", "duration": 62, "dosis": "200", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "19", "end": "61", "duration": 42, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "aa05504f-24b3-4eec-80cc-1e4cb4ed4123", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "326", "age_at_initial_pathologic_diagnosis": "48", "days_to_last_known_alive": "", "days_to_last_followup": "326", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Tanceva", "start": "113", "end": "174", "duration": 61, "dosis": null, "dosis_unit": "mg/day"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "29", "end": "74", "duration": 45, "dosis": "5940", "dosis_unit": null}]}, {"uuid": "60a5b97a-55a0-4b83-8bf7-c8e1e24eb9e9", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "70", "days_to_last_known_alive": "", "days_to_last_followup": "103", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "39", "end": "82", "duration": 43, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "39", "end": "82", "duration": 43, "dosis": "600", "dosis_unit": "cGy"}]}, {"uuid": "bd954a27-2c4a-4b63-b109-6e3f9386e227", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "21", "days_to_last_known_alive": "", "days_to_last_followup": "285", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "19", "end": "61", "duration": 42, "dosis": "75", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "80", "end": "402", "duration": 322, "dosis": "200", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "19", "end": "61", "duration": 42, "dosis": "60", "dosis_unit": "cGy"}]}, {"uuid": "8607f250-609b-452b-aabb-d7e3ab9d47b4", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "33", "age_at_initial_pathologic_diagnosis": "76", "days_to_last_known_alive": "", "days_to_last_followup": "33", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "850bd4b0-9fbd-4d0e-a393-be2d4e3b779e", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "221", "age_at_initial_pathologic_diagnosis": "17", "days_to_last_known_alive": "", "days_to_last_followup": "199", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 5, "drug_details": [{"type": "Chemotherapy", "name": "CCNU", "start": "195", "end": "199", "duration": 4, "dosis": null, "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Thalidomide", "start": "195", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "SCH63666", "start": "73", "end": "123", "duration": 50, "dosis": null, "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Gleevec", "start": "138", "end": "189", "duration": 51, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "24", "end": "52", "duration": 28, "dosis": null, "dosis_unit": "mg/day"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "24", "end": "52", "duration": 28, "dosis": null, "dosis_unit": null}]}, {"uuid": "39661ce6-c487-4abd-957f-443afc56afed", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Glioblastoma Multiforme (GBM)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "40", "days_to_last_known_alive": "", "days_to_last_followup": "504", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "34", "end": "76", "duration": 42, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temodar", "start": "111", "end": "658", "duration": 547, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Avastin", "start": "812", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Lomustine", "start": "847", "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "34", "end": "76", "duration": 42, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "f3c4b89b-bd65-43f2-9b0a-840e10a36424", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "508", "age_at_initial_pathologic_diagnosis": "57", "days_to_last_known_alive": "", "days_to_last_followup": "508", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Avastin", "start": "269", "end": "423", "duration": 154, "dosis": "10", "dosis_unit": "mg/kg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "24", "end": "423", "duration": 399, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 3, "radiation_details": [{"type": "OTHER", "start": "437", "end": "437", "duration": 0, "dosis": "18", "dosis_unit": "cGy"}, {"type": "EXTERNAL BEAM", "start": "24", "end": "86", "duration": 62, "dosis": "46", "dosis_unit": "cGy"}, {"type": "EXTERNAL BEAM", "start": "356", "end": "370", "duration": 14, "dosis": "18", "dosis_unit": "cGy"}]}, {"uuid": "db7da4df-4366-445f-9fa6-0f7c4f24bc22", "tumor_tissue_site": null, "pathologic_stage": "", "histological_type": null, "days_to_death": null, "age_at_initial_pathologic_diagnosis": null, "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": null, "ethnicity": null, "race": null, "vital_status": null, "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "2ad416c6-ddd8-43c8-82a1-9dec6044f869", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "370", "age_at_initial_pathologic_diagnosis": "33", "days_to_last_known_alive": "", "days_to_last_followup": "315", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 5, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "27", "end": "256", "duration": 229, "dosis": null, "dosis_unit": "mg/m2/day"}, {"type": "Chemotherapy", "name": "CCNU", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Celebrex", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Xeloda", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "6 Thiguanine", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "27", "end": "68", "duration": 41, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "c329b41c-76b0-4dba-bbaf-4be812fc436d", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Glioblastoma Multiforme (GBM)", "days_to_death": "121", "age_at_initial_pathologic_diagnosis": "68", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "bba4504e-3d56-4925-9bab-e32a8513eaf9", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Glioblastoma Multiforme (GBM)", "days_to_death": "165", "age_at_initial_pathologic_diagnosis": "71", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "2da5e7d2-8528-46ce-91de-7abf985a431c", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Glioblastoma Multiforme (GBM)", "days_to_death": "6", "age_at_initial_pathologic_diagnosis": "86", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "c38aa628-c5c6-49a7-9846-3e4eeceeed23", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "502", "age_at_initial_pathologic_diagnosis": "67", "days_to_last_known_alive": "", "days_to_last_followup": "502", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Hormone Therapy", "name": "Dexamethasone", "start": "0", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temodar", "start": "46", "end": "167", "duration": 121, "dosis": null, "dosis_unit": "mg"}, {"type": "Hormone Therapy", "name": "Dexamethasone", "start": "205", "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 2, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "46", "end": "77", "duration": 31, "dosis": "6000", "dosis_unit": "cGy"}, {"type": "EXTERNAL BEAM", "start": "293", "end": "293", "duration": 0, "dosis": "1500", "dosis_unit": "cGy"}]}, {"uuid": "6698c033-b2af-4308-ac3a-02c4640ace1d", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "539", "age_at_initial_pathologic_diagnosis": "14", "days_to_last_known_alive": "", "days_to_last_followup": "539", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "HISPANIC OR LATINO", "race": null, "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "04eb4515-7cf5-4e22-b64c-82f21192cedc", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "83", "age_at_initial_pathologic_diagnosis": "75", "days_to_last_known_alive": "", "days_to_last_followup": "83", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "d26ea526-8787-421f-b0c5-be7b2ecfd013", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "1339", "age_at_initial_pathologic_diagnosis": "59", "days_to_last_known_alive": "", "days_to_last_followup": "1315", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 8, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "1063", "end": "1315", "duration": 252, "dosis": "50", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "CCNU", "start": "405", "end": "488", "duration": 83, "dosis": "110", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "24", "end": "66", "duration": 42, "dosis": "75", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "CPT 11", "start": "248", "end": "334", "duration": 86, "dosis": "340", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "248", "end": "334", "duration": 86, "dosis": "10", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "CCNU", "start": "151", "end": "234", "duration": 83, "dosis": "110", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "334", "end": "403", "duration": 69, "dosis": "200", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "90", "end": "151", "duration": 61, "dosis": "200", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "24", "end": "66", "duration": 42, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "53775bcb-38c2-4be9-b132-d90a260371c3", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "620", "age_at_initial_pathologic_diagnosis": "46", "days_to_last_known_alive": "", "days_to_last_followup": "551", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 5, "drug_details": [{"type": "Chemotherapy", "name": "CPT-11", "start": "215", "end": "302", "duration": 87, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Targeted Molecular therapy", "name": "MAb I-131", "start": "13", "end": "125", "duration": 112, "dosis": null, "dosis_unit": "mCi"}, {"type": "Chemotherapy", "name": "Carmustine", "start": "322", "end": "530", "duration": 208, "dosis": null, "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "mu81c6", "start": "13", "end": "125", "duration": 112, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Topecan", "start": "322", "end": "530", "duration": 208, "dosis": null, "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": null, "end": null, "duration": "", "dosis": "6300", "dosis_unit": "cGy"}]}, {"uuid": "677a666e-960e-4587-b09b-2114c9e13681", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "329", "age_at_initial_pathologic_diagnosis": "51", "days_to_last_known_alive": "", "days_to_last_followup": "314", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Vincristine", "start": "97", "end": "128", "duration": 31, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "6 Thioguanine", "start": "97", "end": "128", "duration": 31, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Carmustine", "start": "158", "end": "281", "duration": 123, "dosis": "80", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Estramustine", "start": "97", "end": "128", "duration": 31, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "38", "end": "83", "duration": 45, "dosis": null, "dosis_unit": "cGy"}]}, {"uuid": "01da843d-2942-4fcd-adce-722b5798bd46", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "70", "days_to_last_known_alive": "", "days_to_last_followup": "762", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "10", "end": "57", "duration": 47, "dosis": null, "dosis_unit": "mg/m2/day"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "10", "end": "57", "duration": 47, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "86cf271e-378c-4a40-89c0-86f51d9ff736", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "23", "days_to_last_known_alive": "", "days_to_last_followup": "1246", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 6, "drug_details": [{"type": "Hormone Therapy", "name": "Dexamthasone", "start": "98", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "Tarceva", "start": "102", "end": "549", "duration": 447, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Arsenic Tnoxide", "start": "25", "end": "70", "duration": 45, "dosis": null, "dosis_unit": "mg"}, {"type": "Hormone Therapy", "name": "Dexamethasone", "start": "0", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "1129", "end": "1246", "duration": 117, "dosis": null, "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "102", "end": "1128", "duration": 1026, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "28", "end": "70", "duration": 42, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "7768d53d-61db-440b-8834-3119e2758f39", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "270", "age_at_initial_pathologic_diagnosis": "72", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "ca987bc5-e559-4785-a128-bbdb404019f5", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "31", "days_to_last_known_alive": "", "days_to_last_followup": "873", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "15", "end": "945", "duration": 930, "dosis": null, "dosis_unit": "mg/m2/day"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "15", "end": "945", "duration": 930, "dosis": null, "dosis_unit": "mg/m2/day"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "15", "end": "62", "duration": 47, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "5f0bcd66-51d2-4465-a22b-c39479bcc5f1", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "404", "age_at_initial_pathologic_diagnosis": "65", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "32", "end": "74", "duration": 42, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "32", "end": "82", "duration": 50, "dosis": null, "dosis_unit": null}]}, {"uuid": "3bd1d6c3-6ee8-44a3-8e88-6168129abd0a", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "362", "age_at_initial_pathologic_diagnosis": "40", "days_to_last_known_alive": "", "days_to_last_followup": "327", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "CPT11", "start": "203", "end": "278", "duration": 75, "dosis": null, "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "203", "end": "278", "duration": 75, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "a0684622-5c5e-4e90-97ee-22f03dbcf4bb", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "24", "days_to_last_known_alive": "", "days_to_last_followup": "13", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "7c5af21b-bf8c-48fb-8ee2-03f723c6924c", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "8", "age_at_initial_pathologic_diagnosis": "71", "days_to_last_known_alive": "", "days_to_last_followup": "8", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "82e537a5-9c85-4a98-bcda-fd35b1bbf41d", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "648", "age_at_initial_pathologic_diagnosis": "53", "days_to_last_known_alive": "", "days_to_last_followup": "648", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 7, "drug_details": [{"type": "Chemotherapy", "name": "PC2", "start": "206", "end": "462", "duration": 256, "dosis": "300", "dosis_unit": "mg"}, {"type": "Hormone Therapy", "name": "Levetiracetam", "start": "-7", "end": "648", "duration": 655, "dosis": "1000", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "BCNU", "start": "270", "end": "270", "duration": 0, "dosis": "200", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "2", "end": "3", "duration": 1, "dosis": "160", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "4", "end": "158", "duration": 154, "dosis": "300", "dosis_unit": "mg"}, {"type": "Hormone Therapy", "name": "Dexamethasone", "start": "-7", "end": "648", "duration": 655, "dosis": "4", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "FT", "start": "208", "end": "208", "duration": 0, "dosis": "12", "dosis_unit": "mL"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "55", "end": "100", "duration": 45, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "a7a989d5-7492-4b5f-a6b8-b15912795cbb", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "49", "days_to_last_known_alive": "", "days_to_last_followup": "237", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "32", "end": "73", "duration": 41, "dosis": "75", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "70", "end": null, "duration": "", "dosis": "150", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "32", "end": "73", "duration": 41, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "0a581030-09c1-453a-9197-36ad6859f87c", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "47", "days_to_last_known_alive": "", "days_to_last_followup": "357", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "130", "end": "135", "duration": 5, "dosis": null, "dosis_unit": "mg/day"}, {"type": "Chemotherapy", "name": "Temodar", "start": "24", "end": "107", "duration": 83, "dosis": null, "dosis_unit": "mg/day"}, {"type": "Chemotherapy", "name": "Temodar", "start": "155", "end": "289", "duration": 134, "dosis": null, "dosis_unit": "mg/day"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "561", "end": null, "duration": "", "dosis": "944", "dosis_unit": "mg"}], "qty_radiation": 2, "radiation_details": [{"type": "RADIOISOTOPE", "start": "351", "end": "351", "duration": 0, "dosis": "71", "dosis_unit": "mCi"}, {"type": "EXTERNAL BEAM", "start": "24", "end": "67", "duration": 43, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "8f1baa0c-8495-404c-a130-26329b40ac9a", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "53", "days_to_last_known_alive": "", "days_to_last_followup": "37", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 1, "radiation_details": [{"type": "OTHER", "start": "11", "end": "11", "duration": 0, "dosis": "1400", "dosis_unit": "cGy"}]}, {"uuid": "f860da3e-e150-4be5-aca3-b0f8ada302d3", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "482", "age_at_initial_pathologic_diagnosis": "65", "days_to_last_known_alive": "", "days_to_last_followup": "482", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 6, "drug_details": [{"type": "Chemotherapy", "name": "VP 16", "start": "404", "end": "412", "duration": 8, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "CPT 11", "start": "112", "end": "286", "duration": 174, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "291", "end": "370", "duration": 79, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "404", "end": "412", "duration": 8, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temodar", "start": "34", "end": "82", "duration": 48, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "95", "end": "286", "duration": 191, "dosis": null, "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "34", "end": "82", "duration": 48, "dosis": "5940", "dosis_unit": "cGy"}]}, {"uuid": "3fc15db5-0a78-4ed0-ac59-a022b7138584", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "372", "age_at_initial_pathologic_diagnosis": "56", "days_to_last_known_alive": "", "days_to_last_followup": "346", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 6, "drug_details": [{"type": "Chemotherapy", "name": "Temodor", "start": "141", "end": "213", "duration": 72, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temodor", "start": "18", "end": "67", "duration": 49, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "286", "end": "336", "duration": 50, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temodor", "start": "286", "end": "336", "duration": 50, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "CCNG", "start": "231", "end": "269", "duration": 38, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Immunotherapy", "name": "ACT PEP3 KLH", "start": "104", "end": "215", "duration": 111, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "18", "end": "67", "duration": 49, "dosis": "6120", "dosis_unit": "cGy"}]}, {"uuid": "fca44e95-c7ea-4529-a312-484f088bd78e", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "1315", "age_at_initial_pathologic_diagnosis": "24", "days_to_last_known_alive": "", "days_to_last_followup": "1311", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 16, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "1141", "end": "1274", "duration": 133, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "CCNU", "start": "516", "end": "607", "duration": 91, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "CCNU", "start": "235", "end": "326", "duration": 91, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "CCNU", "start": "892", "end": "1015", "duration": 123, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "VP-16", "start": "1015", "end": "1036", "duration": 21, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Hormone Therapy", "name": "Tamoxifen", "start": "607", "end": "725", "duration": 118, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "1062", "end": "1141", "duration": 79, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temozolamide", "start": "1274", "end": "1311", "duration": 37, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temozolamide", "start": "431", "end": "516", "duration": 85, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "CPT-11", "start": "326", "end": "431", "duration": 105, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temozolamide", "start": "773", "end": "875", "duration": 102, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Targeted Molecular therapy", "name": "MAb I-131", "start": "55", "end": "56", "duration": 1, "dosis": null, "dosis_unit": "mCi"}, {"type": "Chemotherapy", "name": "Temozolamide", "start": "150", "end": "245", "duration": 95, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Targeted Molecular therapy", "name": "MU81C6", "start": "55", "end": "56", "duration": 1, "dosis": null, "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "1141", "end": "1274", "duration": 133, "dosis": null, "dosis_unit": "mg/kg"}, {"type": "Targeted Molecular therapy", "name": "mu81c6", "start": "55", "end": "56", "duration": 1, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "90", "end": "140", "duration": 50, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "fe475053-99fd-4006-a011-68e4286b2e24", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "65", "days_to_last_known_alive": "", "days_to_last_followup": "229", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "110", "end": "114", "duration": 4, "dosis": "280", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "105", "end": null, "duration": "", "dosis": "240", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "25", "end": "53", "duration": 28, "dosis": "140", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "25", "end": "68", "duration": 43, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "9fa60aaf-e0d0-4976-b67d-541ee59d1ee4", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "86", "age_at_initial_pathologic_diagnosis": "54", "days_to_last_known_alive": "", "days_to_last_followup": "86", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "b9fc4990-11bd-4743-90ab-817bf2c8467d", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "231", "age_at_initial_pathologic_diagnosis": "58", "days_to_last_known_alive": "", "days_to_last_followup": "190", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Thalidomide", "start": "126", "end": "191", "duration": 65, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Gliadel Waters", "start": "46", "end": "46", "duration": 0, "dosis": null, "dosis_unit": "{Wafer}"}, {"type": "Chemotherapy", "name": "Cyclophosphamide", "start": "126", "end": "191", "duration": 65, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "71", "end": "113", "duration": 42, "dosis": "6000", "dosis_unit": null}]}, {"uuid": "0259f964-0da3-4307-8576-b8652d8fd7f2", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "42", "days_to_last_known_alive": "", "days_to_last_followup": "358", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 6, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "-1", "end": "57", "duration": 58, "dosis": "140", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "-1", "end": "57", "duration": 58, "dosis": "140", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Avastin", "start": "239", "end": "307", "duration": 68, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Avastin", "start": "239", "end": "307", "duration": 68, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "CPT11", "start": "239", "end": "307", "duration": 68, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "CPT11", "start": "239", "end": "307", "duration": 68, "dosis": null, "dosis_unit": null}], "qty_radiation": 2, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "9", "end": "57", "duration": 48, "dosis": "6600", "dosis_unit": "cGy"}, {"type": "EXTERNAL BEAM", "start": "9", "end": "57", "duration": 48, "dosis": "6600", "dosis_unit": "cGy"}]}, {"uuid": "704d48b4-001d-4ee8-a204-619ace65773b", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "159", "age_at_initial_pathologic_diagnosis": "64", "days_to_last_known_alive": "", "days_to_last_followup": "120", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "21", "end": "63", "duration": 42, "dosis": "75", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "79", "end": "79", "duration": 0, "dosis": "150", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Bevacizumab", "start": "120", "end": "120", "duration": 0, "dosis": "10", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "120", "end": null, "duration": "", "dosis": "75", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "21", "end": "63", "duration": 42, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "6058b4fc-6d38-4909-8914-ae40a0bc312f", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "69", "days_to_last_known_alive": "", "days_to_last_followup": "222", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Targeted Molecular therapy", "name": "Avastin", "start": "44", "end": null, "duration": "", "dosis": "10", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "28", "end": "57", "duration": 29, "dosis": "280", "dosis_unit": "mg/day"}, {"type": "Chemotherapy", "name": "Temodar", "start": "44", "end": null, "duration": "", "dosis": "280", "dosis_unit": "mg/day"}], "qty_radiation": 2, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "28", "end": "57", "duration": 29, "dosis": "6000", "dosis_unit": "cGy"}, {"type": "OTHER", "start": "85", "end": "85", "duration": 0, "dosis": "1700", "dosis_unit": "cGy"}]}, {"uuid": "9127a6ff-70d8-4376-a94a-214c7fd7a24d", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "435", "age_at_initial_pathologic_diagnosis": "64", "days_to_last_known_alive": "", "days_to_last_followup": "428", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "EMD", "start": "14", "end": "53", "duration": 39, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "CPT 11", "start": "79", "end": "430", "duration": 351, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "14", "end": "53", "duration": 39, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Avastin", "start": "79", "end": "430", "duration": 351, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "14", "end": "53", "duration": 39, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "6fa7e929-fc0d-4af1-b5d6-f0e508e5d076", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "225", "age_at_initial_pathologic_diagnosis": "63", "days_to_last_known_alive": "", "days_to_last_followup": "214", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 5, "drug_details": [{"type": "Chemotherapy", "name": "Carboplatin", "start": "169", "end": "200", "duration": 31, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "VP 16 (Etoposide)", "start": "169", "end": "200", "duration": 31, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Vincristine", "start": "95", "end": "169", "duration": 74, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Procarbazine", "start": "95", "end": "169", "duration": 74, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Lomustine", "start": "95", "end": "169", "duration": 74, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "47", "end": "79", "duration": 32, "dosis": null, "dosis_unit": "cGy"}]}, {"uuid": "b76153bc-9095-4436-9538-c630bdab85d8", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "175", "age_at_initial_pathologic_diagnosis": "55", "days_to_last_known_alive": "", "days_to_last_followup": "98", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "7af76f18-a236-4c13-a52b-8c6783c131ba", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "737", "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Avastin", "start": "148", "end": "198", "duration": 50, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temodar", "start": "10", "end": "69", "duration": 59, "dosis": "180", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "104", "end": "135", "duration": 31, "dosis": "350", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "10", "end": "69", "duration": 59, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "a4c2cdc8-c498-4644-84a4-cd51710358c0", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "370", "age_at_initial_pathologic_diagnosis": "63", "days_to_last_known_alive": "", "days_to_last_followup": "316", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Targeted Molecular therapy", "name": "Tamoxifen", "start": "215", "end": "287", "duration": 72, "dosis": null, "dosis_unit": "mg/day"}, {"type": "Chemotherapy", "name": "VP-16", "start": "215", "end": "287", "duration": 72, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temodor", "start": "28", "end": "204", "duration": 176, "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "Thalidomide", "start": "28", "end": "136", "duration": 108, "dosis": null, "dosis_unit": "mg/day"}], "qty_radiation": 2, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "28", "end": "67", "duration": 39, "dosis": "6000", "dosis_unit": "cGy"}, {"type": "OTHER", "start": "218", "end": "218", "duration": 0, "dosis": "1550", "dosis_unit": "cGy"}]}, {"uuid": "f5cf1057-ffc6-408c-b1c4-abac00f73489", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "448", "age_at_initial_pathologic_diagnosis": "86", "days_to_last_known_alive": "", "days_to_last_followup": "414", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "43", "end": "84", "duration": 41, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "106", "end": "218", "duration": 112, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "43", "end": "84", "duration": 41, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "901e2468-80d6-4265-89dc-e24510f601c6", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "114", "age_at_initial_pathologic_diagnosis": "54", "days_to_last_known_alive": "", "days_to_last_followup": "114", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Hormone Therapy", "name": "Dexamethsone", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "5824541a-62c2-4a27-bd5f-3fdacee3ddfe", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "79", "days_to_last_known_alive": "", "days_to_last_followup": "637", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 2, "drug_details": [{"type": "Targeted Molecular therapy", "name": "Bevacizumab", "start": "378", "end": "665", "duration": 287, "dosis": "10", "dosis_unit": "mg/kg"}, {"type": "Chemotherapy", "name": "Irinotecan", "start": "378", "end": "609", "duration": 231, "dosis": "125", "dosis_unit": "mg/m2"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "5f9b8e30-c65d-45cf-b498-06bc7aa7597f", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "36", "days_to_last_known_alive": "", "days_to_last_followup": "305", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "31", "end": "73", "duration": 42, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "104", "end": "206", "duration": 102, "dosis": null, "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Recentin Placebo AXDX2171", "start": "221", "end": "264", "duration": 43, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Lomustine", "start": "221", "end": "221", "duration": 0, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "31", "end": "73", "duration": 42, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "ec252ed1-c4dc-4da2-bc21-c7990cb7e9c5", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "55", "days_to_last_known_alive": "", "days_to_last_followup": "294", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "57", "end": "85", "duration": 28, "dosis": "125", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "113", "end": "117", "duration": 4, "dosis": "250", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Avastin", "start": "153", "end": "295", "duration": 142, "dosis": "630", "dosis_unit": "mg"}], "qty_radiation": 2, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "37", "end": "85", "duration": 48, "dosis": "4500", "dosis_unit": "cGy"}, {"type": "EXTERNAL BEAM", "start": "37", "end": "85", "duration": 48, "dosis": "1440", "dosis_unit": "cGy"}]}, {"uuid": "2dd1635f-0730-48df-acc1-d267415a6952", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "329", "age_at_initial_pathologic_diagnosis": "73", "days_to_last_known_alive": "", "days_to_last_followup": "166", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Carmustin", "start": "99", "end": "160", "duration": 61, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "33", "end": "68", "duration": 35, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "8f33cab9-79c2-4c10-b0c8-b770ee306fb4", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "169", "age_at_initial_pathologic_diagnosis": "65", "days_to_last_known_alive": "", "days_to_last_followup": "79", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Taxol", "start": "26", "end": "79", "duration": 53, "dosis": "175", "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "bc81706e-0fcd-460c-b2f2-536d21ec3c15", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "224", "age_at_initial_pathologic_diagnosis": "76", "days_to_last_known_alive": "", "days_to_last_followup": "224", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "e659bace-f8a6-4001-83f9-a045fa1a4d29", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Glioblastoma Multiforme (GBM)", "days_to_death": "1417", "age_at_initial_pathologic_diagnosis": "32", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Carmustine", "start": null, "end": "134", "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Gliadel Wafers", "start": "179", "end": "179", "duration": 0, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "1330", "end": "1381", "duration": 51, "dosis": null, "dosis_unit": null}], "qty_radiation": 2, "radiation_details": [{"type": "External", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": "cGy"}, {"type": "External", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": "cGy"}]}, {"uuid": "1edc2a22-4082-4974-95e4-b4a57ac63a3b", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "430", "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": "", "days_to_last_followup": "430", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "89", "end": "159", "duration": 70, "dosis": null, "dosis_unit": "mg/m2/day"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "23", "end": "68", "duration": 45, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "521ef427-36d1-46bf-9ff1-01d9bc313f63", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "58", "days_to_last_known_alive": "", "days_to_last_followup": "47", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "31", "end": null, "duration": "", "dosis": "75", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "31", "end": null, "duration": "", "dosis": null, "dosis_unit": "cGy"}]}, {"uuid": "141ad126-de03-4bae-8097-c2690d499f88", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "459", "age_at_initial_pathologic_diagnosis": "43", "days_to_last_known_alive": "", "days_to_last_followup": "459", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "2215d8ae-e103-4370-b5ef-1f40c398cdec", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "52", "days_to_last_known_alive": "", "days_to_last_followup": "474", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 6, "qty_drugs": 8, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "11", "end": "49", "duration": 38, "dosis": "140", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "11", "end": "49", "duration": 38, "dosis": "140", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Avastin", "start": "287", "end": "435", "duration": 148, "dosis": "10", "dosis_unit": "mg/kg"}, {"type": "Chemotherapy", "name": "Avastin", "start": "287", "end": "435", "duration": 148, "dosis": "10", "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temodar", "start": "149", "end": "285", "duration": 136, "dosis": "390", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "CPT11", "start": "287", "end": "435", "duration": 148, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temodar", "start": "149", "end": "285", "duration": 136, "dosis": "390", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "CPT11", "start": "287", "end": "435", "duration": 148, "dosis": null, "dosis_unit": null}], "qty_radiation": 4, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "13", "end": "54", "duration": 41, "dosis": "6000", "dosis_unit": "cGy"}, {"type": "EXTERNAL BEAM", "start": "13", "end": "54", "duration": 41, "dosis": "6000", "dosis_unit": "cGy"}, {"type": "OTHER", "start": "159", "end": "159", "duration": 0, "dosis": "1800", "dosis_unit": "cGy"}, {"type": "OTHER", "start": "159", "end": "159", "duration": 0, "dosis": "1800", "dosis_unit": "cGy"}]}, {"uuid": "e17b73b2-0b8a-43c1-983e-8a37931652f2", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "1282", "age_at_initial_pathologic_diagnosis": "48", "days_to_last_known_alive": "", "days_to_last_followup": "358", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 1, "radiation_details": [{"type": "COMBINATION", "start": "28", "end": "70", "duration": 42, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "a571b531-2fbd-4de3-8aec-ba1613ec1e39", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "804", "age_at_initial_pathologic_diagnosis": "57", "days_to_last_known_alive": "", "days_to_last_followup": "804", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "14", "end": "179", "duration": 165, "dosis": null, "dosis_unit": "mg/m2/day"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "14", "end": "179", "duration": 165, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "CPT 11", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Bevacizumab", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "14", "end": "69", "duration": 55, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "fecccfe0-f36e-4940-ac55-80822a93816c", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "154", "age_at_initial_pathologic_diagnosis": "57", "days_to_last_known_alive": "", "days_to_last_followup": "146", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Hormone Therapy", "name": "Dexamethasone", "start": "-1", "end": "70", "duration": 71, "dosis": null, "dosis_unit": "mg/day"}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "8", "end": "86", "duration": 78, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "8", "end": "86", "duration": 78, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 2, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "18", "end": "22", "duration": 4, "dosis": "3000", "dosis_unit": "cGy"}, {"type": "EXTERNAL BEAM", "start": "46", "end": "50", "duration": 4, "dosis": "3000", "dosis_unit": "cGy"}]}, {"uuid": "c027c68e-dc0e-4d5f-a38b-706b212b7e08", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "108", "age_at_initial_pathologic_diagnosis": "72", "days_to_last_known_alive": "", "days_to_last_followup": "108", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "c3858a17-5a2d-4c4c-9384-86817e308eda", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "144", "age_at_initial_pathologic_diagnosis": "50", "days_to_last_known_alive": "", "days_to_last_followup": "144", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Tamoxifen", "start": "49", "end": "94", "duration": 45, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "49", "end": "94", "duration": 45, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "69651dff-8080-4dad-8e4d-bc428c86a807", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "812", "age_at_initial_pathologic_diagnosis": "63", "days_to_last_known_alive": "", "days_to_last_followup": "702", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Gliadel Wafer", "start": "637", "end": "637", "duration": 0, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "01b38027-17ba-4582-bf28-764d32ffefe1", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "256", "age_at_initial_pathologic_diagnosis": "52", "days_to_last_known_alive": "", "days_to_last_followup": "167", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Carmustine (BCNU)", "start": "39", "end": "98", "duration": 59, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "39", "end": "98", "duration": 59, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "83", "end": "101", "duration": 18, "dosis": "4800", "dosis_unit": "cGy"}]}, {"uuid": "0e30bf64-7563-48fd-a990-32f4f103f687", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "224", "age_at_initial_pathologic_diagnosis": "48", "days_to_last_known_alive": "", "days_to_last_followup": "224", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "129", "end": "161", "duration": 32, "dosis": "200", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "29", "end": "71", "duration": 42, "dosis": "75", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Motexatin Gadoinium", "start": "30", "end": "51", "duration": 21, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "101", "end": "105", "duration": 4, "dosis": "270", "dosis_unit": "mg"}], "qty_radiation": 2, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "189", "end": "203", "duration": 14, "dosis": "3000", "dosis_unit": "cGy"}, {"type": "EXTERNAL BEAM", "start": "30", "end": "72", "duration": 42, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "99a06d8d-7a05-4774-a868-3e9c36dd7915", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "717", "age_at_initial_pathologic_diagnosis": "39", "days_to_last_known_alive": "", "days_to_last_followup": "717", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 8, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "96", "end": "355", "duration": 259, "dosis": "150", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Erlotinib", "start": "495", "end": "513", "duration": 18, "dosis": "150", "dosis_unit": "mg/day"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "586", "end": "678", "duration": 92, "dosis": "100", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "AZD", "start": "389", "end": "431", "duration": 42, "dosis": "20", "dosis_unit": "mg/day"}, {"type": "Chemotherapy", "name": "Irinotecan", "start": "516", "end": "560", "duration": 44, "dosis": "125", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "26", "end": "67", "duration": 41, "dosis": "75", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Lomustine", "start": "389", "end": "389", "duration": 0, "dosis": "160", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Bevacizumab", "start": "516", "end": "658", "duration": 142, "dosis": "10", "dosis_unit": "mg"}], "qty_radiation": 3, "radiation_details": [{"type": "OTHER", "start": "564", "end": "580", "duration": 16, "dosis": "3600", "dosis_unit": "cGy"}, {"type": "OTHER", "start": "678", "end": "684", "duration": 6, "dosis": "2400", "dosis_unit": "cGy"}, {"type": "EXTERNAL BEAM", "start": "26", "end": "67", "duration": 41, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "e493773f-a8e9-4846-9334-293fbc2c81f2", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "313", "age_at_initial_pathologic_diagnosis": "48", "days_to_last_known_alive": "", "days_to_last_followup": "301", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "47", "end": "83", "duration": 36, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "36ae8984-669b-4a5e-854f-f20036aca163", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "208", "age_at_initial_pathologic_diagnosis": "42", "days_to_last_known_alive": "", "days_to_last_followup": "193", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "73", "end": "194", "duration": 121, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "17", "end": "59", "duration": 42, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "f80a26c9-da98-43df-b54d-4f9a08440383", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "262", "age_at_initial_pathologic_diagnosis": "74", "days_to_last_known_alive": "", "days_to_last_followup": "239", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "c8a3b875-0555-4e42-944c-a697f7c5fdda", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "138", "age_at_initial_pathologic_diagnosis": "68", "days_to_last_known_alive": "", "days_to_last_followup": "138", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "83", "end": "115", "duration": 32, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": null, "start": null, "end": "103", "duration": "", "dosis": null, "dosis_unit": null}]}, {"uuid": "d785fcc6-d266-4799-933e-3dc98216487a", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "81", "days_to_last_known_alive": "", "days_to_last_followup": "86", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "26", "end": "37", "duration": 11, "dosis": "75", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "26", "end": "37", "duration": 11, "dosis": "30", "dosis_unit": "cGy"}]}, {"uuid": "b115bcbd-71ca-4736-84fe-090c78d5fbe7", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "231", "age_at_initial_pathologic_diagnosis": "48", "days_to_last_known_alive": "", "days_to_last_followup": "218", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Targeted Molecular therapy", "name": "MAb I-131", "start": "44", "end": "216", "duration": 172, "dosis": null, "dosis_unit": "mCi"}, {"type": "Targeted Molecular therapy", "name": "mu81c6", "start": "44", "end": "216", "duration": 172, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "89", "end": "133", "duration": 44, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "8b9e72ec-1d04-4cae-a1d5-0832a2692cdd", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "588", "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": "", "days_to_last_followup": "39", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "77", "end": "123", "duration": 46, "dosis": "5940", "dosis_unit": "cGy"}]}, {"uuid": "5761ecd9-5deb-41b0-9532-c791a3c443d2", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "560", "age_at_initial_pathologic_diagnosis": "56", "days_to_last_known_alive": "", "days_to_last_followup": "527", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "HISPANIC OR LATINO", "race": null, "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "41", "end": "84", "duration": 43, "dosis": null, "dosis_unit": "mg/day"}, {"type": "Immunotherapy", "name": "IL-13 Pseudomonas exotoxin", "start": "349", "end": "353", "duration": 4, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "106", "end": "328", "duration": 222, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "42", "end": "84", "duration": 42, "dosis": "5976", "dosis_unit": "cGy"}]}, {"uuid": "2527905e-fdb6-4438-942d-566f575134db", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "141", "age_at_initial_pathologic_diagnosis": "51", "days_to_last_known_alive": "", "days_to_last_followup": "141", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "10", "end": "20", "duration": 10, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "26", "end": "41", "duration": 15, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "48", "end": "67", "duration": 19, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "26", "end": "67", "duration": 41, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "b43da449-2191-47d3-90c3-d43f8faef77c", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "52", "days_to_last_known_alive": "", "days_to_last_followup": "343", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "134", "end": "249", "duration": 115, "dosis": "350", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "27", "end": "70", "duration": 43, "dosis": "140", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "106", "end": "110", "duration": 4, "dosis": "270", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "GDC-0449", "start": "287", "end": "343", "duration": 56, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "37", "end": "70", "duration": 33, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "0123811c-1688-436e-addd-fbf896ff5ef4", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "57", "days_to_last_known_alive": "", "days_to_last_followup": "218", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Hormone Therapy", "name": "Dexamethasone", "start": "0", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temodar", "start": "8", "end": null, "duration": "", "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "8", "end": "68", "duration": 60, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "f44db622-f293-448c-9c51-23b34de9c716", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "828", "age_at_initial_pathologic_diagnosis": "69", "days_to_last_known_alive": "", "days_to_last_followup": "801", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "5d8589b3-0b56-4492-92b7-b76c77f99e8f", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "384", "age_at_initial_pathologic_diagnosis": "36", "days_to_last_known_alive": "", "days_to_last_followup": "7", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "d182a65c-03e9-41c0-84d7-a1939a42ff43", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Treated primary GBM", "days_to_death": "822", "age_at_initial_pathologic_diagnosis": "42", "days_to_last_known_alive": "", "days_to_last_followup": "822", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "CCNU", "start": "158", "end": "402", "duration": 244, "dosis": null, "dosis_unit": "mg/m2/day"}, {"type": "Chemotherapy", "name": "Procarbizine", "start": "158", "end": "402", "duration": 244, "dosis": null, "dosis_unit": "mg/m2/day"}, {"type": "Chemotherapy", "name": "Vincristine", "start": "158", "end": "402", "duration": 244, "dosis": null, "dosis_unit": "mg/m2/day"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "44", "end": "90", "duration": 46, "dosis": "5700", "dosis_unit": "cGy"}]}, {"uuid": "75f46d3a-70bd-41d9-b367-1301e34cee15", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "50", "days_to_last_known_alive": "", "days_to_last_followup": "1699", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "84", "end": "1041", "duration": 957, "dosis": null, "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "41", "end": "83", "duration": 42, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "2f5d4c8e-cf89-49ab-95e9-d5427257c81b", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "52", "days_to_last_known_alive": "", "days_to_last_followup": "328", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "176", "end": null, "duration": "", "dosis": "250", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Avastin", "start": "11", "end": null, "duration": "", "dosis": "10", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "OTHER", "start": null, "end": "61", "duration": "", "dosis": "60", "dosis_unit": "cGy"}]}, {"uuid": "07943c98-08ba-47db-8c5f-57d9c96a633a", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "675", "age_at_initial_pathologic_diagnosis": "62", "days_to_last_known_alive": "", "days_to_last_followup": "427", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 6, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "313", "end": "348", "duration": 35, "dosis": "200", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "64", "end": "88", "duration": 24, "dosis": "150", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "355", "end": "427", "duration": 72, "dosis": "150", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "CPT 11", "start": "181", "end": "308", "duration": 127, "dosis": "125", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Gliadel Wafer", "start": "0", "end": "0", "duration": 0, "dosis": "8", "dosis_unit": "{Wafer}"}, {"type": "Chemotherapy", "name": "CCNU", "start": "123", "end": "545", "duration": 422, "dosis": "110", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": null, "end": null, "duration": "", "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "f3f8134f-4a30-4ae9-870f-68ee66f2489f", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "691", "age_at_initial_pathologic_diagnosis": "66", "days_to_last_known_alive": "", "days_to_last_followup": "691", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 5, "drug_details": [{"type": "Chemotherapy", "name": "Suramin", "start": "26", "end": "176", "duration": 150, "dosis": null, "dosis_unit": null}, {"type": "Hormone Therapy", "name": "Tamoxifen", "start": "601", "end": "649", "duration": 48, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "422", "end": "450", "duration": 28, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "BCNU", "start": "481", "end": "511", "duration": 30, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "MGI 114", "start": "207", "end": "391", "duration": 184, "dosis": null, "dosis_unit": "mg/m2"}], "qty_radiation": 2, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "33", "end": "72", "duration": 39, "dosis": "6000", "dosis_unit": "cGy"}, {"type": "OTHER", "start": "524", "end": "558", "duration": 34, "dosis": "5000", "dosis_unit": "cGy"}]}, {"uuid": "f574512a-8936-41ad-824b-292a1dc44d70", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "616", "age_at_initial_pathologic_diagnosis": "64", "days_to_last_known_alive": "", "days_to_last_followup": "578", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "96670269-e352-4a34-b9b0-2fab07abea12", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "87", "age_at_initial_pathologic_diagnosis": "79", "days_to_last_known_alive": "", "days_to_last_followup": "87", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Hormone Therapy", "name": "Dexamethasone", "start": "-6", "end": "87", "duration": 93, "dosis": "8", "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "2699dcaf-02d7-4d3d-8ec6-f3a0455422ba", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Glioblastoma Multiforme (GBM)", "days_to_death": "95", "age_at_initial_pathologic_diagnosis": "79", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "18", "end": "28", "duration": 10, "dosis": "32", "dosis_unit": "Gy"}]}, {"uuid": "a50a281f-8033-469f-8d8e-32b2a9e664e0", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "343", "age_at_initial_pathologic_diagnosis": "37", "days_to_last_known_alive": "", "days_to_last_followup": "343", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Etoposide", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Avastin", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "OTHER", "start": "150", "end": "150", "duration": 0, "dosis": null, "dosis_unit": null}]}, {"uuid": "03d41c99-9236-4966-8883-236f4a57e870", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "320", "age_at_initial_pathologic_diagnosis": "54", "days_to_last_known_alive": "", "days_to_last_followup": "320", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "b7301bc4-2c64-46cc-b486-6d7fbdb3088c", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "764", "age_at_initial_pathologic_diagnosis": "48", "days_to_last_known_alive": "", "days_to_last_followup": "764", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "CCNU", "start": "185", "end": "434", "duration": 249, "dosis": null, "dosis_unit": "mg/m2/day"}, {"type": "Chemotherapy", "name": "Vincristine", "start": "185", "end": "428", "duration": 243, "dosis": null, "dosis_unit": "mg/m2/day"}, {"type": "Chemotherapy", "name": "Procarbazine", "start": "185", "end": "428", "duration": 243, "dosis": null, "dosis_unit": "mg/m2/day"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "33", "end": "76", "duration": 43, "dosis": "5700", "dosis_unit": null}]}, {"uuid": "d9d9d247-a5b3-400e-9617-19a119f38cae", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "47", "days_to_last_known_alive": "", "days_to_last_followup": "259", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 6, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temodar", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 2, "radiation_details": [{"type": "EXTERNAL BEAM", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "EXTERNAL BEAM", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}]}, {"uuid": "2b22eb67-f872-44c1-b7fc-3ff7e327c634", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Glioblastoma Multiforme (GBM)", "days_to_death": "82", "age_at_initial_pathologic_diagnosis": "81", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "53", "end": "58", "duration": 5, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "d3bd0617-2bc9-4fd8-9118-d5b604344166", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "277", "age_at_initial_pathologic_diagnosis": "55", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Targeted Molecular therapy", "name": "Avastin", "start": "202", "end": "277", "duration": 75, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temodor", "start": "63", "end": "101", "duration": 38, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temodor", "start": "130", "end": "201", "duration": 71, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "CPT-11", "start": "202", "end": "277", "duration": 75, "dosis": null, "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "63", "end": "104", "duration": 41, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "92d19001-c56b-4afe-8f69-750c870806f0", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "3881", "age_at_initial_pathologic_diagnosis": "53", "days_to_last_known_alive": "", "days_to_last_followup": "3881", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "CCNU", "start": "3735", "end": "3779", "duration": 44, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "CCNU", "start": "3779", "end": "3821", "duration": 42, "dosis": null, "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "3667", "end": "3716", "duration": 49, "dosis": "5940", "dosis_unit": "cGy"}]}, {"uuid": "2f8df0e5-401b-48ef-8436-d36ab3dd891d", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "737", "age_at_initial_pathologic_diagnosis": "43", "days_to_last_known_alive": "", "days_to_last_followup": "674", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "163cc05b-def3-45cd-90e0-72f3fdbfd8c5", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "71", "days_to_last_known_alive": "", "days_to_last_followup": "4", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "938394f1-df5b-403e-a0f6-c612af48f932", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "493", "age_at_initial_pathologic_diagnosis": "62", "days_to_last_known_alive": "", "days_to_last_followup": "493", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "ba63c9fc-56b2-43f0-bd8c-f0a6b32549ca", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "40", "days_to_last_known_alive": "", "days_to_last_followup": "254", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "10", "end": "116", "duration": 106, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "10", "end": "116", "duration": 106, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "10", "end": "116", "duration": 106, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 2, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "10", "end": "53", "duration": 43, "dosis": "9700", "dosis_unit": "cGy"}, {"type": "EXTERNAL BEAM", "start": "127", "end": "134", "duration": 7, "dosis": "2500", "dosis_unit": "cGy"}]}, {"uuid": "644dfad0-27a0-4780-a74d-edc21c78d848", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "425", "age_at_initial_pathologic_diagnosis": "72", "days_to_last_known_alive": "", "days_to_last_followup": "425", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "53", "end": "73", "duration": 20, "dosis": "4005", "dosis_unit": "cGy"}]}, {"uuid": "67b136f1-7392-4d45-a62f-20d2b6446aba", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "458", "age_at_initial_pathologic_diagnosis": "52", "days_to_last_known_alive": "", "days_to_last_followup": "378", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "cpt-11", "start": "250", "end": "341", "duration": 91, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temodar", "start": "192", "end": "250", "duration": 58, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "CCNU", "start": "91", "end": "192", "duration": 101, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temodar", "start": "33", "end": "78", "duration": 45, "dosis": null, "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "33", "end": "78", "duration": 45, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "e9c1e9f8-0c03-4153-8c32-9261565b4799", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "187", "age_at_initial_pathologic_diagnosis": "84", "days_to_last_known_alive": "", "days_to_last_followup": "8", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "8d0bc15e-61cf-4492-a28b-10d59e5c2417", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "44", "days_to_last_known_alive": "", "days_to_last_followup": "235", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "44", "end": null, "duration": "", "dosis": "320", "dosis_unit": "mg"}, {"type": "Immunotherapy", "name": "ICT-107", "start": "93", "end": "175", "duration": 82, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "IMPLANTS", "start": "44", "end": "86", "duration": 42, "dosis": "60", "dosis_unit": "cGy"}]}, {"uuid": "7ff9e300-1157-49a8-a1eb-898c34ead4fe", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Glioblastoma Multiforme (GBM)", "days_to_death": "180", "age_at_initial_pathologic_diagnosis": "68", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "2ba2ca8f-e3cb-4f68-8f5f-b8c68250cc5f", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "66", "days_to_last_known_alive": "", "days_to_last_followup": "165", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 6, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "33", "end": "77", "duration": 44, "dosis": "140", "dosis_unit": "mg"}], "qty_radiation": 2, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "34", "end": "77", "duration": 43, "dosis": "6000", "dosis_unit": "cGy"}, {"type": "OTHER", "start": "193", "end": "193", "duration": 0, "dosis": "2800", "dosis_unit": "cGy"}]}, {"uuid": "8504bc5f-590e-4c23-8154-dc7e2b12f680", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "946", "age_at_initial_pathologic_diagnosis": "59", "days_to_last_known_alive": "", "days_to_last_followup": "447", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "101", "end": "447", "duration": 346, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "42", "end": "82", "duration": 40, "dosis": null, "dosis_unit": "mg/day"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "42", "end": "84", "duration": 42, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "5fe2fdc9-3557-41a9-a94b-bef258158f86", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "337", "age_at_initial_pathologic_diagnosis": "69", "days_to_last_known_alive": "", "days_to_last_followup": "259", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "36", "end": "79", "duration": 43, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "4fec50a8-521d-4d83-b2cb-168c6619b77c", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "377", "age_at_initial_pathologic_diagnosis": "67", "days_to_last_known_alive": "", "days_to_last_followup": "377", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "9da5473c-c344-4af2-93f8-140207d073cd", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "355", "age_at_initial_pathologic_diagnosis": "54", "days_to_last_known_alive": "", "days_to_last_followup": "355", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "15", "end": "176", "duration": 161, "dosis": null, "dosis_unit": "mg/m2/day"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "15", "end": "176", "duration": 161, "dosis": null, "dosis_unit": "mg/m2/day"}, {"type": "Chemotherapy", "name": "IL 13", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "15", "end": "63", "duration": 48, "dosis": "6000", "dosis_unit": null}]}, {"uuid": "dfc46812-7ad9-4b2f-8715-7fca01301186", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "1062", "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": "", "days_to_last_followup": "1050", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 10, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": "228", "end": "288", "duration": 60, "dosis": "200", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "21", "end": "67", "duration": 46, "dosis": "150", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "VP 16", "start": "291", "end": "358", "duration": 67, "dosis": "50", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Hydroxurea", "start": "750", "end": "792", "duration": 42, "dosis": "500", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "CCNU", "start": "91", "end": "133", "duration": 42, "dosis": "110", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Gleevac", "start": "750", "end": "792", "duration": 42, "dosis": "300", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Hydroxurea", "start": "585", "end": "750", "duration": 165, "dosis": "500", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "VP 16", "start": "469", "end": "571", "duration": 102, "dosis": "50", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Gleevac", "start": "585", "end": "750", "duration": 165, "dosis": "400", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "CCNU", "start": "161", "end": "203", "duration": 42, "dosis": "82.5", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "21", "end": "60", "duration": 39, "dosis": "5800", "dosis_unit": "cGy"}]}, {"uuid": "1fcf31f4-fd24-408e-8d66-62ceebd2fbda", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "603", "age_at_initial_pathologic_diagnosis": "31", "days_to_last_known_alive": "", "days_to_last_followup": "548", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 8, "drug_details": [{"type": "Chemotherapy", "name": "Gliadel Wafer", "start": "280", "end": "280", "duration": 0, "dosis": "6", "dosis_unit": "{Wafer}"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "318", "end": "471", "duration": 153, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Carmustine (BCNU)", "start": "502", "end": "532", "duration": 30, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Reinoid/CIS retinoic acid", "start": "379", "end": "471", "duration": 92, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "06-BG", "start": "502", "end": "532", "duration": 30, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "CAI (NABTT 97212)", "start": "14", "end": "259", "duration": 245, "dosis": "250", "dosis_unit": "mg/day"}, {"type": "Chemotherapy", "name": "06-BG (NABTT 0803)", "start": "280", "end": "285", "duration": 5, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Vatalanib (PTK787)", "start": "471", "end": "502", "duration": 31, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "21", "end": "65", "duration": 44, "dosis": "6000", "dosis_unit": "cGy"}]}, {"uuid": "cf70808b-ee42-4745-8ae7-9fa6315fcaab", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "790", "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": "", "days_to_last_followup": "790", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 21, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "148", "end": "183", "duration": 35, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "CPT-11", "start": "329", "end": "378", "duration": 49, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Targeted Molecular therapy", "name": "MAB I131", "start": "43", "end": "77", "duration": 34, "dosis": null, "dosis_unit": "mCi"}, {"type": "Chemotherapy", "name": "CPT-11", "start": "407", "end": "448", "duration": 41, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "CCNU", "start": "578", "end": "601", "duration": 23, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "CCNU", "start": "211", "end": "288", "duration": 77, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "448", "end": "516", "duration": 68, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Immunotherapy", "name": "Celebrex", "start": "722", "end": "770", "duration": 48, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Immunotherapy", "name": "Celebrex", "start": "327", "end": "378", "duration": 51, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Immunotherapy", "name": "Celebrex", "start": "407", "end": "448", "duration": 41, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Hormone Therapy", "name": "Tamoxifen", "start": "516", "end": "576", "duration": 60, "dosis": null, "dosis_unit": "mg"}, {"type": "Immunotherapy", "name": "Celebrex", "start": "516", "end": "576", "duration": 60, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Hormone Therapy", "name": "Tamoxifen", "start": "578", "end": "601", "duration": 23, "dosis": null, "dosis_unit": "mg"}, {"type": "Immunotherapy", "name": "Celebrex", "start": "448", "end": "516", "duration": 68, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Targeted Molecular therapy", "name": "ch81c6", "start": "43", "end": "77", "duration": 34, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "CCNU", "start": "516", "end": "576", "duration": 60, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Immunotherapy", "name": "Celebrex", "start": "578", "end": "601", "duration": 23, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Immunotherapy", "name": "Celebrex", "start": "601", "end": "722", "duration": 121, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "183", "end": "203", "duration": 20, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Hormone Therapy", "name": "Tamoxifen", "start": "448", "end": "516", "duration": 68, "dosis": null, "dosis_unit": "mg"}, {"type": "Hormone Therapy", "name": "Tamoxifen", "start": "601", "end": "722", "duration": 121, "dosis": null, "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "77", "end": "122", "duration": 45, "dosis": "5940", "dosis_unit": "cGy"}]}, {"uuid": "3387da02-4092-420b-b837-745dc62eba04", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "66", "days_to_last_known_alive": "", "days_to_last_followup": "77", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Temodar", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temodar", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 2, "radiation_details": [{"type": null, "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": null, "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}]}, {"uuid": "1e1b12bb-811b-4ee4-a62b-6b7a7333866f", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "59", "days_to_last_known_alive": "", "days_to_last_followup": "207", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 7, "drug_details": [{"type": "Chemotherapy", "name": "Avastin", "start": "193", "end": null, "duration": "", "dosis": "10", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "90", "end": "151", "duration": 61, "dosis": "200", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Temodar", "start": "16", "end": "63", "duration": 47, "dosis": "75", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "XL 184", "start": "123", "end": "151", "duration": 28, "dosis": "75", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Bevacizumab", "start": "193", "end": "406", "duration": 213, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Carboplatin", "start": "319", "end": "350", "duration": 31, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temozolomide", "start": "363", "end": "455", "duration": 92, "dosis": null, "dosis_unit": null}], "qty_radiation": 4, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "16", "end": "63", "duration": 47, "dosis": "60", "dosis_unit": "cGy"}, {"type": "OTHER", "start": "16", "end": "16", "duration": 0, "dosis": "20", "dosis_unit": "cGy"}, {"type": "OTHER", "start": "16", "end": "54", "duration": 38, "dosis": "20", "dosis_unit": "cGy"}, {"type": "OTHER", "start": "193", "end": "193", "duration": 0, "dosis": "20", "dosis_unit": "cGy"}]}, {"uuid": "440adfc1-ef69-4081-b983-581e382a8341", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "611", "age_at_initial_pathologic_diagnosis": "33", "days_to_last_known_alive": "", "days_to_last_followup": "611", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Cisplatin", "start": "16", "end": "315", "duration": 299, "dosis": null, "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Carmustine (BCNU)", "start": "16", "end": "315", "duration": 299, "dosis": "200", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "83", "end": "121", "duration": 38, "dosis": null, "dosis_unit": "cGy"}]}, {"uuid": "21d8bdab-cdbc-45bc-83b8-d163f38545b3", "tumor_tissue_site": "Brain", "pathologic_stage": "", "histological_type": "Untreated primary (de novo) GBM", "days_to_death": "148", "age_at_initial_pathologic_diagnosis": "70", "days_to_last_known_alive": "", "days_to_last_followup": "148", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Temozolomide", "start": "33", "end": "51", "duration": 18, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "33", "end": "51", "duration": 18, "dosis": null, "dosis_unit": null}]}]